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Attention Deficit Hyperactivity Disorder (ADHD) and Major Depressive 
Disorder (MDD) are among the most common mental disorders experienced in 
childhood and frequently co-occur. Although there appears to be an association 
between ADHD and MDD, previous studies have tended to involve clinical 
samples, used wide age ranges which reduces developmental precision, relied on 
screening measures of MDD which do not align with diagnostic criteria and have 
tended not to include control groups. Additionally, to date, research has focused 
on investigating the co-occurrence from a diagnostic level, i.e. the presence or 
absence of MDD in children with ADHD, with few studies examining their 
overlap using a symptom-based approach. Further, despite the significant 
functional impact of either disorder alone, research is yet to comprehensively 
investigate the association between depressive symptoms and functioning across 
time in young children with ADHD. 
Given the overlap in the symptoms of ADHD and MDD and the clinical 
significance of subthreshold depressive symptoms, a move towards utilising a 
symptom-based approach is important. This will assist with understanding the 
presentation and impact of depressive symptoms in children with ADHD, which 
will inform and improve screening, assessment and treatment processes in clinical 
practice.  
To facilitate a symptom-based approach to understanding the co-
occurrence of ADHD and MDD a measure that assesses for diagnostically 
relevant symptoms, such as a structured diagnostic interview, is required. To 
determine which diagnostic interview would be most useful, current structured 
diagnostic interviews of childhood internalising disorders including MDD need to 
be compared and contrasted.  
 
Aims 
In an attempt to address the above mentioned gaps within the literature the 
following studies were developed: (1) study one, a systematic review describing 
existing structured diagnostic interviews used to assess childhood internalising 
disorders and comparing and contrasting the evidence of their utility and 
psychometric quality, (2) study two, a cross-sectional study, investigating the 
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clinical presentation of depressive symptoms in young children with ADHD 
compared to non-ADHD controls and (3) study three, a longitudinal study, 
investigating the persistence and presentation of depressive symptoms across 
three years and its association with functioning in children with ADHD and non-
ADHD controls. Study two and three used data from the Children’s Attention 
Project, the first community-based Australian longitudinal cohort study of 
primary school aged children with confirmed ADHD and non-ADHD controls 




Eleven structured diagnostic interviews were included in the systematic 
review. Following determination of which structured diagnostic interviews to 
include, several electronic databases from inception through September 2015 
were searched in an attempt to identify all articles that reviewed the chosen 
structured diagnostic interviews. This generated 1174 articles, of which, 86 
articles were retained for data extraction and synthesis.  
 
Study Two and Three.  
Children were recruited into the Children’s Attention Project in their 
second year of school (Grade 1) from 43 schools in Melbourne, Australia. 
Baseline data (ADHD group mean age: 7.31 ± 0.47; non-ADHD control group 
mean age: 7.34 ± 0.39) were used for study two. Baseline and 3 year follow-up 
data (ADHD group mean age: 10.49 ± 0.57; non-ADHD control group mean age: 
10.49 ± 0.47) were used for study three. At both time points primary caregivers 
completed the Diagnostic Interview Schedule for Children IV to assess for the 
presence of ADHD, depressive symptoms and other comorbid disorders. For 
study three, functioning was measured at both time points and included measures 
of quality of life (the Pediatric Quality of Life Inventory completed by the 
primary caregiver) and social, behavioural and academic functioning (Strengths 
and Difficulties Questionnaire completed by the primary caregiver and child’s 
teacher, and the Social Skills Improvement System completed by the child’s 
teacher).  
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Within study two a factor analysis alongside invariance testing was 
utilised to determine whether comparisons across groups with regards to 
depressive symptoms was possible. Unadjusted linear and logistic regressions, chi 
square analyses and t-tests were used in study two and three to examine 
continuous and categorical variables respectively. Analyses involving a group by 
interaction term were used within study three to determine whether or not the 




Study One.  
There are a number of diagnostic interviews available for assessing 
childhood internalising disorders. The diagnostic interviews identified were found 
to be relatively time-consuming, required training and tended to be limited to the 
assessment of children over 6 years of age. Due to the heterogeneity across 
interviews and studies, direct comparisons between diagnostic interviews was 
difficult and the psychometric data under established.  
Nevertheless, the data obtained suggests that diagnostic interviews of 
childhood internalising disorders possess ordinary to excellent inter-rater 
reliability, ordinary test-retest reliability and fair to moderate validity. The DISC 
was the most widely used and researched diagnostic interview for children and 
offered a number of advantages over the others including its alignment with both 
classification systems, its inter-rater reliability and applicability cross culturally.  
 
Study Two.  
The factor structure of depressive symptoms was similar, with one factor 
found to underlie depressive symptoms in both groups. This meant comparisons 
between the two groups were possible.  
Children with ADHD experienced significantly more depressive 
symptoms (5.6 ± 0.27) than non-ADHD controls [2.03 ±0.17, t(389) = -11.69, p < 
.001, Cohen’s d = 1.19]. Depressive symptoms of sadness (32% versus 14%, p < 
.001), irritability (52% versus 19%, p < .001), insomnia (56% versus 22%, p < 
.001), psychomotor agitation (53% versus 9%, p < .001), feeling bad about 
oneself (50% versus 24%, p < .001) and difficulty concentrating (75.0% versus 
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14%, p < .001) and making decisions (56% versus 17%, p < .001) were elevated 
in children with ADHD relative to non-ADHD controls.  
 
Study Three.  
At age 10, the occurrence of depressive symptoms across the two groups 
continued to differ, with significantly more children within the ADHD group 
experiencing depressive symptoms (6  ± 0.35) and meeting criteria for MDD 
when compared to the non-ADHD control group [2.38 ± 0.22, t(264) = -8.7, p 
<0.001, Cohen’s d = 1.07; X2 (2, N = 266) = 25.21, p <0.001, Cohen’s d = 0.64]. 
Within the ADHD and non-ADHD control group, depressive symptoms at age 7 
were significantly associated with depressive symptoms at age 10 [ADHD 
Adjusted R² = 0.21, F(1, 126) = 34.49, p < .001; non-ADHD Adjusted R² = 0.24, 
F(1, 136) = 44.93, p < .001]. Depressive symptoms at age 7 were also associated 
with meeting criteria for MDD at age 10 in children with ADHD [Adjusted OR = 
1.36, 95% CI (1.18-1.56], p < .001]. In univariate analyses, depressed mood 
(criterion 1), sadness, irritability/grouchiness, anhedonia, loss of weight and 
appetite, increased hunger, insomnia, psychomotor agitation, blaming oneself and 
indecisiveness at age 7 were all associated with MDD at age 10 in children with 
ADHD.  
Depressive symptoms at age 7 in children with ADHD were significantly 
associated with poorer quality of life (Adjusted R2 = 0.22, β = 0.31, p = .001), 
peer and conduct problems as reported by caregivers (Adjusted R2 = 0.03, β = 
0.20, p = .02; Adjusted R2 = 0.06, β = 0.26, p = .003) and academic difficulties 
(Adjusted R2 = 0.03, β = -0.19, p = .04) at age 10. Results remained largely 
similar following adjustments for child sex, the presence of externalising 
comorbidities, use of medication, caregiver education level, caregiver relationship 
status and clinical levels of caregiver mental health difficulties. Depressive 
symptoms at age 7 in the non-ADHD control group were significantly associated 
with poorer quality of life at age 10 (Adjusted R2 = 0.04, β = -0.21, p = .03). 
Following adjustments, depressive symptoms at age 7 in the non-ADHD control 
group continued to be associated with poorer quality of life (Adjusted R2 = 0.07, β 
= -0.17, p = .02) whilst associations with peer problems (Adjusted R2 = 0.07, β = -
0.15, p = .01) and conduct problems at age 10 (Adjusted R2 = 0.16, β = 0.09, p = 
.01) became evident. Although functioning within the ADHD and non-ADHD 
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control groups was significantly different, with the ADHD group tending to have 
poorer functioning across all outcomes, there was no interaction effect. This 
suggests that the strength of the association between depressive symptoms and 
functioning was similar for children with ADHD and non-ADHD controls. 
 
Contribution 
This thesis contributes to an understanding of the available structured 
diagnostic interviews for assessment of childhood internalising disorders that can 
be utilised within research and practice. Study one indicated that the DISC offers 
a number of strengths which suggest it should be the diagnostic interview of 
choice. Study two confirmed that the measurement of MDD in children with and 
without ADHD is similar and that comparisons of depressive symptoms across 
these groups is possible. The findings have highlighted the importance of 
considering and assessing for depressive symptoms, not just MDD, in young 
children with ADHD. This thesis has documented the young age at which 
depressive symptoms present in children with ADHD as well as the early 
functional impact of depressive symptoms in children with and without ADHD. 
Finally, this thesis has made the assessment process easier by identifying the 
depressive symptoms that are key in the presentation and development of MDD in 
children with ADHD. All of which will inform early intervention and treatment. 
As findings are limited to a specific age group, further investigation into the 
presence, association and functional impact of comorbid ADHD and depressive 
symptoms in older children and adolescents represents the next step forward in 
the research on comorbid ADHD and MDD.  
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Prelude to the Introductory Chapters 
Before seeking to understand the co-occurrence of ADHD and MDD, it is 
important that the research on ADHD and MDD, individually, and then 
combined, is explored and understood. To facilitate this, the introductory chapters 
are structured as follows: 
1) Chapter one reviews the research on ADHD. 
2) Chapter two reviews the research on MDD. 
3) Chapter three reviews the research on comorbid ADHD and MDD.   
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1. Attention Deficit Hyperactivity Disorder in Childhood 
1.1 Chapter One Synopsis 
This chapter will summarise what is known about Attention Deficit 
Hyperactivity Disorder (ADHD) in children, broadly covering the prevalence, 
diagnosis and clinical features of ADHD. This chapter will also review the course 
and associated impairments, theoretical and aetiological explanations for its 
development as well as the current treatment options for ADHD in children.  
 
1.2 Prevalence of ADHD in Childhood 
1.2.1 Overall prevalence estimates. ADHD is the most common 
neurodevelopmental disorder experienced in childhood, affecting approximately 
7% of Australian children and 3 to 9% of children worldwide (Graetz, Sawyer, 
Hazell, Arney, & Baghurst, 2001; Lawrence et al., 2015; Polanczyk, de Lima, 
Horta, Biederman, & Rohde, 2007; Polanczyk et al., 2014). Despite these pooled 
worldwide prevalence rates, across studies, the prevalence estimates of ADHD in 
children varies between 1 and 20% (Bener, Al Qahtani, & Abdelaal, 2006; 
Cantwell et al., 1997; Cardo, Servera, & Llobera, 2006; Cornejo et al., 2004; de la 
Barra, Vicente, Saldivia, & Melipillan, 2013; Montiel, Peña, Montiel-Barbero, & 
Polanczyk, 2008; Skounti, Philalithis, & Galanakis, 2007; Skounti, Philalithis, 
Mpitzaraki, Vamvoukas, & Galanakis, 2006; Polanczyk et al., 2007; Polanczyk et 
al., 2014; Wolraich et al., 2012). 
1.2.2 Explanations for the large variation in prevalence estimates. 
Whilst the reason for the highly variable prevalence estimates remains largely 
unknown, researchers have suggested that it is likely due to the use of varied 
methodologies across studies (Faraone, Sergeant, Gillberg, & Biederman, 2003; 
Swanson et al., 1998; Timimi, 2005). Providing support for the impact of varying 
methodologies is a study which found that worldwide prevalence rates become 
similar, approximately 5%, when methodologies are adjusted and made 
comparable (Polanczyk & Rohde, 2007). Further support for the impact of 
methodological variation comes from a systematic review and meta-regression 
analysis of studies on the epidemiology of ADHD across the human lifespan 
(Polanczyk et al., 2014). This review indicated that heterogeneous results were 
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largely due to variations in the source of information, impairment criterion and 
classification systems/diagnostic criteria used across studies.  
As mentioned above, the use of varied classification systems and 
diagnostic tools provides another explanation for the large discrepancy in 
prevalence estimates. Research has suggested that the use of the International 
Classification of Diseases (ICD) results in significantly lower prevalence 
estimates whilst the Diagnostic and Statistical Manual of Mental Disorders 
(DSM) results in significantly higher prevalence estimates (Polanczyk et al., 
2007; Polanczyk et al., 2014; Swanson et al., 1998). This is likely due to the more 
stringent criteria seen in the ICD (Döpfner et al., 2008). Specifically, the ICD 
defines ADHD as hyperkinetic disorder which is considered by many to be 
narrower and a more severe form of ADHD as it requires a full set of symptoms 
of inattention, hyperactivity and impulsivity, whereas the DSM recognises 
presentations (e.g., inattentive, hyperactive-impulsive and combined presentation) 
and thus does not require as many symptoms to be present for a diagnosis to be 
made (Döpfner et al., 2008; World Health Organization, 2015). Further, the ICD 
does not allow for a diagnosis if the individual experiences comorbid mood or 
anxiety disorders, pervasive developmental disorder or schizophrenia, whereas 
the DSM does (provided that symptoms are not explained by the comorbid 
disorder; Lee et al., 2008; Setyawan et al., 2018).  
Use of different versions of the ICD and DSM also accounts for the 
significant variability in prevalence estimates, with research suggesting that the 
ICD-10 and the DSM-III-R result in significantly lower prevalence estimates than 
the DSM-IV (2% and 4% lower respectively; Polanczyk et al., 2014). More 
rigorous criteria such as that used in structured diagnostic interviews also result in 
lower prevalence estimates, whilst screening measures which tend not to utilise 
rigorous criteria result in higher prevalence estimates (American Psychiatric 
Association [APA], 2000, Baumgaertel et al., 1995; Canino et al., 2004; Wolraich 
et al., 1996). Finally, studies with an impairment criterion tend to report 
significantly lower prevalence estimates than those without a measure of 
impairment (Graetz et al., 2001; Polanczyk et al., 2014; Shaffer et al., 1996; 
Wolraich, Hannah, Baumgaertel, & Feurer, 1998; Wolraich, Hannah, Pinnock, 
Baumgaertel, & Brown, 1996).  
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Several studies have indicated that the choice of respondent also impacts 
prevalence estimates (Breton et al., 1999; Polanczyk et al., 2014; Stanger & 
Lewis, 1993). For example, research suggests that mean prevalence estimates for 
children aged 6 to 11 using children’s reports is approximately 3%, caregiver 
report 5% and teacher report 9% (Breton et al., 1999). Further impacting 
prevalence estimates is the number of respondents used. When one respondent is 
used, research suggests that higher rates of ADHD are typically reported (10%), 
whilst use of two respondents tends to result in lower prevalence estimates (2%; 
Gomez, Harvey, Quick, Scharer, & Harris, 1999).  
There have also been suggestions that the highly varied prevalence 
estimates may be due to the differences in the presentation and occurrence of 
ADHD across countries. This hypothesis comes from research indicating that in 
Europe and countries with similar socio-cultural settings prevalence rates are 
significantly lower than for America and other Western countries (Anderson, 
1996; Bird, 2002; Ford, Goodman, & Meltzer, 2003; Gau, Chong, Chen, & 
Cheng, 2005; Kashala, Tylleskar, Elgen, Kayembe, & Sommerfelt, 2005; Rhode 
et al., 1999; Steinhausen, Metzke, Meier, & Kannenberg, 1998; Timimi & Taylor, 
2004). Whilst there have been suggestions that this is largely due to the reliance 
on the ICD in European countries, differences in cultural expectations and 
perceptions of children’s behaviours is also said to account for this variation 
(Berry et al., 2002; Gau et al., 2005; Kashala et al., 2005). As non-western 
countries (i.e. European and similar socio-cultural countries) tend to value 
collectivism, researchers suggest that when symptoms of ADHD are expressed 
within these cultures they tend to be attributed to failures of the community rather 
than a disorder (Berry et al., 2002). Consequently, these cultures are less likely to 
seek professional input, less likely to undergo assessments, less likely to be 
diagnosed with ADHD and thus have lower prevalence rates (Berry et al., 2002; 
Gau et al., 2005; Kashala et al., 2005; O'Leary, Vivian, & Cornoldi, 1984). When 
they do seek input, research suggests that the interpretation and perception of 
symptoms and thus diagnosis, even with the use of standardised assessments, 
tends to be significantly impacted by the respondent’s culture (Mann et al., 1992).  
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1.2.3 Prevalence by sex. Research has found a higher prevalence of 
ADHD in males, with ADHD two to three times more common in males than 
females (APA, 2013; Bianchini et al., 2013; Biederman et al., 2002; Merikangas 
et al., 2010). Despite these findings, there have been suggestions that the 
differences in prevalence estimates between males and females may not be as 
large as once thought and may rather reflect the under-identification of ADHD in 
females (Gaub & Carlson, 1997b; Quinn, 2008). Specifically, it has been argued 
that ADHD in males is characterised by more overt, hyperactive and disruptive 
symptoms, whereas ADHD in females comprises mainly inattentive symptoms 
and less disruptive symptoms (Gaub & Carlson, 1997b; Gershon, 2002). These 
differences in the phenotypic expression of ADHD is likely to result in higher 
detection of males than females, resulting in more males being diagnosed and thus 
higher prevalence rates for males (Gaub & Carlson, 1997b).  
Contrasting this argument is research that has suggested that males and 
females with ADHD show more similarities than differences in the number and 
types of symptoms (Brown, Madan-Swain, & Baldwin, 1991; Chandola, Robling, 
Peters, Melville-Thomas, & McGuffin, 1992; deHaas, 1986; Faraone, Biederman, 
Keenan, & Tsuang, 1991). These researchers suggest that the proposed 
phenotypic differences do not account for the male predominance and argue 
instead that the differences in prevalence estimates are valid (Brown et al., 1991; 
Chandola et al., 1992; deHaas, 1986; Faraone et al., 1991).  
Impeding on an adequate understanding of prevalence with regards to sex 
effects and ADHD in childhood is: the mixed findings, use of small sample sizes, 
limited scope of assessment, focus almost exclusively on males and the absence 
of sex-matched control groups in available studies (Biederman et al., 2002; Gaub 
& Carlson, 1997; Sharp et al., 1999). Nevertheless, there is consensus that by 
adulthood the sex distribution and prevalence tends to be more balanced 
(Biederman, Faraone, Monuteaux, Bober, & Cadogen, 2004).  
  
1.3 Diagnostic Criteria for ADHD 
See Table 1 for an outline of the specific diagnostic criteria for ADHD 
according to the DSM-5.  
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Table 1.  
Diagnostic Criteria for ADHD, According to the DSM-5 (APA, 2013) 
Attention-Deficit/Hyperactivity Disorder (ADHD) 314.0X (F90.X) 
A. A persistent pattern of inattention and/or hyperactivity-impulsivity that 
interferes with functioning or development, as characterized by (1) and/or (2): 
1. Inattention: Six (or more) of the following symptoms have persisted 
for at least six months to a degree that is inconsistent with 
developmental level and that negatively impacts directly on social and 
academic/occupational activities. For those aged 17 and older at least 5 
symptoms are required. 
a. Often fails to give close attention to details or makes careless 
mistakes in schoolwork, at work, or during other activities (e.g., 
misses details, work is inaccurate).  
b. Often has difficulty sustaining attention in tasks or play 
activities (e.g., has difficulty remaining focused during school, 
conversations, or lengthy reading).  
c. Often does not seem to listen when spoken to directly (e.g., 
mind seems elsewhere, even in the absence of any obvious 
distraction). 
d. Often does not follow through on instructions and fails to finish 
schoolwork, chores, or duties in the workplace (e.g., starts tasks 
but quickly loses focus and is easily side-tracked). 
e. Often has difficulty organizing tasks and activities (e.g., 
difficulty managing sequential tasks; difficulty keeping 
materials and belongings in order; messy, disorganized work; 
has poor time management; fails to meet deadlines). 
f. Often avoids, dislikes, or is reluctant to engage in tasks that 
require sustained mental effort (e.g., schoolwork or homework 
for older adolescents and adults, preparing reports, completing 
forms, reviewing lengthy papers). 
g. Often loses things necessary for tasks or activities (e.g., school 
materials, pencils, books, tools, wallets, keys, paperwork, 
glasses, mobile telephones). 
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h. Is often easily distracted by extraneous stimuli (for older 
adolescents and adults, may include unrelated thoughts). 
i. Is often forgetful in daily activities (e.g., doing chores, running 
errands; for older adolescents and adults, returning calls, paying 
bills, keeping appointments). 
2. Hyperactivity and impulsivity: Six (or more) of the following 
symptoms have persisted for at least six months to a degree that is 
inconsistent with developmental level and that negatively impacts 
directly on social and academic/occupational activities. For those aged 
17 and older at least 5 symptoms are required. 
a. Often fidgets with or taps hands or feet or squirms in seat.  
b. Often leaves seat when remaining seated is expected (e.g., 
leaves his or her place in the classroom, in the office or other 
workplace, or in other situations that require remaining in place). 
c. Often runs about or climbs in situations where it is 
inappropriate. (Note: In adolescents or adults, may be limited to 
feeling restless).  
d. Often unable to play or engage in leisure activities quietly. 
e. Is often “on the go,” acting as if “driven by a motor” (e.g., is 
unable to be or uncomfortable being still for extended time, as in 
restaurants, meetings; may be experienced by others as being 
restless or difficult to keep up with).  
f. Often talks excessively.  
g. Often blurts out an answer before a question has been completed 
(e.g., completes people’s sentences; cannot wait for turn in 
conversation). 
h. Often has difficulty waiting his or her turn (e.g., while waiting in 
line).  
i. Often interrupts or intrudes on others (e.g., butts into 
conversations, games, or activities; may start using other 
people’s things without asking or receiving permission; for 
adolescents and adults, may intrude into or take over what others 
are doing). 
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Note: The symptoms are not solely a manifestation of oppositional behaviour, 
defiance, hostility, or failure to understand tasks or instructions.  
 
B. Several inattentive or hyperactive-impulsive symptoms were present prior to 
age 12 years. 
C. Several inattentive or hyperactive-impulsive symptoms are present in two or 
more settings (e.g., at home, school, or work; with friends or relatives; in other 
activities). 
D. There is clear evidence that the symptoms interfere with, or reduce the 
quality of, social, academic, or occupational functioning. 
E. The symptoms do not occur exclusively during the course of schizophrenia 
or another psychotic disorder and are not better explained by another mental 
disorder (e.g., mood disorder, anxiety disorder, dissociative disorder, 
personality disorder, substance intoxication or withdrawal). 
 
Specify whether:  
314.01 (F90.2) Combined Presentation: If both Criterion A1              
(inattention) and Criterion A2 (hyperactivity-impulsivity) are met for 
the past six months.  
314.00 (F90.0) Predominantly Inattentive Presentation: If Criterion 
A1 (inattention) is met but Criterion A2 (hyperactivity-impulsivity) is 
not met for the past six months.  
314.01 (F90.1) Predominantly Hyperactive/Impulsive Presentation: 
If Criterion A2 (hyperactivity-impulsivity) is met but Criterion A1 
(inattention) is not met over the past six months. 
 
Specify current severity:  
Mild: Few, if any, symptoms in excess of those required to make the 
diagnosis are present, and only minor functional impairments. 
Moderate: Symptoms or functional impairment between “mild” and 
“severe” are present.  
Severe: Many symptoms in excess of those required to make the 
diagnosis, or several symptoms that are particularly severe, are present, 
or the symptoms result in marked impairment in social or occupational 
functioning. 
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1.4 Diagnosis and Clinical Presentation of ADHD in Childhood 
As ADHD is a heterogeneous, neurodevelopmental disorder characterised 
by different presentations and degrees of severity based on the number and 
frequency of symptoms, there is no uniform presentation (Adler, 2004; APA, 
2013; Biederman, 2005; Wilens et al., 2004). The three presentations, as outlined 
in the DSM-5, are predominantly inattentive, predominantly hyperactive-
impulsive and combined presentation involving inattention, hyperactivity and 
impulsivity (APA, 2013). Allocation to a presentation depends on the number of 
symptoms endorsed within each symptom domain (Abed, 2014; Hardy, 
Warmbrodt, & DeBasio, 2004). A meta-analysis of 86 studies on children and 
adolescents with ADHD worldwide indicated that the predominantly inattentive 
presentation of ADHD was the most common in all samples, except pre-school 
aged children where the predominantly hyperactive-impulsive presentation 
occurred more frequently (Willcutt, 2012).  
Despite symptoms tending to arise in children as young as 3 years of age, 
diagnosis commonly occurs when children start formal schooling at the age of 5 
or 6 (Barkley, 2006). This occurs because the school setting commonly places 
higher expectations and restrictions on children and so there is more opportunity 
for symptoms to be detected and diagnosed (Barkley, 2006). Since children 
commonly display a number of the predefined ADHD symptoms as an element of 
regular maturation, diagnosis of ADHD requires a persistent and pervasive pattern 
of six or more symptoms of hyperactivity/impulsivity and/or six or more 
symptoms of inattention before the age of 12, lasting at least six months and 
occurring in at least two different environmental settings (APA, 2013). These 
symptoms need to impair functioning and be developmentally inappropriate, 
relatively stable and chronic (APA, 2013). 
The assessment and diagnosis of ADHD involves an interview with 
caregivers and children to assess the child’s development, symptoms, 
impairments and family history, in addition to behaviour rating scales and 
observational measures (Barkley, 1998; Taylor et al., 2004). This extensive 
assessment procedure is required as the diagnosis of ADHD is complicated by the 
overlap of symptoms and behaviours commonly seen in other conditions 
including childhood internalising disorders specifically MDD (British 
Psychological Society, 2000; Hill & Taylor, 2001; Thompson et al., 2004). 
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Despite the overlap of symptoms, ADHD is viewed as clinically distinct from 
other disorders, with consensus that ADHD is a stable and valid disorder 
(Biederman et al., 1996; Jiron, Sherrill, & Chiodo, 1995). 
 
1.5 Course and Associated Impairments of ADHD in Childhood 
Research has consistently demonstrated that children with ADHD have 
poorer social, behavioural and academic functioning when compared to peers 
without ADHD (Faraone, Biederman, Monuteaux, Doyle, & Seidman, 2001; 
Ohan & Johnston, 2007; Sciberras, Roos, & Efron, 2009). Children with ADHD 
are more likely to receive special education, experience academic 
underachievement, repeat a grade and have lower rates of high school and tertiary 
education completion (LeFever et al., 2001; Loe & Feldman, 2007). They are also 
reported to experience significant difficulties with sleep and they tend to have 
poorer quality of life than children without ADHD (Efron et al., 2014; Karande, 
2012; Sung, Hiscock, Sciberras, & Efron, 2008; Lycett, Mensah, Hiscock, & 
Sciberras 2014; Mrug et al., 2012; Nijmeijer et al., 2008; Wehmeier, Schacht, & 
Barkley, 2010).  
Research suggests that individuals with ADHD frequently experience 
impaired emotion regulation and mood instability (Braaten & Rosén, 1997; Scime 
& Norvilitis, 2006). Observational studies using frustration inducing tasks 
indicate that children with ADHD respond with heighted frustration and 
emotional reactions when compared to children without ADHD (Melnick & 
Hinshaw, 2000; Walcott & Landau, 2004; Wheeler, Maedgen, & Carlson, 2000). 
Additionally, reports from caregivers suggest that children with ADHD have 
greater difficulty in self-regulating negative emotions, display enhanced levels of 
guilt, sadness and anger and are more emotionally reactive to negative events than 
peers (Berlin, Bohlin, Nyberg, & Janols, 2004; Braaten & Rosén, 2000; Jensen & 
Rosen, 2004). 
ADHD is associated with more comorbidities than randomly expected 
(Kessler et al., 1994). Specifically, approximately 60 to 80% of children with 
ADHD meet diagnostic criteria for at least one other mental disorder (Barkley, 
2014; Efron & Sciberras, 2010; Elia, Ambrosini, & Berrettini, 2008; Simonoff et 
al., 2008). Disorders commonly associated with ADHD include oppositional 
defiant disorder (45 to 65%), mood disorders (7 to 50%), anxiety disorders (27 to 
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33%) and conduct disorders (14 to 23%; Biederman et al., 1996a, b; Frazier, 
Youngstrom, Glutting, & Watkins, 2007; Gadow, Devincent, Pomeroy, & 
Azizian, 2005; Ghanizadeh, Mohammadi, & Moini, 2008; Wilens et al., 2002). 
Children with ADHD also have high rates of language and speech problems (12 
to 40%), as well as learning disorders (30 to 70%; Elia, Ambrosini & Berrettini, 
2008; Becker, Luebbe, & Langberg, 2012; Larson, Russ, Kahn, & Halfon, 2007; 
Mayes, Calhoun, & Crowell, 2000; Sciberras, Mueller et al., 2014). 
Whilst symptoms are reported to decline with age, for approximately 50 to 
70% of cases symptoms and impairments associated with ADHD persist into 
adulthood (Barkley, Fischer, Smallish, & Fletcher, 2002; Weiss & Hechtman, 
1993; Wilens & Spencer, 2010). The strongest predictor of the persistence of 
ADHD symptoms into adulthood is said to be the severity of ADHD symptoms in 
childhood (Kessler et al., 2005). In addition to the impairments experienced in 
childhood, adults with ADHD tend to be at a higher risk of unstable relationships 
and divorce, antisocial behaviour, risky driving, lower socioeconomic status and 
poorer occupational performance (Adler, 2004; Faraone et al., 2000; Kessler et 
al., 2005; Mannuzza & Klein, 2000; Mannuzza, Klein, Abikoff, & Moulton Iii, 
2004; Secnik et al., 2005; Wilens et al., 2004; Wilens & Spencer, 2010).  
In conjunction with the widespread and enduring impact of ADHD on 
individuals, research indicates that family members tend to be greatly affected 
(Johnston & Mash, 2001). Research suggests that in comparison to caregivers of 
children without ADHD, caregivers of children with ADHD have higher rates of 
MDD and anxiety (Cussen, Sciberras, Ukoumunne, & Efron, 2012; Pressman et 
al., 2006; van Steijn, Oerlemans, van Ajen, Buitelaar, & Rommelse, 2014). 
Further, in comparison to caregivers of children without ADHD, caregivers of 
children with ADHD report greater disturbances in family and marital 
functioning, reduced parenting self-efficacy, increased caregiver stress and 
disrupted caregiver-child relationships (Harpin, 2005; Johnston & Mash, 2001). 
Additionally, siblings report that the disruption associated with ADHD leaves 
them feeling highly worried, anxious and sad (Kendall, 1999). Similarly, in 
comparison to siblings of children without any disorders, siblings of children with 
ADHD report increased familial conflict and less warmth and closeness as well as 
higher than average levels of internalising and externalising problems (Listug-
Lunde, Zevenbergen, & Petros, 2008; Mikami & Pfiffner, 2008). From the 
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research presented it is clear that the impact of ADHD is significant and far-
reaching.  
 
1.6 Theoretical Explanations of ADHD 
There are a number of theoretical explanations that have been proposed to 
account for the occurrence of ADHD. These include, but are not limited to, social 
construction theory, executive functioning deficit theory and motivational deficit 
theory. These will be summarised in the sections below. 
1.6.1 Social construction theory. The social construction theory of 
ADHD argues that a diagnosis of ADHD is a socially constructed explanation of 
behaviours that do not meet prescribed socially constructed norms (Block, 1977; 
Parens & Johnston, 2009). Social constructionists argue that, whilst symptoms of 
ADHD exist, they are a result of environmental causes or the child’s personality 
and are within the normal spectrum of behaviour, are not dysfunctional and thus 
ADHD is not a disorder (Timimi & Taylor, 2004). They suggest that medically 
defining children’s behaviour, in societies and environments where passivity and 
order are expected, means that those on the active spectrum are labelled as 
problems and receive a diagnosis which removes the blame from those causing 
the problem (Timimi & Radcliffe, 2005). Critics of the social construction theory 
argue that ADHD is a valid disorder as studies have consistently demonstrated 
significant neurological, psychological and social differences and impairments 
between those with ADHD and those without (Taylor, 1989; Timimi & Taylor, 
2004). However, social constructionists assert that researchers have not explained 
the specific reasons for these differences, and argue that these differences are 
instead a result of the medication prescribed for children with ADHD (Rutter, 
1983; Taylor, 1989; Reid et al., 1993; Koriath et al., 1985; Timini, 2002).  
1.6.2 Executive functioning deficit theory. A prominent 
neuropsychological theory suggests that symptoms of ADHD arise from a 
primary deficit in executive functions (Barkley, 1997; Willcutt, 2005). Executive 
functions are a set of processes that assist individuals with focusing attention, 
processing information and planning and executing behaviour in order to achieve  
the desired goal (Geurts et al., 2005). Executive functions are governed by many 
parts of the brain including the thalamus, basal ganglia and prefrontal cortex 
(Fuster, 1997; Middleton & Strick 2001, 2002; Pennington, 2002). Executive 
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functions include attentional control/flexibility, problem solving, planning, 
cognitive and behavioural inhibition and working memory (Barkley, 1997).  
Support for executive functioning deficit theory stems from several meta-
analytic reviews examining the neuropsychological correlates of ADHD which 
have found that children with ADHD, when compared to children without, 
experience specific weaknesses in a subset of executive functioning domains 
particularly working memory and behavioural inhibition (Barkley, 1997; 
Castellanos & Tannock, 2002; Fuster, 1997; Pennington & Ozonoff, 1996; 
Schachar et al., 2000; Stuss & Benson, 1986; Willcutt et al., 2005a,b). Further 
supporting the role executive functioning deficits plays in ADHD is the finding 
that deficits in attention, planning, behavioural inhibition and working memory 
remain significant even after controlling for age, language, general intelligence, 
reading ability and symptoms of other mental disorders (Willcutt et al., 2005a,b).  
Behavioural inhibition and working memory are the two executive 
functions that, to date, have been the focus of much of the research. Behavioural 
inhibition or response inhibition is considered to be an endophenotype of ADHD 
(biological marker that demonstrates heritability; Gottesman & Gould, 2003) and 
is associated with the severity of ADHD symptoms (Barkley, 1997; Nigg, 2001; 
Wodushek & Neumann, 2003). Researchers have suggested that behavioural 
inhibition deficits account for many symptoms of ADHD due to the inability to 
assess demands or possible outcomes, the inability to interrupt ongoing behaviour 
even when feedback suggests it is not appropriate and the inability to delay 
rewards (Barkley, 1997; Oosterlaan, Logan, & Sergeant, 1998). Like deficits in 
behavioural inhibition, widespread deficits in working memory have also been 
found in those with ADHD (Alderson, Rapport, Hudec, Sarver, & Kofler, 2010; 
Barnett et al., 2001; Schweitzer et al., 2000; Willcutt et al., 2005). Interestingly, 
deficits in phonological and visuospatial working memory appear to be specific to 
individuals with impulsive and combined presentations but not specific to 
individuals with inattentive presentations (Pasini et al., 2007).  
Despite consensus that ADHD is characterised, in many cases, by 
weaknesses in executive functioning, deficits in executive functioning, 
particularly behavioural inhibition and working memory deficits, have been 
documented in individuals without ADHD and likewise not all individuals with 
ADHD experience these deficits (Barkley, 1997; Geurts et al., 2005; Willcutt et 
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al., 2005). Additionally, at this point deficits in executive functioning are not 
necessary for a diagnosis of ADHD (APA, 2013; WHO, 2016). Consequently, 
further research into the specificity of executive functioning deficits is required.  
1.6.3 Motivational deficits theory.  Whilst ADHD is typically 
characterized as a disorder of inattention and hyperactivity/impulsivity, there is 
increasing evidence that motivational deficits play an important role in the 
presentation of ADHD (Pliszka, Hatch, Borcherding, & Rogeness, 1993; Volkow 
et al., 2011). Specifically, individuals with ADHD have consistently been found 
to experience persistent difficulties with motivation and performance (Johansen et 
al., 2009; Volkow et al., 2011). Research indicates that individuals with ADHD 
show atypical regulation of motivational states in that they respond to immediate, 
regular rewards whilst being less sensitive to delayed or intermittent rewards 
(Volkow et al., 2011). fMRI studies examining motivation and the responses of 
individuals with ADHD and those without, measured the activity of the dopamine 
neurons within the mesolimbic dopamine reward pathway (Plichta, 2009; Ströhle 
et al., 2008). They found that relative to individuals without ADHD, individuals 
with ADHD exhibited decreased dopamine activity within this circuit. 
Consequently, it was concluded that the dopamine activity within this circuit and 
thus motivation is significantly altered in individuals with ADHD (Olivier & 
Steenkamp, 2004). Further support for the importance of motivational 
deficits/dopamine comes from the success of methylphenidate, one of the most 
frequently used pharmacological interventions for ADHD (Engert & Pruessner, 
2008). Methylphenidate increases dopamine in the striatum and enables dopamine 
cells to fire more effectively (Engert & Pruessner, 2008). 
As can be seen, a number of theories have emerged in an effort to 
understand the development of ADHD. Whilst these theories are important in 
stimulating discussion and research in the field, to date, social construction 
theory, executive functioning deficits and motivational deficits are neither 
necessary nor sufficient in explaining all cases of ADHD and thus they remain 
purely theories (Chandler, 2010). The complexity of ADHD and the difficulties in 
finding a clear cut explanation for its development and continuation is also 
evident when examining the aetiology of ADHD.   
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1.7 Aetiology of ADHD 
Whilst the exact aetiology of ADHD is unknown, it is accepted that 
ADHD is a multifactorial disorder in which numerous genes, all with a small 
effect, interact with environmental risk factors (Franke, Neale, & Faraone, 2009). 
Brain imaging studies have indicated that, in comparison to children without 
ADHD, children with ADHD have a number of functional and structural brain 
abnormalities. These abnormalities are believed to underlie the symptoms of 
ADHD and occur throughout the brain but particularly within the prefrontal, 
fronto-striatal, fronto-cerebellar, fronto-parieto-temporal networks and parietal 
cortex (Rubia, Alegria, & Brinson, 2014a, b; Silk, Vance, Rinehart et al., 2005). 
Research has found that, when compared to children without ADHD, children 
with ADHD have delayed structural brain maturation, decreased cerebral 
volumes, reduced grey matter in the basal ganglia and right posterior cerebellum, 
abnormal grey matter overall and cortical thickness in the frontal, cerebellar and 
temporal regions (Krain & Castellanos, 2006; Rubia et al., 2014a, b). Although 
the exact impact of these biological changes/differences are unknown, it is 
believed that due to the high occurrence in individuals with ADHD, they play a 
role in the aetiology of ADHD.  
ADHD is highly heritable, with heritability approximately 76 to 80% 
(Coghill & Banaschewski, 2014; Faraone, Perlis, & Doyle, 2005; Franke, Neale, 
& Faraone, 2009; Freitag, Rohde, Lempp, & Romanos, 2010; Sharp, McQuillin & 
Gurling, 2009; Thapar, Cooper, Jefferies, & Stergiakouli, 2012; Thapar et al., 
2005; Waldman & Gizer, 2006). Supporting the heritability of ADHD is a study 
which found that rare chromosomal duplications and deletions are higher in 
children with ADHD than those without ADHD, though common in disorders 
such as autism and schizophrenia (Williams et al., 2010). The first approach to 
identifying genes related to ADHD was hypothesis-driven candidate gene 
association studies which investigated specific genes that were thought to be 
related to ADHD. These studies focused on the dopamine system and found that 
dopamine D4 and D5 receptor genes were associated with ADHD (Brookes et al., 
2006). Though far from conclusive, a newer approach, genome-wide linkage 
studies, involving a hypothesis free examination of all human genes in order to 
identify those that may be implicated in ADHD, are increasingly being 
undertaken and through stringent screening processes have found that the 
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following candidates SLC9A9, NOS1 and CNR1 occur more frequently in those 
with ADHD when compared to those without ADHD  and thus may be key in the 
development of ADHD (Brookes et al., 2006; de Silva et al., 2003; Franke et al., 
2009). 
A number of environmental factors have been found to be associated with 
ADHD (Banerjee, Middleton, & Faraone, 2007; Lahey, D’Onofrio, & Waldman, 
2009; Nigg, 2008; Rowe, & Rowe, 1994; Rutter, 2007; Thapar, Cooper, Eyre, & 
Langley, 2013; Thapar & Rutter, 2009). Prenatal and perinatal environmental risk 
factors include; maternal smoking, alcohol and substance misuse, maternal stress, 
low birth weight and prematurity (Thapar et al., 2011; Thapar et al., 2013). 
Environmental toxins such as organophosphate pesticides, polychlorinated 
biphenyls and lead have also been implicated in the development of ADHD 
(Nigg, 2008). Potential dietary risk factors for ADHD include; nutritional 
deficiencies such as zinc, magnesium and polyunsaturated fatty acids, nutritional 
surpluses such as artificial food colours, sugar and low and high GI foods (Thapar 
et al., 2011; Thapar et al., 2013). Psychosocial risk factors for the development of 
ADHD include; family adversity and low income, caregiver and child 
hostility/conflict and severe early deprivation (Cussen et al., 2012; Freitag et al., 
2012; Johnston & Mash, 2001; Modesto-Lowe, Danforth & Brooks, 2008).  
 
1.8 Treatment of ADHD in Childhood 
As ADHD is a chronic disorder, many individuals continue to experience 
difficulties even after treatment (Langberg & Becker, 2012; Molina et al., 2009; 
Shaw et al., 2012). Nevertheless, the empirical literature indicates that when 
seeking to improve symptoms and functioning in children with ADHD there are 
two main treatments that should be considered (American Academy of Pediatrics, 
2001; Pelham & Murphy, 1986; Pelham & Waschbusch, 1999). These are 
pharmacological and psychosocial interventions. 
Pharmacological interventions including methylphenidate, 
dexamphetamine and other amphetamine-based stimulants are the most frequently 
utilised intervention for managing symptoms of ADHD (Biederman, Spencer, & 
Wilens, 2004; Brue & Oakland, 2002; Feldman & Rieff, 2014; LeFever et al., 
2002). Pharmacological interventions are highly effective for the management of 
the core symptoms of ADHD and result in significant improvements (Boonstra, 
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Kooij, Oosterlaan, Sergeant, & Buitelaar, 2005; Chandler, 2011; Greenhill, 2001; 
Scheffler, et al., 2009; Solanto, Schachar, & Ickowicz, 2007). Approximately 
70% of children with ADHD respond when a single stimulant is tried and 
approximately 90% when a second stimulant is tried (Spencer et al., 2006). In 
relation to core symptoms of ADHD including inattention, hyperactivity, 
oppositional and defiant behaviour and impulsivity, according to both caregivers 
and teachers, improvements are quick and considerable (Barkley, 1998; Clark, 
Prior, & Kinsella, 2002; Clarke et al., 2005; Conners, 2002; Forte, 2006; Pelham 
et al., 2005; Pelham et al., 2000). Despite the benefits, a number of side effects 
including decreased appetite and insomnia occur in one in five children treated 
pharmacologically (Schachter et al., 2001). Discontinuation is common due to the 
side effects as opposed to the inefficacy of the medications (Schwartz & Correll, 
2014). The benefits of pharmacological interventions with regards to long term 
academic achievement, social skills and relationships have yet to be strongly 
demonstrated (Greenhill et al., 1999; Hoza et al., 2005; Whalen & Henker, 1991). 
If stimulants are ineffective or side-effects problematic, there is evidence 
for the use of non-stimulants, the most notable being atomoxetine (Pliszka, 2007; 
Schwartz & Correll, 2014; Wolraich et al., 2011). Atomoxetine when compared to 
placebos has consistently been found to be effective in reducing ADHD 
symptoms (Cheng, Chen, Ko, & Ng, 2007; Kratochvil, Milton, Vaughan, & 
Greenhill, 2008; Martenyi et al., 2010; Michelson et al., 2001a; Michelson, 
Faries, Wernicke, & Spencer, 2001b; Schwartz & Correll, 2014; Weiss et al., 
2005; Wilens et al., 2006). Atomoxetine does, however, take approximately three 
to four weeks to start taking effect (Chandler, 2011). Further, like stimulants, the 
effectiveness varies and research regarding its efficacy across the long term is 
under established (Chandler, 2011).  
Psychosocial interventions for ADHD can be divided into four categories; 
(1) direct contingency management (e.g., behavioural classroom interventions), 
(2) clinical behaviour therapy (e.g., behavioural parent training), (3) intensive 
packaged behavioural treatments (e.g., a combination of clinical behaviour 
therapy and direct contingency management) and (4) cognitive-behavioural 
treatments (e.g., verbal self-instructions, social skills training, problem-solving 
strategies and cognitive modeling; Pelham & Murphy, 1986; Pelham et al., 1998). 
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The research regarding the effectiveness of psychosocial interventions in 
reducing symptoms of ADHD and improving outcomes remains largely mixed. 
Some studies and meta-analytic reviews present clear and strong support for 
psychosocial interventions in improving sleep, increasing positive parenting and 
reducing ADHD symptoms and behavioural difficulties in children with ADHD 
(Daley et al., 2014; Daley & Thompson, 2007; DuPaul & Eckert, 1997; DuPaul & 
Weyandt, 2006; Fabiano et al., 2009; Northup et al., 1999; Pelham et al., 2000; 
Pelham & Waschbush, 1999; Sibley, Kuriyan, Evans, Waxmonsky, & Smith, 
2014). Whilst others suggest that the evidence regarding the efficacy and 
effectiveness of psychosocial interventions in treating symptoms of ADHD and 
addressing academic and social functioning, particularly across the long term, is 
equivocal (DuPaul & Weyandt, 2006; Evans, Owens, & Bunford, 2014; Pelham et 
al., 1998; Lonigan et al., 1998; Sonuga-Barke et al., 2013; Zwi et al., 2011). All 
research reviewed indicated a need for further evidence, particularly with regards 
to functional and long term outcomes.  
In addition to the above mentioned treatment options, a number of other 
treatments have been developed including but not limited to; neuro-feedback, 
dietary interventions and cognitive training. Neuro-feedback is a form of 
biofeedback linked to the electrical activity of the brain and works by increasing 
the excessively slow theta activity and decreasing excessively fast beta activity 
(Lubar, 1991; Lubar & Shouse, 1977; Lubar & Deering, 1981; Lubar & Lubar, 
1984). Whilst some research suggests that neuro-feedback training significantly 
reduces symptoms of ADHD (Arns et al., 2009; Arns et al., 2014; Micoulaud-
Franchi et al., 2014), others have found no significant effect (Cortese et al., 2016; 
Sonuga-Barke et al., 2013). Dietary interventions tend to reduce the intake of 
sugar, food dyes and/or preservatives as they are believed to increase hyperactive 
symptoms and/or decrease the intake of fatty acids which are essential for brain 
development and function (McCann et al., 2007; Schab & Trinh, 2004). Although 
a change in diet has been found to have positive effects on behaviour, there is 
currently insufficient evidence to suggest that dietary interventions improve the 
symptoms of ADHD (Ballard, Hall, & Kaufmann, 2010; Bloch & Qawasmi, 
2011; Conners, 1980; Hirayama, Hamazaki, & Terasawa, 2004; Nigg et al., 2012; 
Schab & Trinh, 2004; Wender, 1986). Nevertheless, if caregivers report a 
connection between dietary intake and their child’s behaviour the National 
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Institute for Health and Clinical Excellence guidelines (2018) recommend referral 
to a dietician to ensure expert exploration and guidance. Cognitive training 
involves targeting neuropsychological deficits that to mediate ADHD (e.g., 
attentional and inhibitory control and working memory) through controlled 
exposure to information processing tasks (Cortese et al., 2015). Despite having 
little evidence indicating efficacy in treating core symptoms of ADHD, some 
significant improvements in neuropsychological functioning particularly with 
regards to visual and verbal working memory have been found, suggesting 
cognitive training may be an effective adjunctive treatment (Cortese et al., 2015; 
Sonuga-Barke et al., 2013).  
Currently, treatment guidelines suggest treatment of ADHD should be 
multifaceted, with both pharmacological and evidence based psychosocial 
interventions (for example, direct contingency management, clinical behaviour 
therapy, intensive packaged behavioural treatments and cognitive-behavioural 
treatments) considered (American Academy of Child and Adolescent Psychiatry, 
2007; National Health and Medical Research Council, 2012). This is because 
studies have demonstrated that whilst the magnitude of superiority when 
comparing pharmacological interventions to multimodal approaches is small to 
moderate, multimodal approaches produce consistently greater gains than either 
alone, particularly with regards to improving core ADHD symptoms, behavioural 
difficulties, internalising symptoms and improving social skills and reading 
achievement (Conners et al., 2001; MTA Cooperative Group., 1999, 2004; 
Pfiffner et al., 2007;  Swanson et al., 2000). Further, multimodal approaches 
permit lower doses of pharmacological intervention which appears to increase 
compliance thereby improving outcomes (Klein, Abikoff, Hechtman, & Weiss, 
2004; Jensen, 1999; Wells et al., 2000). 
 
1.9 Conclusion 
In conclusion, ADHD is a complex disorder with many different 
presentations, consequences and treatment options. There is consensus that 
ADHD is the most common neurodevelopmental disorder in childhood and has 
three primary symptom clusters: inattention, hyperactivity and impulsivity. 
Currently there are two sets of criteria that can be used to classify ADHD; the 
DSM-5 and ICD-10. ADHD is two to three times more common in males than 
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females. ADHD has been found to significantly impact quality of life and social, 
behavioural and academic functioning. Several theoretical explanations have been 
put forth to explain ADHD, though it is widely accepted that the aetiology of 
ADHD is multifactorial, stemming from a combination of genetic, biological and 
environmental factors. As ADHD is a chronic disorder, treatments are aimed at 
symptom management and functional improvements. Evidence based treatments 
include pharmacological and psychosocial treatments.  
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2. Major Depressive Disorder in Childhood 
2.1 Chapter Two Synopsis 
This chapter will summarise what is known about Major Depressive 
Disorder (MDD) in children, broadly covering the prevalence, diagnosis and 
clinical features of MDD. This chapter will also review the course and associated 
impairments, theoretical and aetiological explanations for its development and the 
current treatment options for MDD in children.  
 
2.2 Prevalence of MDD in Childhood  
MDD is ranked by the World Health Organization (2001) as the fourth 
leading cause of disability worldwide (Murray & Lopez, 1996). Despite the 
widespread investigation of MDD in individuals aged 15 and over, little research 
focuses on the prevalence of MDD in childhood. As MDD in preschool and 
primary school is not inherently disruptive, and young children are less likely to 
spontaneously report their internalised distress, early onset depressive symptoms 
often go undetected and thus are under-diagnosed and treated (Egger & Angold, 
2006; Luby & Morgan, 1997; Luby et al., 2004; Luby et al., 2009). 
Nevertheless, research suggests that 2.6% of children worldwide and 1.2 
to 1.6% of Australian children meet criteria for MDD (Angold et al., 2005; 
Chrisman et al., 2006; Costello et al., 2006; Polanczyk et al., 2015). A national 
survey of mental health and wellbeing was conducted in the homes of 3,597 
Australian children aged 4 to 17 years in 1998 (Sawyer et al., 2000). In 1998, 
approximately 82,032 children and adolescents in Australia met diagnostic 
criteria for MDD. The overall prevalence of MDD for children aged 4 to 11 years 
was 1.4% for males and 1.3% for females in 1998. The second largest Australian 
child and adolescent survey of mental health and wellbeing was conducted in the 
homes of over 6,300 children and adolescents aged 4 to 17 years in 2014 
(Lawrence et al., 2015). In 2014, approximately 112,000 children and adolescents 
in Australia met diagnostic criteria for MDD. The overall prevalence of MDD for 
children aged 4 to 11 years was 1.2% for males and 1.6% for females in 2014. In 
families where children were living with both caregivers and where there were no 
step children the prevalence was 1.7%. Prevalence was higher in step families 
(4.7%) and in families with one caregiver (5.5%). There was no statistically 
significant difference in the prevalence of MDD with regards to caregiver 
ADHD AND MDD IN CHILDHOOD                                                           21 
 
Claire I Joseph Deakin University 210667098 
 
education. However, prevalence of MDD was highest in families with a 
household income of under $AU56,000 (3.8%) and lowest in families with an 
income of $AU130,000 or more (1.8%). Children in families where a sole 
caregiver was unemployed experienced significantly more MDD (6.9%) whereas 
families with two caregivers in employment experienced less (1.8%). Prevalence 
remained the same across greater capital cities and rural areas. The prevalence of 
MDD was higher in children from families with poorer levels of family 
functioning (7.7%) than those classified as “having very good” family functioning 
(2.1%). A recent study seeking to determine whether the prevalence rates of 
childhood disorders in Australian children and adolescents changed between 1998 
and 2014 found that children in 2014 were 1.5 times more likely to have MDD 
than children in 1998 even after adjusting for age, sex, family structure and family 
income (Sawyer, Reece, Sawyer, Johnson, & Lawrence, 2018). All papers 
reviewed determined prevalence through surveys/interviews which assessed for 
the presence of MDD criteria and did not present information about the child’s 
diagnostic status. Consequently, the prevalence rate of those with an actual 
diagnosis of MDD is not unknown. 
 
2.3 Diagnostic Criteria for MDD 
See Table 2 for an outline of the specific diagnostic criteria for MDD 
according to the DSM-5.  
 
Table 2.  
Diagnostic Criteria for MDD, According to the DSM-5 (APA, 2013) 
Major Depressive Disorder 296.xx (F32.x and F33.x) 
A. Five (or more) of the following symptoms have been present during the 
same 2-week period and represent a change from previous functioning; at least 
one of the symptoms is either (1) depressed mood or (2) loss of interest or 
pleasure. 
1. Depressed mood most of the day, nearly every day, as indicated by 
either subjective report (e.g., feels sad, empty, hopeless) or observation 
made by others (e.g., appears tearful). (Note: In children and 
adolescents, can be irritable mood.)  
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2. Markedly diminished interest or pleasure in all, or almost all, activities 
most of the day, nearly every day (as indicated by either subjective 
account or observation.)  
3. Significant weight loss when not dieting or weight gain (e.g., a change 
of more than 5% of body weight in a month) or decrease or increase in 
appetite nearly every day. (Note: In children, consider failure to make 
expected weight gain.)  
4. Insomnia or hypersomnia nearly every day.  
5. Psychomotor agitation or retardation nearly every day (observable by 
others, not merely subjective feelings of restlessness or being slowed 
down).  
6. Fatigue or loss of energy nearly every day.  
7. Feelings of worthlessness or excessive or inappropriate guilt (which 
may be delusional) nearly every day (not merely self-reproach or guilt 
about being sick).  
8. Diminished ability to think or concentrate, or indecisiveness, nearly 
every day (either by subjective account or as observed by others).  
9. Recurrent thoughts of death (not just fear of dying), recurrent suicidal 
ideation without a specific plan, or a suicide attempt or a specific plan 
for committing suicide 
 
B. The symptoms cause clinically significant distress or impairment in social, 
occupational, or other important areas of functioning.  
C. The episode is not attributable to the physiological effects of a substance or 
to another medical condition. 
D. The occurrence of the major depressive episode is not better explained by 
schizoaffective disorder, schizophrenia, schizophreniform disorder, delusional 
disorder, or other specified and unspecified schizophrenia spectrum and other 
psychotic disorders. 
E. There has never been a manic episode or a hypomanic episode. This 
exclusion does not apply if all of the manic-like or hypomanic-like episodes are 
substance induced or are attributable to the physiological effects of another 
medical condition. 
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Note: Do not include symptoms that are clearly attributable to another medical 
condition. 
Note: Criteria A-C represent a major depressive episode. 
Note: Responses to a significant loss (e.g., bereavement, financial ruin, losses 
from a natural disaster, a serious medical illness or disability) may include the 
feelings of intense sadness, rumination about the loss, insomnia, poor appetite, 
and weight loss noted in Criterion A, which may resemble a depressive 
episode. Although such symptoms may be understandable or considered 
appropriate to the loss, the presence of a major depressive episode in addition 
to the normal response to a significant loss should also be carefully considered. 
This decision inevitably requires the exercise of clinical judgment based on the 
individual’s history and the cultural norms for the expression of distress in the 
contest of loss. 
 
Specify:  
With anxious distress  
With mixed features  
With melancholic features  
With atypical features  
With mood-congruent psychotic features  
With mood-incongruent psychotic features  
With catatonia.  
With peripartum onset  
With seasonal pattern (recurrent episode only) 
 
The criteria for MDD is much the same across the ICD and DSM (APA, 
2013; World Health Organization, 2015). The primary difference is the DSM’s 
specific outline of time, duration and symptoms vs the ICD’s less stringent and 
specific criteria (APA, 2013; World Health Organization, 2015). Research 
indicates that this difference results in more diagnoses of MDD, particularly 
moderate MDD, when using the ICD, and less diagnoses of MDD when using the 
DSM (Saito et al., 2010).   
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2.4 Diagnosis and Clinical Presentation of MDD in Childhood 
The diagnosis of MDD requires either a distinct change of mood 
characterised by dysphoria (namely, the feeling of 
sadness/emptiness/tearfulness/irritability) or markedly diminished interest or 
pleasure (anhedonia) in most activities, most of the day for at least two weeks 
(APA, 2013). During this period, there needs to be a change from previous 
functioning in at least four of the following areas; cognition (inappropriate guilt 
and feelings of worthlessness, inability to concentrate or suicidal ideation), 
psychophysiological functions (sleep, sexual, weight or appetite disturbances) and 
psychomotor activity (clearly observable retardation or agitation, fatigue or loss 
of energy; APA, 2013; Fava & Kendler, 2000). These changes must cause 
significant impairment in functioning (social, occupational, educational) or 
distress and cannot be due to the physiological effects of a substance or another 
medical condition (APA, 2013). Due to the controversy related to diagnosing 
children and the developmental differences that exist, the phenomenology and 
diagnostic criteria of MDD across the lifespan continues to be debated (Birmaher 
et al., 2004; Chrisman et al., 2006; Fava & Kendler, 2000; Luby et al., 2002, 
2003b; Rohde et al., 2012).  
Nevertheless, similar to the clinical presentation in adulthood, behavioural 
patterns commonly seen in children with MDD include cognitive distortions (e.g., 
maladaptive attributional patterns), social withdrawal and poor social functioning, 
deterioration of academic performance and sleep and appetite disturbances 
(Asarnow & Bates, 1988; Garber & Hilsman, 1992; Garber, Weiss, & Shanley, 
1993; Gladstone & Kaslow, 1995; Gotlib, Lewinsohn, Seeley, Rohde, & Redner, 
et al., 1993; Hilsman & Garber, 1995; Iwadare et al., 2015; Luby et al., 2002; 
Marton, Churchard, & Kutcher, 1993a; Marton, Connolly, Kutcher, & 
Korenblum, 1993b; Marton & Kutcher, 1995; Turner Jr & Cole, 1994). Dissimilar 
to adults, however, is the manifestation of these symptoms, which, tends to be in 
the form of irritability, tiredness, behavioural problems or aggression, separation 
anxiety, school refusal and somatic complaints including headaches and stomach 
aches (APA, 2013; Birmaher et al., 2004; Kashani, Holcomb, & Orvaschel, 1986; 
Klein, Dougherty, & Olino, 2005; Kristensen, Oerbeck, Torgersen, Hansen, & 
Wyller, 2014; Luby et al., 2002; McCauley et al., 1993; Thombs, Roseman, & 
Kloda 2012).  
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The presence of shame in conjunction with pathological guilt (i.e., an 
overwhelmingly sense of guilt, over things others would consider minor, that 
impairs functioning; Poznanski, 1982) has been found to be highly specific to 
preschool and childhood MDD, differentiating MDD from other mental disorders 
in childhood (Axelson & Birmaher, 2001; Barrett, Zahn-Waxler, & Cole, 1993; 
Belden et al., 2015; Luby, Belden, Pautsch, Si, & Spitznagel, 2009a; Luby & 
Belden, 2012). Based on observational measures of children’s responses to 
stressful interactions and caregiver reports, children who manifest pathological 
guilt as expressed via self-depreciation (expressing the self-perception of being 
stupid or bad) before the age of 3, are approximately ten times more likely to be 
diagnosed with MDD by 5 years of age than same aged peers without 
pathological guilt (Luby et al., 2009a; Luby & Belden, 2012). Whilst further 
research is required in order to understand the presentation of MDD in childhood, 
these findings provide support for the importance of symptom-based 
investigation. 
Further support for the importance of research that utilises a symptom-
based approach stems from the tendency of young children to experience 
subthreshold depressive symptoms, a chronic course and a number impairments 
when depressive symptoms (even subclinical) are present (Fried & Nesse, 2015a).  
 
2.5 Course and Associated Impairments of MDD in Childhood   
MDD is a chronic, recurrent and disabling mental disorder (APA, 2013; 
Fava & Kendler, 2000; Soleimani, Lapidus, & Iosifescu, 2011) and is considered 
among the most burdensome mental disorders worldwide. Initially believed to be 
a disorder that only occurred in adolescence and adulthood, a growing body of 
literature has established that childhood MDD has a stable, specific and 
discriminant symptom constellation, with children as young as 3 years of age 
found to experience depressive symptoms (Chrisman, Egger, Compton, Curry, & 
Goldston, 2006; Kashani, Ray, & Carlson, 1984; Luby et al., 2002; Luby et al., 
2003a, b; Luby, Gaffrey, Tillman, April, & Belden, 2014; Luby, Si, Belden, 
Tandon, & Spitznagel, 2009b; Stalets & Luby, 2006).  
Like ADHD, MDD continues throughout the lifespan and, when compared 
to those without MDD, is more common in those who have experienced a 
previous episode, particularly if the episode occurs in childhood (Lewinsohn et 
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al., 1999; Zisook et al., 2007). Research suggests that the average duration of a 
depressive episode in childhood is approximately nine months and approximately 
70% of those who experience MDD in childhood go on to experience another 
depressive episode within five years of the initial depressive episode (Birmaher et 
al., 2002, 2004; Kovacs, Feinberg, Crouse-Novak, Paulauskas, Pollock, & 
Finkelstein, 1984; Kovacs, Obrosky, Gatsonis, & Richards, 1997; Rao et al., 
1995). Additionally, within 15 years of the first episode of MDD, approximately, 
5 to 10% of those with MDD in childhood or adolescence commit suicide 
(Weissman et al., 1999).  
The continuity of childhood MDD has also been highlighted in a 
longitudinal study by Luby and colleagues (2014) spanning approximately six 
years. Luby and colleagues found that preschool depression (i.e. subthreshold 
MDD) was a significant and robust predictor for MDD in childhood and early 
adolescence (N = 246, aged 6 to 13). The association between preschool 
depression and later MDD remained strong and undiminished even when other 
key familial and environmental risk factors such as maternal MDD, parenting and 
traumatic life events were accounted for. Overall, it was concluded that preschool 
MDD predicted future occurrence of MDD and other disorders. This is consistent 
with previous research indicating that children with MDD have a high likelihood 
of experiencing MDD again and are at an increased risk of developing other 
mental disorders later in life (Bittner et al., 2007; Brückl et al., 2007; Canals, 
Domènech-Llaberia, Fernández-Ballart, & Martí-Henneberg, 2002; Ferdinand & 
Verhulst, 1995; Keller et al., 1992; Kovacs, 1996b; Weissman et al., 1987, 1988; 
Woodward & Fergusson, 2001). Specifically, those who experience MDD in 
childhood and adolescence have been found to experience more anxiety disorders 
(39 to 80%) and externalising and psychiatric disorders (20 to 30%; Birmaher et 
al., 1996; Lewinsohn et al., 1999).  
In addition to the chronic and recurrent course, MDD is associated with a 
number of poor outcomes. Specifically, research has consistently demonstrated 
that MDD in childhood is associated with increased suicidal behaviour, 
impairments in social and familial interactions, substance abuse, physical illness, 
psychiatric and medical hospitalisations and early unplanned pregnancies (Angst, 
Angst, & Stassen, 1999; Briggs-Gowan, Horwitz, Schwab-Stone, Leventhal, & 
Leaf, 2000; Druss & Rosenheck, 1999; Fergusson & Woodward, 2002; Garrison 
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et al., 1990; Goldston et al., 1999; Haarasilta, Marttunen, Kaprio, & Aro, 2005; 
Harrington et al., 1990; Kovacs, Goldston, & Gatsonis, 1993; Lewinsohn, Holm-
Denoma, Small, Seeley, & Joiner, 2008; Lewinsohn, Rohde, Seeley, Klein, & 
Gotlib, 2000; Pfeffer et al., 1993; Shaffer et al., 1996). MDD is also associated 
with a number of substantial indirect (e.g., costs related to disability and medical-
related absenteeism) and direct costs (Greenberg et al., 2003; Luber et al., 2000; 
Simon et al., 2000; Simon, VonKorff, & Barlow, 1995; Sobocki, Jönsson, Angst, 
& Rehnberg, 2006). Children with MDD, when compared to peers without MDD, 
have been found to have higher morbidity and mortality (Herrman, Maj, & 
Sartorius, 2009; Lépine & Briley, 2011; Lynch & Clarke, 2006; Rhode et al., 
2013; Richards, 2011; Wulsin, Vaillant, & Wells, 1999). Individuals with MDD 
in comparison to those without any psychiatric disorders are also said to 
experience significantly poorer quality of life, poorer social, occupational, 
behavioural, academic and physical functioning (Saarijärvi, Salminen, Toikka, & 
Raitasalo, 2002; Spitzer et al., 1995).  
In conjunction with the widespread and enduring impact of MDD on 
individuals experiencing it, research indicates that family members tend to be 
impacted (Keitner & Miller, 1990). Specifically, research suggests that the mental 
health of caregivers of adolescents experiencing MDD is significantly worse than 
caregivers of adolescents without any disorders (Tamplin, Goodyer, & Herbet, 
1998). MDD in childhood is associated with a lack of emotional bonding and 
cohesiveness in the family (Asarnow et al., 1987; Kashani et al., 1995). Children 
with MDD report an increase in family discord, particularly with regards to 
difficulties in communication and problem solving (Keitner & Miller, 1990). 
These difficulties continue even after recovery (Keitner et al., 1987). Whilst 
MDD in childhood appears to increase family discord, family discord is also said 
to result in increased relapse rates, shorter periods in recurrence and suicidal 
behaviour (Tamplin et al., 1998).  
The significant impairments coupled with the incidence of relapse 
highlight the considerable impact of childhood MDD and emphasise the 
importance of further research designed to enhance early identification and 
treatment outcomes (Elmquist, Melton, Croarkin, & McClintock, 2010; Kovacs, 
1996a; Mash & Hunsley, 2005). 
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2.6 Theoretical Explanations of MDD 
As MDD was one of the first recognised mental illnesses, referred to as 
the ‘common cold of psychiatry’ due to its frequency within the population 
(Seligman, 1973), many theoretical explanations exist.  
2.6.1 Evolutionary theory. A prominent theoretical explanation of MDD  
stems from evolutionary psychology which suggests that depressive symptoms 
serve an adaptive function (Andrews & Thomson, 2009; Nesse, 2000). They 
propose that MDD is nature’s way of telling the individual that they have 
complex difficulties that require attention (Andrews & Thomson, 2009). 
Evolutionary psychologists have suggested that biasing cognitions enable 
individuals to avoid losses and conserve energy whilst motivating the individual 
to disengage from unobtainable goals (Engel & Schmale, 1972; Schmale & Engel, 
1975). They believe that all symptoms solicit resources and promote analytical 
thinking which assists in solving the difficulty without distraction (Gilbert, 2016; 
Watkins & Baracaia, 2001). For example, social isolation and the inability to 
derive pleasure assists with avoiding other situations that require thinking and act 
as a distraction, thereby allowing the individual to focus purely on survival 
(Gilbert, 2016).  
2.6.2 Behavioural theory. Behaviourists have suggested that MDD 
results from individuals’ interactions with their environment (Carvalho & Hopko, 
2011). Several behavioural theories have been developed. According to classical 
conditioning, MDD is learnt when an individual associates negative emotional 
states with certain stimuli (Seligman, 1975). Social learning theory suggests that 
MDD is learnt through the observation, imitation and reinforcement of depressive 
symptoms (Lewinsohn & Arconad, 1981). Finally, according to operant 
conditioning, MDD results from a reduction in positively reinforced ‘healthy 
behaviour’ and inadvertent reinforcement of depressive symptoms (Ferster, 1973; 
Lewinsohn, 1974; Martell, Addis, & Jacobson, 2001).  
2.6.3 Psychodynamic theory.  Psychodynamic theorists suggest that 
MDD is the result of unconscious, intrapsychic processes and early childhood  
losses (Taylor, 2009). They suggest that excessive neediness, ambivalence and 
dependence predisposes an individual to MDD (Taylor, 2009). MDD is then 
triggered when earlier difficulties and losses are continuously re-evoked and the 
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individual is unable to cope with these. MDD is also believed to be due to 
inwardly directed anger, severe super ego demands, excessive narcissistic 
deprivation (hypersensitivity to loss of social resources), oral or anal personality 
needs, loss of self-esteem and deprivation from mothers or loss of a caregiver in 
the first year of a child’s life (Bibring, 1953; Chodoff, 1972; Fenichel, 1968; 
Freud, 1917; Kleine, 1934). Freud (1901) suggested that MDD is a process of 
mourning one’s own deficiencies and then gradually integrating the less perfect 
self into the ego. The mourning process is said to result in the cardinal symptom 
of anhedonia by robbing the person of all pleasure and interest (Muscroft & Bowl, 
2000).  
2.6.4 Cognitive theory.  In contrast to the other theories, cognitive 
theories focus on an individual’s beliefs, with depressive symptoms said to be due 
to systematic negative biases in thought processes (Power, 1987). Through his 
research Beck (1976) found that individuals with MDD appraised events 
negatively and consequently suggested that three mechanisms, through their 
interaction and interference with cognitive processing, were responsible for 
MDD. These three mechanisms (the cognitive triad of oneself, the world and the 
future), negative schemas and faulty information processing are said to become 
automatic in individuals with MDD and thus serve to perpetuate symptoms. A 
further cognitive theory is that of learned helplessness, whereby when an 
individual learns that their attempts to escape negative situations are unsuccessful, 
they become passive and helpless and give up trying to escape, even if possible 
(Abramson et al., 1978). Learned helplessness theorists contend that this 
experience of a lack of control seems to precipitate and perpetuate MDD. 
 
2.7 Aetiology of MDD 
Like ADHD, the aetiology of MDD remains unclear. However, research 
indicates that MDD is multifactorial, stemming from a combination of genetic, 
biological and psychosocial/environmental factors (Berridge & Robinson, 1998, 
2003; Chau, Roth, & Green, 2004; Dichter, 2010; Drevets, 2001; Epstein et al., 
2006; Forbes et al., 2009; Kendler et al., 2002; Kringelbach & Berridge, 2010; 
Merikangas & Swendsen, 1997; Nestler et al., 2002; Tye & Janak, 2007; Wacker, 
Dillon, & Pizzagalli, 2009; Waelti, Dickinson, & Schultz, 2001).  
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Biological explanations suggest MDD results from genetic 
predispositions, chemical deficiencies and overloads within neuro-receptors 
(Muscroft & Bowl, 2000). In the biological model, causes of MDD are said to be 
due to a malfunction of neurotransmission or brain circuitry related to mood, 
pleasure, reward and executive function (Muscroft & Bowl, 2000). Support for 
this comes from research which indicates that MDD is associated with deficits in 
the neural circuitry of reward, mesocorticolimbic dopamine functioning, 
dopamine interaction with glutamate, reduced activity in ventral striatal brain 
regions, prefrontal cortex and nucleus acumens (Berridge & Robinson, 1998, 
2003; Chau, Roth, & Green, 2004; Drevets, 2001; Epstein et al., 2006; Forbes et 
al., 2009; Kringelbach & Berridge, 2010; Tye & Janak, 2007; Wacker, Dillon, & 
Pizzagalli, 2009; Waelti, Dickinson, & Schultz, 2001). 
The hippocampus forms part of the limbic system and is highly involved 
with emotions, memory and motivation (Eichenbaum et al., 2016). The size of the 
hippocampus is hypothesised to be related to its functioning (Tse et al., 2014). 
This is of interest as across a number of studies, individuals with MDD have been 
found to have 9 to 13% smaller hippocampal volumes than those without MDD 
(Bremner et al., 2000; Frodl et al., 2002; Lyons et al., 2001; Sapolsky, 2000; 
Sheline, Sanghavi, Mintun, & Gado, 1999; Sullivan, Pfefferbaum, Swan, & 
Carmelli, 2001). Whilst there were arguments that this was due to the experiences 
of MDD rather than a cause, a study of individuals experiencing their first episode 
of MDD contradicts this theory. In this study, it was found that smaller 
hippocampus volumes were a risk factor rather than a consequence of MDD 
(Frodl et al., 2002). In addition to being a risk factor in the development of MDD, 
smaller hippocampal volumes have been found to be associated with greater 
recurrence and duration of MDD (Sheline et al., 1999). Whilst hippocampal size 
is largely genetically determined, excessive glucocorticoid activity early in life 
has been implicated in the atrophy that occurs within the hippocampus (Sheline et 
al., 1999; Sullivan et al., 2001). Support for this comes from research into the 
impact of antidepressants which spur the growth of nerve cells specifically in the 
hippocampus whilst reducing glucocorticoid activity (Tsai et al., 2003). Overall, 
glucocorticoid and hippocampal functioning are believed to play a large role in 
the aetiology of MDD.   
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It has also been suggested that temperament is an early risk 
factor/vulnerability for childhood MDD. Specifically, research indicates that 
temperamental dispositions towards stress reactivity, impulsivity and avoidance 
are stronger predictors of depressive symptoms than exposure to early life stress 
(Lewis & Olsson, 2011; Silvia, 1990). Support for this stems from the Lewis and 
Olsson (2011) study which indicated that temperament at two years of age, 
independently and uniquely, predicted depressive symptoms in children aged 4 
and 5 years old. Consequently, genetics via the expression of temperament is said 
to be an important aetiological factor in the development of MDD.  
Further highlighting the importance of genetics are studies comparing 
concordance rates for MDD between dizygotic and monozygotic twins. They 
suggest that heritability of MDD is approximately 30 to 40% (Heim & Binder, 
2012; Kendler, Gardner, & Prescott, 1999). This rate increases to 45 to 60% in 
early-onset, severe and recurrent MDD (Heim & Binder, 2012; Kendler et al., 
1999).  
Although certain chromosomal regions/polymorphisms have been 
identified, to date, researchers have been unable to consistently replicate findings 
(Holmans et al., 2007; Kendler, Gatz, Gardner, & Pedersen, 2006; Lasky-Su et 
al., 2005; Levison, 2006; Wray et al., 2010). Nevertheless, one polymorphism that 
is highly associated with the expression of MDD is the short allele of the 
serotonin transporter gene (5-HTTLPR; Caspi et al., 2003; Heils et al., 1996; 
Lasky-Su et al., 2005; Lesch et al., 1996; Levison, 2006; Willeit & Praschak-
Rieder, 2010). Interestingly, research indicates that the occurrence of MDD 
increased when individuals with the short 5-HTTLPR allele were exposed to 
stressful life events or childhood maltreatment (Caspi et al., 2003; Fortier et al., 
2010; Uher, 2008; Uher & McGuffin, 2008). When exposed to positive 
environments the risk decreased and was similar to that of individuals with the 
long allele of the 5-HTTLPR (Belsky et al., 2009; Homberg & Lesch, 2010; 
Kaufman et al., 2006; Wilhelm et al., 2006). Consequently, 5-HTTLPR is 
believed to reflect a general genetic sensitivity that is malleable to environmental 
factors.  
Environmental factors strongly associated with the development of MDD 
include; maltreatment, parental loss, adverse caregiver-child interactions, 
socioeconomic disadvantage, early deprivation and difficulties with handling 
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important life changes (Agid et al., 1999; Dichter, 2010; Kendler et al., 2000; 
Lizardi et al., 1995; Muscroft & Bowl, 2000). Whilst research indicates that 
stressful life events are among the strongest predictors of MDD, this appears to be 
moderated by pre-existing genetic vulnerabilities and the neurodevelopmental 
stage of the brain at the time of exposure (Brown, Craig, & Harris, 2008; 
Constantino et al., 2002; Kagan, Snidman, Zentner, & Peterson, 1999; Karevold 
et al., 2009; Karg et al., 2011; Lenroot & Giedd, 2011). Specifically, stress or 
trauma before the age of 12 has been found to be associated with significantly 
higher MDD than that occurring after 12 years of age (Agid et al., 1999; 
Carpenter et al., 2004; Carpenter et al., 2009; Heim et al., 2008; Maercker et al., 
2004; Rogeness & McClure, 1996; Tottenham et al., 2010).  
Further elucidating the genetic and environmental link in the development 
of MDD are studies investigating epigenetics in both humans and animals. These 
suggest that early environmental factors, both antenatal and postnatal, leave long 
term epigenetic marks in the genome which alters genes and brain structure and 
function and subsequently influences neurobiological substrates into adulthood 
(Kaffman & Meaney, 2007; Lupien et al., 2009; McGowan et al., 2009; 
McGowan et al., 2011; Murgatroyd et al., 2009; Plotsky et al., 2001; Szyf, 2009; 
Weaver et al., 2004). A seminal study in 2008 provided the first evidence for 
early life adversity inducing differential effects on brain development. This study 
investigated regional brain volumes of 26 women aged 18-22 years and found that 
those who experienced sexual abuse at ages 3-5 and 11-13 years had reduced 
hippocampal volume, whereas those who experienced sexual abuse at ages 14-16 
years had attenuated frontal cortex volume (Andersen et al., 2008). Other 
structural changes that have been found in individuals with MDD and early 
maltreatment that may underlie the development of MDD included reduced 
medial prefrontal cortical volume and orbital-frontal cortical volume and 
increased amygdala volume (Pollak et al., 2010; Tottenham et al., 2010; van 
Harmelen et al., 2010). Other studies have found that individuals who have 
experienced early life stress or abuse have increased neuroendocrine and 
autonomic responses, increased levels of inflammation, central corticotrophin-
releasing hormone activity, glucocorticoid resistance and decreased neuropeptide 
and oxytocin (Carpenter et al., 2004; Danese et al., 2008; Danese et al., 2011; 
Heim et al., 2001; Heim et al., 2008; Heim et al., 2009a; Heim et al., 2009b). 
ADHD AND MDD IN CHILDHOOD                                                           33 
 
Claire I Joseph Deakin University 210667098 
 
Consequently, negative environments are said to have a profound impact on the 
biology of individuals and the development of MDD.  
 
2.8 Treatment of MDD in Childhood 
Despite established research regarding the effectiveness of treatment for 
MDD in adults, there is less evidence supporting the long term efficacy of 
treatments for MDD in children (Barlow et al., 2004; Barret, Farrell, Ollendick, & 
Dadds, 2006; Beidel & Turner, 2005; Brent et al., 1997; Lener & Iosifescu, 2015). 
Despite this, the American Psychological Association (APA) and the American 
Academy of Child and Adolescent Psychiatry recommend that psychotherapy 
should always be incorporated in the treatment of childhood MDD and should 
continue for at least six months following remission (APA, 2011; Cincinnati 
Children’s Hospital Medical Center, 2010).  
Hundreds of studies have been undertaken in an attempt to determine the 
effectiveness of various psychotherapies in the treatment of childhood MDD. 
Despite this, little clarity regarding best-practice evidence based treatment exists. 
In an attempt to understand the current literature base, a number of meta-analysis 
have been conducted, though, findings vary. For example; one meta-analyses of 
35 studies (N = 2095) investigating the impact of psychological treatment on 
MDD in children and adolescents aged 19 and under found modest effect sizes 
(0.36-0.42) for various psychotherapies including CBT, attachment-based family 
treatment, interpersonal therapy and systemic behavioural family therapy when 
compared to untreated, waitlist, minimally treated, or active placebo control 
groups (Weisz, McCarty, & Valeri, 2006). A later meta-analysis of 27 studies (N 
= 1744) seeking to examine the clinical benefits of psychotherapies in comparison 
with no treatment, waiting list controls, attention placebos and treatment as usual 
in youths aged 12 to 18 with MDD found psychotherapies were significantly 
superior to waitlists post-treatment but not at follow-up (Watanabe, Hunot, 
Omori, Churchilld, & Furukawa, 2007).  
The discrepancy across research is largely accounted for by the 
heterogeneity within key methodological characteristics (for example, the broad 
range of control conditions and psychotherapies, the large age range and the 
population choice; Spielmans & Fluckiger, 2018; Zhou et al., 2015). To overcome 
the discrepancy in findings a network meta-analysis, a methodological approach 
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that facilitates simultaneous comparisons of multiple psychotherapies within a 
single analysis while preserving randomisation, was conducted in order to 
determine the efficacy of current psychotherapies in the treatment of MDD in 
3,805 youths aged 7 to 18 years (Zhou et al., 2015). Analyses were undertaken on 
52 randomised controlled trials which investigated interpersonal, supportive, 
cognitive behavioural, family, play, behavioural, problem solving and 
psychodynamic therapy in comparison to waitlist, no treatment, treatment as usual 
and psychological placebo. In contrast to the above findings, it found that only 
interpersonal therapy and cognitive behavioural therapy were significantly more 
beneficial than the other active psychotherapies and control conditions at post-
treatment and follow up (Zhou et al., 2015).  
Consequently, the two main psychotherapies currently utilised in the 
treatment of childhood MDD are CBT and interpersonal therapy. CBT typically 
involves behavioural activation as well as techniques to increase problem solving 
abilities, coping skills, improve communication and peer problems and address 
negative thinking patterns (David-Ferdon & Kaslow, 2008; Richardson & 
Katzenellenbogen, 2005; Weersing & Brent, 2006). Interpersonal therapy focuses 
mainly on assisting clients to adapt to changes in relationships and roles and 
assists with developing stable interpersonal relationships (David-Ferdon & 
Kaslow, 2008; Richardson & Katzenellenbogen, 2005). 
Whilst psychotherapy is the first line of treatment, in some cases, 
particularly if MDD does not remit, adjunctive use of pharmacological treatment 
is appropriate ((APA, 2011; Cincinnati Children’s Hospital Medical Center, 
2010). Like psychotherapy, little solid research regarding the effectiveness of 
pharmacological treatment in children with MDD exists. Nevertheless, a 
Cochrane review of 12 trials (N = 2,288) has indicated that, across three 
randomised control trials, fluoxetine is the only pharmacological treatment that 
has been effective in decreasing depressive symptoms in children and adolescents 
aged between 6 and 18 who possessed a primary diagnosis of MDD (Hetrick, 
Merry, McKenzie, Sindahl, & Proctor, 2007). Within this study participants using 
fluoxetine were significantly less likely to experience a relapse than those 
receiving a placebo. Consequently, currently, fluoxetine is believed to be the most 
appropriate pharmacological treatment available for children over the age of 12 
(Emslie et al., 2004). 
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2.9 Conclusion 
Research examining childhood MDD is rapidly increasing and there is 
now consensus that MDD does occur in childhood. Research suggests that 
approximately 2.6% of children worldwide and 1.2 to 1.6% of Australian children 
meet criteria for MDD. Whilst the core features of MDD are similar across the 
lifespan, irritable mood is an alternative to depressed mood for children and 
adolescents. In addition to irritability, pathological guilt, tiredness, behavioural 
problems or aggression, separation anxiety, school refusal and somatic complaints 
including headaches and stomach aches are symptoms found to be of significance 
in childhood MDD. Despite these findings, research continues to suggest that 
early onset depressive symptoms often go undetected. This is a concern when the 
duration of episodes, high recurrence and poor outcomes are considered. There 
are numerous theoretical explanations used to explain the onset and maintenance 
of MDD symptoms. Research indicates that the aetiology of MDD is 
multifactorial, though stems largely from a gene-environment interaction. 
Treatment for childhood MDD tends to encompass psychotherapies including 
CBT and interpersonal therapy. However, consistent research determining the 
effectiveness of these modalities in children is lacking. Overall, further research is 
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3. Attention Deficit Hyperactivity Disorder and Major Depressive 
Disorder in Childhood 
3.1 Chapter 3 Synopsis 
This chapter will summarise what is known about the co-occurrence of 
ADHD and MDD in children, covering the prevalence, diagnosis and clinical 
presentation, associated impairments, proposed explanations for the co-
occurrence and treatment options. The chapter will focus on current research gaps 
within this area, particularly with regards to the presentation of depressive 
symptoms and the association with functioning in children with ADHD. Finally, it 
will identify directions for future research.  
 
3.2 Prevalence of Comorbid ADHD and MDD in Childhood 
The assessment of comorbid ADHD and MDD is complicated by several 
factors including overlapping symptoms, methodological artefacts and use of 
varying samples (Angold et al., 1999; Biederman et al., 1998; Bird, Gould, & 
Staghezza, 1993; Butler, Arrendondo, & McCloskey, 1995; Daviss, 2008; Jensen, 
1999; Murphy & Tsuang, 1995). Consequently, the prevalence estimates of 
comorbid ADHD and MDD in childhood, across studies, is highly heterogeneous 
(Daviss, 2008).  
3.2.1 Cross-sectional prevalence estimates versus longitudinal 
prevalence estimates.  The heterogeneity in prevalence estimates is evident in 
cross-sectional and longitudinal studies which suggest that the prevalence of 
comorbid ADHD and MDD in children and adolescents ranges from 5 to 40% 
(Biederman, Newcorn, & Sprich, 1991; Biederman et al., 2008; Chen et al., 2013; 
Di Trani et al., 2014; Graetz et al., 2001; Jerrell et al., 2015; Klein et al., 2012; 
McIntyre et al., 2010; Yuce et al., 2013). Despite these heterogeneous findings, 
there is consensus that, in comparison to youth without ADHD, youth with 
ADHD experience elevated rates of MDD and display significantly higher levels 
of subclinical depressive symptoms (Meinzer et al., 2014; Ostander et al., 2006). 
Within a meta-analysis of 19 cross-sectional studies, 90% reported a positive 
correlation between ADHD and MDD with a medium effective size found 
(Meinzer et al., 2014). Within this same meta-analysis seven of the 12 
longitudinal studies, with follow up intervals ranging from one to 21 years, 
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indicated that, in comparison to those without ADHD, children and adolescents 
with ADHD were at a significantly higher prospective risk of MDD.  
Findings from a 13 year follow up of children with (n = 123) and without 
ADHD (n = 66) aged between 4 and 12 at baseline indicated that 26% of the 
ADHD group in comparison to only 4% of the control group met criteria for 
MDD (Fischer, Barkley, Smallish, & Fletcher, 2002). A 10 year follow up of 
males with (n = 112) and without ADHD (n = 105) aged between 6 and 18 at 
baseline found that at follow up 46% of males with ADHD in comparison to only 
7% of males without ADHD met criteria for MDD (Biederman et al., 2006). Both 
studies used rigorous diagnostic procedures involving screening measures and 
structured diagnostic interviews, the controls were matched on age and sex and 
both studies had similar follow up participation rates (Fischer; 93% for ADHD 
and 90% for control; Biederman; 80% for ADHD and 88% for control). Whilst 
these procedures and findings are similar, the higher rate of MDD in Biederman 
and colleague’s study (2007) versus Fischer and colleague’s study (2002) is likely 
due to the use of caregiver report as opposed to child report. Specifically, 
Biederman completed the diagnostic interview with children alone whereas 
Fischer utilised both caregiver and child report for 62% of the interviews and 
child report alone for 22% of the interviews. Despite the differences, both studies 
indicated that those with ADHD experience MDD at a substantially higher rate 
than those without ADHD, highlighting the need to investigate this comorbidity 
further.  
3.2.2 Community sample prevalence estimates versus clinical sample 
prevalence estimates.  To date, most studies have examined ADHD and MDD 
utilising clinical samples. Research indicates that MDD is higher in clinical 
samples as opposed to community samples (Brunsvold, Oepen, Federman, & 
Akins, 2008; Ghanizadeh, Mohammadi, & Moini, 2008; Pliszka, 1998; Spencer et 
al., 1999). Specifically, the estimates of MDD among individuals with ADHD in 
clinical samples is approximately 60%, while in community samples it is 
estimated to range between 13 to 27% (Furman, 2005; Kessler et al., 2005; 
Lawrence et al., 2015; Thakker & Adler, 2006). Due to the inherent nature of 
clinical samples experiencing symptoms that are severe enough to warrant 
professional input, higher prevalence estimates in clinical samples is expected. 
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Although the prevalence of ADHD and MDD is lower in community samples, it 
remains higher than the prevalence rates of MDD in children without ADHD 
(Lawrence et al., 2015). Additionally, both clinical and community-based 
research indicates that, independent of other comorbidities, MDD is one of the 
most common disorders to co-occur with ADHD (Blackman et al., 2005). Once 
again highlighting the importance of researching this comorbidity further.  
3.2.3 Sex differences in prevalence estimates.  Most studies suggest that 
females with ADHD experience higher rates of MDD than their male counterparts 
(Arcia & Conners, 1998; Brunsvold, Oepen, DeYound, & Klinteberg, 2008; Gaub 
& Carlson, 1997b; Ghada et al., 2012; Neuman et al., 2001; Rucklidge & 
Tannock, 2001; Turgay et al., 2005; Yang, Shang, & Gau, 2011; Yoshimasu et al., 
2012). For example, a study investigating 70 children (45 males and 25 females) 
aged 6 to 16 years with ADHD found that depressive symptoms were 
significantly more prevalent among female participants than male participants 
(64% versus 16% experienced one or more depressive symptoms; Hassan et al., 
2013). Similarly, significantly more females with ADHD met criteria for MDD 
than males with ADHD (52% versus 13%). The predominance of females 
experiencing MDD in ADHD within this study is consistent with MDD research 
which indicates that MDD occurs at a significantly higher rate in females than 
males (Lawrence et al., 2015). 
3.2.4 Differences in prevalence estimates across classification systems.  
Despite consensus regarding the presence of MDD in children with ADHD, as 
demonstrated, large variability in prevalence estimates exists. One explanation for 
the variation in prevalence estimates is the differences in the classification 
systems used across studies. As discussed, the ICD and DSM consist of varying 
diagnostic criteria with regards to ADHD and MDD (APA, 2013; World Health  
Organization, 2015). Specifically, the ICD-10 is said to be more stringent and 
thus studies that utilise this criterion tend to report lower prevalence estimates for 
both ADHD and MDD. Evidence for the impact of the discrepancy between the 
two diagnostic classification systems was demonstrated in a study of 2,452 
children aged 7 to 17 years. This study found that prevalence estimates for the 
diagnosis of ADHD was 1% using the ICD-10 compared to 5% using the DSM-
IV (Döpfner, 2008). Another study utilising both the ICD-10 and DSM-IV-TR to 
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diagnose 199 consecutively referred child psychiatric clients found that more 
children met criteria for ADHD, and MDD when utilising the DSM-IV-TR 
(Sørensen, Mors, & Thomsen, 2005). This research highlights the impact the 
choice of classification systems has on findings and the importance of using a 
measure that assess symptoms in accordance with both the ICD and DSM. 
Though not as widely investigated, the use of different revisions of these 
classification systems appears to impact the detection of cases. For example, 
within a meta-regression analysis study use of the DSM-III-TR produced lower 
rates of ADHD and MDD when compared to those utilising the DSM-IV 
(Polanczyk et al., 2014). Further, the use of screening measures as opposed to 
structured diagnostic interviews tends to result in much higher prevalence 
estimates due higher sensitivity and lower thresholds (Connor, 2002). Whilst 
screening measures play an important role in screening for symptoms, they tend 
not to assess for the presence of symptoms in accordance to diagnostic criteria. 
Further, screening measures focus solely on the presence or absence of symptoms 
whereas diagnostic interviews utilise an impairment threshold for diagnosis 
(Roberts, Lewinsohn, & Seeley, 1991). Consequently, screening measures are 
likely to overestimate the prevalence of ADHD and MDD and thus should not be 
used as diagnostic measures (Belfer, 2007; Bird et al., 1990; Birmaher et al., 1996). 
3.2.5 Differences in prevalence estimates due to large age ranges.   The 
inclusion of participants across a large age range is also likely to contribute to the 
variation in prevalence estimates. The impact of age on prevalence rates has been 
demonstrated in a number of studies which indicated that the prevalence rates 
decline for ADHD and increase for MDD as age advances (Brenton et al., 1999; 
Cohen et al., 1993; Gómez‐Beneyto et al., 1994; Nolan, Gadow, & Sprafkin, 
2001). For example, the prevalence of ADHD for children aged 3 to 12 years was 
18% compared to 9% in those aged 12 to 17 whereas the prevalence of MDD for 
children aged 4 to 11 years was 1% compared to 5% in those aged 12 to 17 
(Cohen et al., 1993; Lawrence et al., 2015; Nolan et al., 2001). Consequently, 
when studies use a large and varied age range, prevalence estimates are unlikely 
to reflect true prevalence rates for specific age groups and are likely to vary 
widely. As such, it is important for future research to focus on targeted age groups 
in order to obtain the most accurate prevalence estimate.   
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3.3 Aetiology of Comorbid ADHD and MDD 
It is unclear why children with ADHD are at an increased risk for MDD. 
Whilst several potential biological, genetic and environmental explanations have 
been offered, further investigation into the potential causes of comorbid ADHD 
and MDD is required. Nevertheless, what is known is presented below.  
3.3.1 Clinical characteristics.  Researchers have suggested that the 
pharmacotherapy used to treat ADHD may increase the risk for MDD given the 
known side effects such as dysphoric and labile moods (Bolanos et al., 2003; 
Carlezon et al., 2003; Wilens & Spencer, 2000). Contrasting this is a case-control 
study (N = 75) which found that ADHD pharmacotherapy did not increase the risk 
of MDD in children with ADHD but rather had a protective effect (Daviss et al., 
2008). This study also found that, relative to previously reported risk factors of 
MDD including trauma history and comorbidity, delay in the commencement of 
pharmacotherapy for ADHD was the strongest predictor of later MDD in children 
(Daviss et al., 2008).  
Due to the deficits in emotion regulation found in both ADHD and MDD 
(Compas et al., 2009; Durbin & Shafir, 2008; Feng et al., 2009; Martel, 2009; 
Melnick & Hinshaw, 2000; Maedgen & Carlson, 2000; Nigg et al., 2004; 
Tortella-Feliu et al., 2010), researchers have suggested that deficits in emotion 
regulation account for the comorbidity (Seymour et al., 2012, 2014). A cross-
sectional study of youths aged 10 to 14 (n = 37 with ADHD, n = 32 without 
ADHD) and a longitudinal study of youths aged 9 to 12 (N = 277) sought to 
examine the relationship between ADHD, emotion regulation and depressive 
symptoms via caregiver and youth ratings (Seymour et al., 2012; Seymour et al., 
2014). In addition to emotion regulation being significantly associated with each 
disorder alone, both the cross-sectional and longitudinal study indicated that 
emotion regulation fully mediated the association between ADHD and depressive 
symptoms (Seymour et al., 2012; Seymour et al., 2014). Consequently, deficits in 
emotional regulation appear to underlie this comorbidity, though further research, 
utilising much larger samples, is required to confirm this.  
3.3.2 Genetic/familial factors.    As ADHD and MDD are both 
moderately to highly heritable and have similar biological underpinnings, 
research has examined the extent to which comorbid ADHD and MDD is  
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heritable. Results from a twin study indicated that there is a large genetic overlap 
between ADHD and MDD (75% in males; 84% in females) and a smaller 
influence of non-shared environments (24% for males, 16% for females; Cole et 
al., 2009). Research has indicated that whilst there is a familial link between 
ADHD and MDD, shared genetic factors play an indirect role in the comorbidity 
(Beardslee et al., 1988; Biederman et al., 1990; Biederman et al., 1992; Cantwell, 
1972; Chronis-Tuscano et al., 2010; Cole et al., 2009; Elner & Rice, 1988; 
Faraone & Biederman, 1997; Grigoroiu-Serbanescu et al., 1991; Hammen et al., 
1990; Levy & Nurcombe, 1979; Morrison & Stewart, 1971; Orvaschel et al., 
1988; Weissmem et al., 1984; Weissman et al., 1987; Welner et al., 1977). 
Specific genes implicated in the co-occurrence include the synaptosomal 
associated protein of 25 kd and the brain derived neurotrophic factor gene (Kim et 
al., 2007; Sen et al., 2003; Tsai, Cheng, Yu, Chen, & Hong, 2003; Tsai, 2007).  
Further supporting the role genetics has in comorbid ADHD and MDD is 
research which suggests that ADHD and MDD are related to antisocial disorders. 
These studies have indicated that the familial risk for MDD is greatest when 
antisocial disorders and ADHD are present within families (Angold & Costello, 
1993; August et al., 1983; Barkley et al., 1990; Biederman et al., 1991; Faraone et 
al., 1991, 1995; Lahey et al., 1988; Loney et al., 1981; Mannuzza et al., 1993; 
Stewart et al., 1981; Tsuang & Faraone, 1990). Whilst these studies point to a 
potential genetic/familial factor underlying the co-occurrence, they did not 
account for other internalising disorders such as anxiety. Consequently, the 
specificity of results is unclear.  
Research has also suggested that a possible endophenotype for comorbid 
ADHD and MDD is reward responsivity (Meinzer, Pettit, & Viswesvaran, 2014). 
Molecular genetic studies have linked several dopaminergic (DAT1, D2, D4 
AND D5 receptor genes) and serotonergic transporter and receptor genes to 
disrupted reward functioning in ADHD and MDD (DiMaio, Grizenko, & Joober, 
2003; Durston, 2003; Epstein et al., 2006; Gizer, Ficks, & Waldman, 2009; Kato, 
2007; Meinzer, Pettit, & Viswesvaran, 2014; Meinzer, Pettit, Leventhal, & Hill, 
2012; Pizzagalli et al., 2008; Scheres, Milham, Knutson, & Castellanos, 2007; 
Wood & Neale, 2010). A study aiming to investigate whether low reward 
responsivity is an explanatory variable in the relationship between ADHD and 
depressive symptoms (N = 198, mean age = 21) found that ADHD was 
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significantly associated with depressive symptoms. Reward responsivity was 
negatively correlated with both ADHD and depressive symptoms and low reward 
responsivity partially accounted for the association between ADHD and 
depressive symptoms. Consequently, comorbid ADHD and MDD appears to be 
explained, at least partially, by genetic factors related to low reward responsivity 
(Meinzer, Pettit, & Viswesvaran, 2014).  
3.3.3 Environmental factors.   According to the Negative-Reactive 
Response Pattern Theory, children with ADHD exhibit higher rates of disruptive 
behaviour than their peers (Johnston, 1996). This behaviour commonly leads to 
increased caregiver control, inconsistent caregiving and disapproving behaviour 
from caregivers and peers (Johnston, 1996; Wells et al., 2006). This then 
undermines children’s perceptions of control and belonging and increases feelings 
of demoralisation and the risk of internalising disorders such as MDD (Chorpita, 
Brown, & Barlow, 1998; Meinzer et al., 2014; Rudolph, Kurlakowsky, & Conley, 
2001). 
Due to the cumulative impact of impairments related to ADHD, the 
negative environmental circumstances triggered by symptoms of ADHD and the 
later onset of MDD, there have been suggestions that MDD is secondary to 
ADHD (Biederman et al., 2004; Blackman et al., 1996; Blackman et al., 2005; 
Daviss, 2008; Downey et al., 1997; Herman et al., 2007; Jensen et al., 1993; Kooij 
et al., 2001; McGough et al., 2005; Ostrander et al., 2006; Secnik et al., 2005; 
Waxmonsky, 2003). Support for this comes from research that indicates that the 
more symptoms of ADHD an individual has, the more depressive symptoms they 
experience (Angold & Costello, 1993; Biederman et al., 1991; Jensen et al., 1993; 
Kitchens et al., 1999; LeBlanc & Morin, 2004). Similarly, both academic 
impairment and peer problems have been found to predict depressive symptoms 
in children with ADHD (McCarty et al., 2008; Seroczynskim, Cole, & Maxwell, 
1997). In contrast to this research, some researchers have demonstrated that the 
formation and persistence of MDD in individuals with ADHD is independent of 
ADHD-related impairment (Biederman et al., 1998; Drabick et al., 2006). 
Consequently, it remains unknown whether the ADHD related impairments 
account for the co-occurrence of MDD.  
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3. .4 Treatment of Comorbid ADHD and MDD in Childhood 
Whilst there are several pharmacotherapies and manualised 
psychotherapies available for the treatment of MDD, none have been specifically 
studied in children and adolescents with comorbid ADHD and MDD (Weersing & 
Brent, 2006). Subsequently, little is known about how best to treat comorbid 
ADHD and MDD in childhood. Nevertheless, as with all mental disorders in 
childhood, use of a biopsychosocial approach with an individualised treatment 
plan is recommended (Daviss, 2008). The psychotherapies recommended for the 
treatment of depressive symptoms in children with ADHD are the same as those 
recommended for the treatment of MDD in typically developing children and thus 
can be reviewed within chapter 2, section 2.8.  
3.4.1 Pharmacotherapy.  Although no study has directly compared 
treatment responses in youth with ADHD with and without MDD, some studies 
have examined the effects of pharmacological treatments in youth with depressive 
and anxiety symptoms and ADHD (Birmaher et al., 2000; Daviss et al., 2001; 
Emslie et al., 1997; Emslie et al., 2002; Keller et al., 2001). Whilst these studies 
are limited, as seen below, they provide preliminary evidence with regards to 
which pharmacotherapy treatments assist with reducing depressive symptoms in 
children with ADHD. 
A 12 week prospective study (N = 32, aged 9 to 17) with fluoxetine 
(common antidepressant for treatment of MDD) added and gradually titrated 
while methylphenidate (common stimulant for treatment of ADHD) was 
maintained found that adding fluoxetine was well tolerated and helpful in 
reducing both ADHD and MDD symptoms (Gammon & Brown, 1993). Using an 
RCT design, Kratochvil and colleagues (2005) compared the efficacy of 
fluoxetine and atomoxetine (common norepinephrine reuptake inhibitor for 
treatment of ADHD) versus placebo/atomoxetine in youth with ADHD and 
depressive or anxious symptoms (N = 173). Initially the participants, aged 7 to 17, 
were randomly assigned to either the fluoxetine (n = 127) or placebo (n = 46) 
condition. After 3 weeks atomoxetine was added to every participant’s treatment 
regimen. Results indicated that ADHD and depressive symptoms significantly 
improved over an 8 week period in both those that received fluoxetine and 
atomoxetine and those that received the placebo and atomoxetine. Whilst the 
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reduction of depressive symptoms across the conditions was similar according to 
the Children's Depression Rating Scale-Revised (atomoxetine and fluoxetine 
mean reduction= -22.9, SD = 15.2 versus mean reduction = -19.8 SD = 13.3, p = 
.34), the mean reduction in the Children's Depression Inventory (CDI) scores was 
significantly greater (p = .04) in the fluoxetine and atomoxetine condition (mean 
reduction = -8.8 ± 8.1) when compared to the placebo and atomoxetine condition 
(mean reduction =. – 5.4 ± 10.0). These findings suggest that treatment with 
atomoxetine alone is effective in treating both ADHD and depressive symptoms, 
though if the child is already using fluoxetine then the addition of atomoxetine is 
useful.  
A later RCT examining adolescents aged 12 to 18 with a confirmed 
diagnosis of ADHD and MDD found that, across a 9 week period, when 
compared to the placebo group (n = 70) participants randomised to the 
atomoxetine group (n = 72) experienced greater improvements in ADHD but not 
MDD (Children’s Depression Rating Scale-Revised mean reduction = -14.8 ± 
13.3 versus -12.8 ± 10.4, p = .34; Bangs et al., 2007). This study indicated that the 
pharmacotherapy for ADHD, i.e. atomoxetine, was not useful in improving 
depressive symptoms within this group. The differences in the severity of 
depressive symptoms at baseline across the studies is likely to account for the 
discrepancies in findings, as milder depressive symptoms (as evidenced in the 
Kratochvil and colleagues study) may respond better to atomoxetine whilst 
moderate depressive symptoms (as evidenced in Bangs and colleagues study) may 
not. These findings suggest the need for further research that includes a range of 
depressive severity across fluoxetine, atomoxetine and placebo groups.   
As a result of the discrepancies in findings, the Texas Children's 
Medication Algorithm Project (CMAP) utilising an algorithm developed by 
clinicians, researchers, administrators, consumers and families, recommends a 
“conservative” approach to pharmacological treatment. Given that improvements 
in one disorder may coincide with improvements in the other, the CMAP 
recommend the use of a single medication to target the more severe disorder, as 
opposed to a combination of medications (Pliszka et al., 2006; Hughes et al., 
2007). For example, if ADHD is judged to be more severe, they suggest an initial 
trial of a stimulant medication. If symptoms of ADHD and MDD persist then the 
stimulant should be changed to an SSRI. If ADHD symptoms reduce but 
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depressive symptoms remain, then the addition of a SSRI is recommended. 
However, when MDD is judged to be more severe, CMAP recommends 
consecutive trials of two separate SSRIs with the addition of a stimulant if ADHD 
symptoms persist (Pliszka et al., 2006; Hughes et al., 2007).  
3.4.2 Combination of pharmacotherapy and psychotherapy.   Whilst 
research has yet to examine the efficacy of combining pharmacotherapy and 
psychotherapy to manage MDD in children with ADHD, two large studies 
investigating the efficacy of combining pharmacotherapy and psychotherapy in 
individuals with comorbid ADHD and anxiety have indicated that a combination 
of treatment is superior to either treatment modality alone (March et al., 2004; 
MTA-Cooperative-Group 1999). As childhood anxiety disorders present similarly 
to childhood MDD and children with ADHD and MDD are believed to 
experience difficulties beyond that addressed by either treatment modality alone, 
it is likely that a combination of pharmacotherapy and psychotherapy will result 
in a reduction of ADHD and depressive symptoms beyond that of either treatment 
modality alone. However, further research specifically investigating the impact of 
combining pharmacotherapy and psychotherapy in the treatment of comorbid 
ADHD and MDD is required. In order to develop targeted treatments, the 
characterisation of depressive symptoms and thus identification of which 
symptoms to target needs to be thoroughly investigated.   
 
3.5 Diagnosis and Clinical Presentation of Comorbid ADHD and MDD in 
Childhood 
3.5.1 Diagnosis.  Accurate assessment and diagnosis of MDD in children 
and adolescents with ADHD is challenging given the non-specific, overlapping 
diagnostic criteria/shared symptoms. For example, psychomotor agitation and 
diminished ability to concentrate are diagnostic criteria for both disorders (Jensen 
et al., 1988; Milberger et al., 1995). Due to this overlap in symptoms, research 
suggests that symptoms may be erroneously attributed to the disorder already 
diagnosed, despite it actually occurring because of the other (i.e. psychomotor 
agitation in a child with ADHD attributed to ADHD when in actual fact it is a 
symptom of MDD; Diler et al., 2007; Jensen, Burke, & Garfinkel, 1988; 
Milberger et al., 1995; Pliszka, 1988). Similarly, there have been suggestions that 
the side effects of medications used to treat ADHD such as insomnia, loss of 
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appetite, irritability and fatigue, are incorrectly attributed to MDD or vice versa 
with MDD incorrectly attributed to the side effects of these medications (Diler et 
al., 2007; Jensen, Burke, & Garfinkel, 1988; Milberger et al., 1995; Pliszka, 
1988). Due to the overlapping symptoms and side effects of ADHD medications, 
research suggests that scores on validated depressive measures may be distorted 
when children with ADHD are screened for MDD (Daviss et al., 2006).  
Consequently, whilst diagnosis of ADHD and MDD follows the same 
process of either alone, with the same criteria used, diagnosis of MDD in children 
with ADHD is a complex task. To reduce this complexity, further understanding 
with regards to how depressive symptoms present in children with ADHD and 
whether this presentation is different from those without ADHD is required. 
Having this knowledge will enable a move towards a more proficient and accurate 
diagnostic process.   
3.5.2 Clinical presentation of MDD in ADHD.  There is limited research 
regarding the clinical presentation of depressive symptoms in ADHD. In general 
those who experience comorbid ADHD and MDD have an earlier age of onset, 
longer duration of MDD and experience greater impairments than those without 
ADHD (Biederman et al., 2008; Chronis-Tuscano et al., 2010; Rohde et al., 
2001). Further, research suggests that subclinical depressive symptoms predict 
later experiences of MDD (Horwath, Johnson, Klerman, & Weissman, 1992; 
Pine, Cohen, Cohen, & Brook, 1999). 
A 5 year prospective study by Biederman and colleagues (2008) aimed to 
evaluate the association between ADHD and MDD in females, aged 6 to 18, from 
pediatric and psychiatric settings. They utilised a structured diagnostic interview 
to confirm the presence of ADHD and assess depressive symptoms. Results 
indicated that those with ADHD and MDD (n = 140) experienced an earlier age 
of MDD onset, longer depressive episodes, more severe MDD associated 
impairments and were more likely to require psychiatric hospitalisation or more 
extensive treatment than those with ADHD only (n = 122). Those with ADHD 
and MDD also experienced higher rates of suicidality than those with ADHD 
only. As this study focused on females, further research utilising male participants 
as well is required.  
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Suicide appears to be common in the clinical presentation of many 
individuals with ADHD and MDD, with research suggesting that children either 
with ADHD or MDD are more likely to report suicidal ideation and attempts 
during high school than those without either disorder (Barkley & Fischer, 2005; 
Biederman et al., 2008; Monuteaux, Faraone, Gross, & Biederman, 2007). A 13 
year longitudinal study of 158 children with ADHD and 81 controls aged between 
4 and 12 at baseline found that 49% of those who considered suicide in high 
school (n = 70) had developed MDD compared to 10% of those who had not 
considered suicide in high school (n = 155). Similarly, suicide attempts in those 
with ADHD were more than twice as likely to be associated with MDD (73% had 
MDD vs 34% who did not; Barkley & Fischer, 2005). Additionally, a review of 
16 autopsy studies of children, adolescents and young adults and six longitudinal 
ADHD follow up studies indicated that youth with comorbid ADHD and MDD 
were three times more likely to complete suicide than youth diagnosed with either 
disorder alone (James et al., 2004). Overall, the findings indicate that comorbid 
ADHD and MDD results in a more severe clinical presentation that encompasses 
suicidal ideation and suicide. Though further research is required to confirm this.  
 
3.6 Symptom-based Approaches in Examining MDD in ADHD  
3.6.1 Benefits of a symptom-based approach.  To date, the majority of 
research has been limited to defining the overlap between ADHD and MDD and 
examining the presence or absence of the two disorders (Angold et al., 1999). 
Whilst this research has provided useful information, few studies have used a 
symptom-based approach to understand this comorbidity and thus how depressive 
symptoms present in children with ADHD is unknown.  
There are roughly 1,000 unique symptom combinations that can result in a 
diagnosis of MDD (Fried & Nesse, 2015b). These symptoms, even when 
experienced at a subthreshold level, have been found to impact functioning (Fried 
& Nesse, 2015a). This is especially relevant when the nature of childhood MDD, 
that is, the tendency for children to experience subthreshold depressive 
symptoms, is considered. Overall, the large number of symptom combinations, 
the high occurrence of subthreshold symptoms in childhood, the overlapping 
symptoms and the impact of these symptoms suggests that just knowing that 
MDD occurs in those with ADHD is not enough. Knowing which depressive 
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symptoms present more commonly and thus which symptoms to screen for in 
children with ADHD would increase early identification, prevention and 
maximise early treatment responses. Consequently, research utilising a symptom-
based approach to examine this comorbidity is urgently required.  
3.6.2 Studies utilising a symptom-based approach to understand MDD 
in ADHD.  Whilst only two studies have been identified which use a symptom-
based approach to understand MDD in children with ADHD (presented at the end 
of this section), two additional studies (presented below) have examined the 
presentation of depressive symptoms more generally. 
Biederman and colleagues (1996a) sought to investigate whether the 
comorbidity between ADHD and MDD was due to assessment bias (n = 27 with 
MDD, n = 97 with ADHD, n = 67 with ADHD and MDD and n = 115 with 
neither diagnosis). Though not seeking to specifically investigate the presentation 
of specific depressive symptoms, findings from this study indicated that children 
with ADHD and MDD had higher attention problems, delinquent and aggressive 
behaviour, somatic complaints and anxious/depressed subscale scores than 
children with either disorder alone. Interestingly, in comparison to children with 
ADHD only, thought problems such as difficulties concentrating occurred more in 
children with MDD and children with ADHD and MDD.  
Consistent with the above findings is a study investigating the frequency 
of ADHD symptoms in Norwegian adolescents (N = 9,614) aged 16 to 19 who 
had a diagnosis of MDD (Lundervold et al., 2016). This study, using the short 
version of the Mood and Feelings Questionnaire found that depressed mood, 
fatigue, restlessness, concentration difficulties and feeling lonely were the most 
frequently documented depressive symptoms. Whilst this provides some insight, 
the study focused on looking at symptoms of ADHD that were experienced by 
those with MDD and thus did not differentiate whether the expression of 
depressive symptoms is different for children with ADHD as opposed to those 
without.  
Although the above studies point to the potential importance of depressed 
mood, attention problems/concentration difficulties, fatigue, restlessness and 
feeling lonely in the presentation of childhood MDD the following two studies 
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extend on this by utilising a symptom based approach and applying it to a 
population with both ADHD and MDD.  
A study of 111 youth aged 5 to 18 years sought to identify which 
depressive symptoms best differentiate MDD among youths with ADHD (Diler et 
al., 2007). This study utilised the Schedule for Affective Disorders and 
Schizophrenia for School-Age Children and the Mood and Feelings Questionnaire 
to measure depressive symptoms. Depressive symptoms were classified as present 
if rated as ‘sometimes’ or ‘true’ by either caregiver and/or child. To increase 
sensitivity to depressive symptoms, both caregiver and child ratings for each 
depressive symptom were combined and the highest rating, when disagreement 
occurred, taken. Of the youths with ADHD, 18 met criteria for MDD 
(MDD/ADHD) and 93 did not (No MDD/ADHD). Findings indicated that four 
mood and anhedonia symptoms, all depressive cognitions and three physical 
symptoms discriminated youths with MDD and ADHD from those without MDD 
(Diler et al., 2007). Using the following depressive symptoms; mood, anhedonia, 
depressive cognitions and physical symptoms a stepwise logistic regression 
correctly classified 89% of the participants with MDD. Anhedonia, depressive 
cognitions (e.g., thoughts that bad things would happen), suicidal thoughts and 
psychomotor retardation were most important and comprised the final model. As 
expected, the symptoms of ADHD and MDD that overlap (e.g., irritability, 
concentration problems, psychomotor agitation) did not differentiate those with 
MDD from those without MDD. Despite findings, this study did not include a 
control group and included a broad age range (5 to 18 years) which reduced 
developmental sensitivity. Further, the cross-sectional nature of the study 
prevented conclusions regarding the temporal course of depressive symptoms in 
youths with ADHD. Finally, findings were limited to a clinical sample which 
tends to over represent youth with significant mental health difficulties and 
underrepresent females with ADHD. The use of an exclusively clinical sample is 
an issue as females with ADHD tend to experience MDD at a higher rate than 
males with ADHD (Brassett-Harknett & Butler, 2007). Similarly, clinical samples 
tend to consist of individuals with higher rates of other comorbid disorders which 
may impact the presentation of depressive symptoms (Brassett-Harknett & Butler, 
2007; Sciberras, Roos, & Efron, 2009). Despite these limitations, this study 
represents one of the first attempts at documenting depressive symptoms in 
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youths with ADHD and MDD and offers insight into what depressive symptoms 
may be important to screen for in children with ADHD. 
A further study sought to compare depressive symptoms, via individual 
interviews and completion of the CDI, in children aged 7 to 12 with (n = 34) and 
without ADHD (n = 34; LeBlanc & Morin, 2004). Findings indicated that those 
with ADHD experienced significantly more depressive symptoms than those 
without. Anhedonia was the most common depressive symptom in both groups, 
though those with ADHD experienced significantly more anhedonia than those 
without ADHD. Negative mood, feelings of ineffectiveness and negative self-
esteem were more frequently reported in those with ADHD. Interestingly, 
interpersonal problems, though present, were not common in both groups. Finally, 
15% of children with ADHD versus 0% of children without ADHD endorsed the 
suicide item. Whilst this study provides the most relevant findings with regards to 
the differences in the presentation of depressive symptoms in those with ADHD 
versus those without, it is limited by a number of factors. Firstly, the sample was 
recruited from French Canadian schools and was small. Thus, it is unclear how, 
and if, findings generalise to a larger, more geographically and culturally diverse 
population. Finally, a large proportion (91%) of the children within the ADHD 
group were taking stimulants. Thus it is not clear whether the increased 
depressive symptoms were due to stimulant side effects (Barkley, 1998). 
Overall, the studies by Diler and LeBlanc suggest that the depressive 
symptoms of most interest in children with ADHD are depressed mood, 
irritability, anhedonia, feelings of guilt, negative cognitions about oneself, 
psychomotor agitation and retardation and suicidal ideation. However, further 
research, using a structured diagnostic assessment, that aims to specifically 
explore the frequency and presentation of diagnostically aligned depressive 
symptoms in a community-based sample of those with and without ADHD, is 
required. To ensure specificity of findings this research should be 
developmentally sensitive through the inclusion of a restricted age range.  
 
3.7 Impact of Depressive Symptoms in Children with ADHD 
Despite consensus that MDD frequently occurs in individuals with 
ADHD, little is known about the unique influence depressive symptoms have on 
functioning in children with ADHD. Despite not directly investigating the unique 
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impact of MDD on ADHD, the following section presents several studies that 
may point to the functional impairments associated with depressive symptoms in 
those with ADHD.  
3.7.1 Studies investigating quality of life.   Quality of life is an 
important, multidimensional measure of wellbeing that covers an individuals’ 
subjective perception of their physical, social and psychological wellbeing 
(Danckaerts et al., 2009; Felce & Perry, 1995; Wehmeier, Schacht, & Barkley, 
2010).  
Two studies examining those with ADHD suggest that the co-occurrence 
of depressive symptoms negatively impacts quality of life. The first, a study 
utilising several self-report questionnaires to assess 929 Taiwanese army draftees 
(n = 328 ADHD; n = 601 non-ADHD; mean age = 22) found that, in comparison 
to those without ADHD and internalising symptoms, those with ADHD and 
internalising symptoms had a lower quality of life (Chao et al., 2008). A later 
study utilising four self-report questionnaires to assess 1384 military personnel 
(ADHD n = 196; non-ADHD n = 1186; mean age = 23.5) found that ADHD and 
comorbid depressive and anxious symptoms were strongly related to poorer 
quality of life and depressive symptoms in childhood significantly mediated the 
association between childhood ADHD and poor quality of life in adulthood (Yang 
et al., 2013).  
Although these studies suggest that comorbid depressive symptoms in 
those with ADHD impacts quality of life, their findings should be interpreted in 
light of several limitations. Firstly, they did not investigate the unique 
contribution of depressive symptoms. Thus, it is unclear whether the reduced 
quality of life was associated with anxiety symptoms alone, depressive symptoms 
alone or both in combination. Further the samples were male, military personnel, 
studies relied on participants’ recall of childhood ADHD symptoms, did not 
utilise a structured diagnostic assessment or confirm the diagnosis of ADHD. 
Consequently, it is unclear whether these findings extend to children (from both 
sexes) who have a confirmed diagnosis of ADHD.  
Whilst one study investigating the association between internalising 
symptoms and quality of life in children with ADHD has contrasted the above 
findings and suggested that quality of life is no different between those with 
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internalising comorbidities and those without (discussed in more detail below; 
Armstrong, Lycett, Hiscock, Care, & Sciberras, 2015), others investigating the 
elements that make up quality of life including stress levels and relationship 
functioning suggest that there are significant differences. Specifically, a study, via 
four assessments, found that children aged 8 to 9 who had ADHD and 
internalising disorders (n = 47) experienced significantly higher levels of stress 
than those with ADHD only (n = 47; Jeensen et al., 1993). A further prospective 
four year follow up study which utilised several assessments including the DSM-
III-RV indicated that males with ADHD and MDD (n = 140) experienced higher 
levels of stress and familial problems than males without (n = 120). They also 
experienced a chronic course of MDD and severe psychosocial dysfunction. 
Taken together findings suggest that comorbid ADHD and MDD may negatively 
impact quality of life. Nevertheless, the contrasting findings and lack of research 
within this field suggests that further research to determine the association 
between depressive symptoms and functioning in those with ADHD is required.  
3.7.2 Studies investigating social, behavioural and academic 
functioning.  Few studies have examined the impact of depressive symptoms on 
the social, behavioural and academic functioning of children with ADHD. 
Existing research has primarily focused on ADHD and anxiety disorders and has 
produced mixed findings (Armstrong et al., 2015). Furthermore, most existing 
studies have focused on social and academic functioning as opposed to 
behavioural functioning. Consequently, little is known with regards to how 
comorbid ADHD and depressive symptoms impact social and academic 
functioning and even less is known in relation to the impact on behavioural 
functioning. 
Mentioned briefly above, Armstrong and colleagues (2015) examined the 
functional outcomes for children aged 5 to 13 with ADHD (n = 54), with ADHD 
and internalising comorbidities (n = 33), with ADHD and externalising 
comorbidities (n = 41) and finally children with ADHD and both internalising 
and externalising comorbidities (n = 71). They utilised caregiver and teacher 
report and assessed peer problems, daily functioning and quality of life at baseline 
and 12 months later. Findings indicated that there were no differences in peer 
problems and daily functioning in those with ADHD only and those with ADHD 
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and internalising comorbidities. As functioning was only assessed a year later 
only the short term impact on functioning was captured. It is possible that long 
term functional outcomes are different. Consequently, assessment across a longer 
period of time is required. This longitudinal research should also seek to 
specifically investigate the association between depressive symptoms and 
functioning in children with ADHD. 
Despite the lack of research, there is research which has suggested that 
social functioning but not academic functioning is negatively impacted in those 
with comorbid ADHD and MDD. This research sought to investigate the 
relationship between depressive and anxiety symptoms and functioning in 125 
school children with ADHD (Karustis et al., 2000). A multimethod battery was 
utilised to assess academic and social functioning, with caregiver and child 
reports used to assess depressive and anxious symptoms. This study found that 
whilst social difficulties occurred in those with comorbid ADHD and depressive 
symptoms, depressive symptoms were not associated with reduced academic 
functioning. This is consistent with Biederman’s (1996a) study which suggested 
that those ADHD and MDD did not differ from the ADHD group with regards to 
academic competence. In contrast, however, the findings from Karustis study 
suggested that those with ADHD and depressive symptoms did experience 
significant difficulties (not seen in those with anxiety and ADHD) in relation to 
completing homework. Similarly, a study on the impact of psychiatric 
comorbidities in a community-based sample of children indicated those with 
ADHD and MDD or anxiety (n = 18) were substantially more likely to have 
below average academic performance than those with ADHD only (n = 259; OR 
= 10.8; CI = [2.4, 49.1]; Cuffe et al., 2015). As can be seen the impact of 
depressive symptoms on children with ADHD is largely unknown with much of 
the research providing conflicting, unclear findings.  
These conflicting findings are interesting as previous research on either 
disorder alone has consistently suggested that academic outcomes are poorer for 
those with ADHD alone and those with MDD alone (Loe & Feldman, 2007; 
Rhode et al., 2013). Given those findings, one would think that the combination 
of these disorders would result in further functional impairments, though this 
research suggests that this may not be the case. Importantly, these studies did not 
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utilise a control group. Thus it is unclear whether these findings are comparable to 
same aged peers without ADHD.  
 Extending on the previous study, Blackman and colleagues (2005) 
examined the clinical characteristics among a community sample of children in 
Grade 1 to 4 with and without ADHD. They utilised a two-stage assessment 
strategy, multiple respondents and eight questionnaires to compare the social, 
behavioural, academic and clinical functioning of children with ADHD (n = 111), 
children with ADHD and MDD (n = 26) and children without either disorder (n = 
130). They found that those with ADHD and MDD experienced significantly 
more impairments in academic and social functioning than children without either 
disorder. Whilst social impairments were also greater in children with ADHD and 
MDD when compared to the ADHD only group, there were no differences in 
conduct problems or academic functioning in children with ADHD and MDD 
when compared to children with ADHD only. These findings suggest that 
significant social difficulties are a unique impairment for those with ADHD and 
MDD and behavioural and academic difficulties are unique to children with 
ADHD only. However, the cross-sectional nature limits the ability to determine a 
causal relationship between ADHD, MDD and functioning. Consequently, it is 
unclear whether comorbid MDD exacerbates deficits or if those with ADHD and 
impairments in social functioning are more likely to experience MDD. In order to 
determine whether functioning in children with comorbid ADHD and MDD is 
impaired across time and thus whether or not they require specific intervention, 
future research should investigate the association between depressive symptoms 
and social, behavioural and academic functioning in children with and without 
ADHD longitudinally.  
3.7.3 Impairments into adulthood.  Research indicates that MDD is one  
of the most commonly occurring mental disorders in adults with ADHD (Fischer 
et al., 2007). A study on 394 participants (205 with ADHD and 189 without 
ADHD) aged 18 to 25 years was conducted in order to determine whether ADHD 
in childhood significantly predicted depressive symptoms in adulthood (Meinzer 
et al., 2016). It found that, in comparison to those without ADHD, those with 
ADHD experienced significantly higher levels of depressive symptoms across 
early adulthood. Further, elevated levels of depressive symptoms during early 
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adulthood in those with ADHD was associated with a number of long term 
negative outcomes including lower levels of educational attainment, income and 
social and familial impairments (Yaroslavsky, Pettit, Lewinsohn, Seeley, & 
Roberts, 2013).   
Research suggests that, in comparison to those with ADHD only, those 
with ADHD and MDD engage in significantly more psychotherapeutic and 
pharmacological treatments across their lifetime (Fischer et al., 2007). Even after 
successful treatment, individuals with comorbid ADHD and MDD experience 
higher rates of depressive recurrence and continue to have substantially higher 
overall health care costs than those with MDD alone (Fishman et al., 2007; Rhode 
et al., 2001). A study involving 249,874 adults indicated that comorbid ADHD 
and MDD was associated with significantly higher direct medical costs than 
MDD alone (Fishman et al., 2007). A cross-sectional study using questionnaires 
ratings of past and present symptoms of ADHD, comorbid conditions including 
internalising disorders, treatment history and work status was conducted on 414 
clinically diagnosed adults with ADHD. They found that those with comorbid 
internalising disorders (n = 399) were more likely to be out of work (Unadjusted 
OR = 2.9, p < .001; Halmøy, Fasmer, Gillberg, & Haavik, 2009). The low 
education attainment, high unemployment in conjunction with the high costs 
associated with this comorbidity is likely to further perpetuate depressive and 
stress symptoms thereby impairing functioning, particularly quality of life. 
Though research confirming this is required. 
A further study comprising 320 adults with ADHD sought to evaluate the 
implications of comorbid MDD in adulthood (Fischer et al., 2007). This study 
found that in comparison to those with ADHD only those with ADHD and MDD 
were more likely to experience social phobia and generalised anxiety disorder, 
though were less likely to experience substance dependence disorders. 
Interestingly, within this study those with ADHD and MDD experienced less 
behavioural and academic problems at school than those with ADHD only. As 
both groups within their study experienced similar levels of externalising 
disorders whereas previous research has tended to have higher rates of 
externalising disorders within the ADHD only groups, authors hypothesised that 
the behavioural and academic difficulties found in previous research were due to 
the presence of externalising disorders as opposed to comorbid ADHD and MDD. 
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Nevertheless, the experience of ADHD and MDD may have prolonged negative 
impacts on functioning, emphasising the need for early detection and subsequent 
intervention. 
 
3.8 Gaps within the Literature and Future Directions  
To date, approximately 70 studies investigating comorbid ADHD and 
MDD in childhood have been published. As mentioned, the majority of these 
studies have focused on a diagnostic level as opposed to using a symptom-based 
approach. Consequently, there is little understanding regarding how depressive 
symptoms present and whether the presentation is different or similar in children 
with and without ADHD.   
Understanding whether there are differences in depressive symptoms 
between those with and without ADHD is important given the vast number of 
symptom combinations that qualify for a diagnosis of MDD (Fried & Nesse, 
2015b). It is possible that children with ADHD experience a heterogeneous 
pattern of symptoms relative to children without ADHD. If the pattern is 
heterogeneous this suggests that the measures currently assessing MDD in 
children with ADHD are not accurately capturing MDD and thus comparisons of 
depressive symptoms between those with and without ADHD should not be 
undertaken. To our knowledge, no study has specifically sought to determine 
whether the construct of MDD is measured consistently in those with and without 
ADHD. Without this knowledge it is not known whether comparisons between 
those with ADHD and MDD and those without ADHD and MDD are valid and 
can be made.  
The studies reviewed have tended to include large age ranges and clinical 
populations. This is an issue for a number of reasons. Firstly, MDD is a disorder 
that tends to present differently across the lifespan, particularly in childhood 
versus adolescence. Additionally, research indicates that adolescence, as part of 
normative development, is marked with a substantial increase in emotional and 
behavioural difficulties (Buitelaar, 2012). Consequently, grouping children and 
adolescents together is likely to result in important information regarding 
developmental changes in the presentation of depressive symptoms being missed 
and the determination regarding what symptoms are common at specific ages 
unlikely. Approximately one in five children and adolescents with mental health 
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disorders access clinical assistance (Sawyer et al., 2001). Consequently, research 
using clinical samples has the potential of missing four in five children with 
mental health disorders. Similarly, research suggests that in comparison to 
community samples of children with ADHD, clinical samples are predominately 
male, consist of children with greater symptomatology and more comorbidities, 
and underrepresents females and those with ADHD inattentive presentation 
(Brassett-Harknett & Butler, 2007; Sciberras et al., 2009). As females tend to 
experience MDD at a significantly higher rate than males (Lawrence et al., 2015), 
inclusion of females within research investigating ADHD and MDD is important. 
Given the characteristics of clinical samples, the use of community-based samples 
is likely to produce more accurate representations of how depressive symptoms 
present and impact functioning.  
In order to overcome the above mentioned issues and increase 
understanding regarding the presentation of depressive symptoms in children with 
ADHD and thus facilitate early identification, a symptom-based approach with a 
community-based sample that includes young children from a range of socio-
economic backgrounds is required. Similarly, as developmental dynamics are 
likely to influence the presentation of depressive symptoms as well as 
functioning, reducing the age range and becoming more developmentally 
sensitive will aid in ascertaining when symptoms emerge, how symptoms and 
difficulties change across early development and thus represents an essential next 
step for research. 
Whilst research suggests that subclinical depressive symptoms are 
associated with later experiences of MDD, to our knowledge, no research has 
investigated the association of specific depressive symptoms and later MDD. 
Consequently, nothing is known with regards to which specific early depressive 
symptoms are most associated with later MDD. Obtaining this knowledge will 
identify the symptoms that require intervention and thus through early 
intervention will prevent depressive symptoms from developing into MDD.  
It is still unclear how comorbid depressive symptoms impact the 
functioning of children with ADHD. The research reviewed with regards to the 
functional impact of comorbid ADHD and MDD tends to be mixed, with some 
suggesting functioning is negatively impacted and others that they are not. The 
studies conducted within the topic have tended to combine MDD and anxiety 
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together or investigated internalising disorders as a whole (Booster, DuPaul, 
Eiraldi, & Power, 2012; Bowen et al., 2008; Greene et al., 2001; Hoza et al., 
2005; Mikami, Ransone, & Calhoun, 2011). As these disorders vary widely, the 
true impact of comorbid ADHD and MDD is not able to be delineated, meaning 
that understanding regarding the association between depressive symptoms and 
functioning in children with ADHD is limited.  
In addition, most of the research has tended to be cross-sectional which 
does not enable directionality between the symptoms and functioning to be 
inferred. Further, the majority of studies have not utilised structured diagnostic 
interviews at baseline and few have confirmed diagnostic status at follow up. 
Confirming diagnostic status and understanding the diagnostic characteristics 
including severity of the sample is central to determining specificity and 
generalisability of findings (Green, Rinehart, Anderson, & Sciberras, 2015). Use 
of structured diagnostic interviews can assist in understanding the presentation of 
diagnostically relevant depressive symptoms in children with ADHD as these 
measures ensure symptoms reviewed align with diagnostic classification systems. 
To facilitate a symptom-based approach and thus in depth understanding of the 
presentation of depressive symptoms in children with ADHD a diagnostic 
interview should be used. To do this, identification of available diagnostic 
interviews and which offers the highest number of advantages is necessary.  
 
3.9 Conclusion 
In conclusion, independent of other comorbidities, MDD is one of the 
most common disorders to co-occur with ADHD, occurring four to five times 
more often in those with ADHD when compared to those without ADHD. Despite 
the high prevalence, there is little understanding regarding what depressive 
symptoms are cardinal in those with ADHD. Aetiological explanations for the co-
occurrence of ADHD and MDD are unclear. Nevertheless, research suggests that 
ADHD and MDD share familial risk factors, though environmental factors play a 
large part as well. Whilst research has established the vast functional impairments 
that result from either disorder alone, little consistent research regarding the 
specific impact of depressive symptoms on ADHD in childhood exists. The 
research that is available is mixed with some indicating that comorbid ADHD and 
MDD is impairing, and others suggesting there are few impairments. 
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Nevertheless, as those with comorbid ADHD and MDD have an earlier age of 
onset and longer duration of MDD, this co-morbidity is likely to represent more 
severe prognosis during a vulnerable developmental period, which warrants 
continued investigation. Consequently, understanding the characteristics 
associated with ADHD and MDD and the association between depressive 
symptoms and functioning represents a critical step in developing preventative, 
diagnostic and treatment options. 
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4. The Present Studies  
4.1 Rationale and Overall Aims 
The present thesis aimed to (i) identify and compare existing structured 
diagnostic interviews assessing childhood internalising disorders including MDD, 
(ii) determine the clinical presentation of depressive symptoms in children with 
ADHD versus non-ADHD controls at age 7 and (iii) investigate the persistence, 
presentation and impact of depressive symptoms from age 7 to age 10 in children 
with ADHD and non-ADHD controls. These aims were examined via a 
systematic review (aim i), a cross-sectional study (aim ii) and a longitudinal study 
(aim iii). Study two, the cross-sectional study, has been published in the European 
Child and Adolescent Psychiatry Journal (Joseph et al., 2019). See Appendix A for 
the published article and Appendix B for the authorship statement.  
 
4.2 Study One Aims  
4.2.1 Aim 1. Identify and describe existing structured diagnostic 
interviews used in assessing childhood internalising disorders.    
4.2.2 Aim 2. Compare and contrast the utility and psychometric qualities 
of existing structured diagnostic interviews used in assessing childhood 
internalising disorders.   
 
4.3 Study Two Aims and Hypotheses 
4.3.1 Aim 1. Examine whether the measurement of MDD is represented 
similarly across those with ADHD relative to non-ADHD controls.    
4.3.2 Aim 2. Determine whether children with ADHD have elevated 
depressive symptoms relative to non-ADHD controls and whether depressive 
symptoms in children with ADHD differ according to key clinical characteristics 
(i.e., ADHD presentation and comorbidity status).   
4.3.3 Aim 3. Examine the profile of depressive symptoms in children with 
ADHD relative to non-ADHD controls and identify which depressive symptoms, 
if any, discriminate ADHD and non-ADHD samples.  
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4.3.4 Hypotheses.  
1. As the factor analysis was exploratory no hypothesis regarding 
measurement invariance between the two groups was created. 
2. It was hypothesised that children with ADHD would experience 
significantly more depressive symptoms than non-ADHD controls. 
3. Determining the specific profile of depressive symptoms in 
children with and without ADHD was exploratory. Nevertheless, it 
was anticipated that a higher proportion of children with ADHD 
would endorse each depressive symptom compared to non-ADHD 
controls. 
 
4.4 Study Three Aims and Hypotheses 
4.4.1 Aim 1. Understand the presentation of depressive symptoms and 
MDD in children with and without ADHD across 3 years. To achieve this study 
three aimed to: 
a. Determine whether depressive symptoms at age 7 were associated 
with depressive symptoms at age 10 in children with ADHD and 
non-ADHD controls. 
b. Determine whether depressive symptoms at age 7 were associated 
with MDD at age 10 in children with ADHD and non-ADHD 
controls. 
c. Determine which depressive symptoms at age 7 were associated 
with MDD at age 10 in children with ADHD and non-ADHD 
controls.  
4.4.2 Aim 2. Examine the association between depressive symptoms at 
age 7 and functioning (social, behavioural, academic and quality of life) at age 10 
in children with and without ADHD. 
 
4.4.3 Hypotheses.   
a. It was hypothesised that depressive symptoms at age 7 would be 
positively associated with depressive symptoms at age 10 in 
children with ADHD and non-ADHD controls.  
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b. It was hypothesised that depressive symptoms at age 7 would be 
positively associated with MDD at age 10 in children with ADHD 
and non-ADHD controls.  
c. As this is the first study to examine whether specific depressive 
symptoms are associated with MDD at age 10, no specific 
hypothesis regarding the association of depressive symptoms 
was developed.   
1. It was hypothesised depressive symptoms would be associated 
with poor functioning across all domains in children with ADHD 
and non-ADHD controls. 
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5. Structured Diagnostic Interviews of Childhood Internalising 
Disorders: A Systematic Review 
To diagnose psychiatric disorders and inform treatment planning various 
structured diagnostic interviews have been developed. Currently there is a lack of 
a robust resource for clinicians and researchers to consult when deciding which 
structured diagnostic interview is most suitable for the assessment of childhood 
internalising disorders. To address this gap within the literature, chapter five 
presents a systematic review of structured diagnostic interviews for childhood 
internalising disorders. Childhood internalising disorders as opposed to MDD 
were the focus of this review due to the tendency of available research to group 
all depressive and anxiety related disorders together rather than assess them 
individually (Anderson & McGee, 1994; Barlow, Allen, & Choate, 2004; Brauner 
& Stephens, 2006; Cummings, Caporino, & Kendall, 2014; Seligman & 
Ollendick, 1998). Although not specific to MDD, findings were considered 
relevant to the assessment of MDD due to the strong overlap between depressive 
and anxiety related disorders across childhood. At this point, by facilitating 
understanding of the available structured diagnostic interviews, this systematic 
represents the first step towards use of symptom-based approaches within 
research.   
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5.1 Abstract 
5.1.1 Background.  Internalising disorders are highly prevalent in 
childhood and represent an important focus in psychology. Currently, there are 
several structured diagnostic interviews that diagnose childhood internalising 
disorders. Despite this, no resource outlining diagnostic interviews exists. The 
current paper aimed to identify and describe existing structured diagnostic 
interviews used to diagnose childhood internalising disorders and compare their 
psychometric qualities.  
5.1.2 Method.  Six electronic databases from inception through 
September 2015 were searched. This generated 1174 articles, of which, 86 articles 
were retained for data extraction and synthesis.  
5.1.3 Results.  Thirteen structured diagnostic interviews were identified 
with 11 meeting inclusion and exclusion criteria. Overall, these diagnostic 
interviews were found to be relatively time-consuming, required training and 
tended to be limited to children over 6 years of age. Direct comparisons between 
structured diagnostic interviews was difficult due to the heterogeneity across 
interviews and studies, the diverse nature of the data and small sample sizes. 
Nevertheless, articles reviewed suggest inter-rater reliability across diagnostic 
interviews was ordinary to excellent, test-retest reliability ordinary, validity fair to 
moderate, and sensitivity and specificity relatively good. 
5.1.4 Conclusion.  The synthesized description and psychometric qualities 
of diagnostic interviews reported aids researchers and clinicians in making 
informed decisions regarding which diagnostic interview to utilise. Availability of 
a resource that reviews the available diagnostic interviews will facilitate 
symptom-based approaches into the investigation of childhood internalising 
disorders. Whilst structured diagnostic interviews provide a wealth of knowledge 
and aid in effective assessment of children, they are far from optimal. 
Consequently, future research is required to enhance the format, utility and 
psychometric quality of these diagnostic interviews.  
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5.2 Introduction 
Depressive and anxiety related disorders in childhood, broadly labelled 
‘internalising disorders’, are frequent, recurrent and commonly associated with a 
number of serious developmental and functional consequences including impaired 
academic and social functioning and psychiatric hospitalisations (Amico et al., 
2011; Angold, Costello, & Erkanli, 1999; Avenevoli, Stolar, Dierker, & 
Merikangas, 2001; Rao & Chen, 2009; Yorbik, Birmaher, Axelson, Williamson, 
& Ryan, 2004). Understanding the characterisation of symptoms in children via 
accurate, symptom focused assessment of childhood internalising disorders is an 
essential first step in informing research and treatment (Johnco, Salloum, Lewin, 
McBride, & Storch, 2015; Owens, Stevenson, Hadwin, & Norgate, 2012). 
Structured diagnostic interviews are the preferred diagnostic measure as they 
permit diagnostic assessment in accordance with systematic, standardised and 
specific criteria and aid in increasing diagnostic reliability (Hodges, 1993; 
Calinoiu & McClellan, 2004).   
In research as well as practice, the purpose, respondent, ease of use, cost, 
clinicians’ level of experience, and the psychometric properties often determines 
which instrument is used (Chrisman et al., 2006). At present, there are a variety of 
structured diagnostic interviews which evaluate childhood internalising disorders 
(Calinoiu & McClellan, 2004; Gray et al., 2009). The development of these 
diagnostic measures has improved understanding, awareness, diagnosis and 
treatment by facilitating symptom-based investigation, systematic research and 
evidence based practice (Pine et al., 2002; Scheeringa, 2003). Nevertheless, it has 
also resulted in discrepancies in the literature, failure to achieve wide spread 
usage in clinical settings and a lack of consensus regarding the optimal instrument 
(Pine et al., 2002; Scheeringa, 2003).  
Given the importance of appropriate and effective assessment and the 
confusion regarding which measure to utilise when investigating and assessing 
childhood internalising disorders, particularly if seeking to differentiate symptoms 
in disorders that have overlapping symptoms such as ADHD and MDD, it is 
essential researchers and clinicians are better equipped (Angold & Egger, 2004; 
Calinoiu & McClellan, 2004). Consequently, the aim of this systematic review is 
to identify and describe existing structured or semi-structured diagnostic 
interviews of childhood internalising disorders. This review also sought to 
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examine the evidence of their psychometric quality thereby supporting 
researchers and clinicians in making best-practice, evidence based choices. 
 
5.3 Method 
The systematic review followed the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses guidelines (PRISMA, Moher et al., 
2009). The final search was conducted on September 18th, 2015. 
5.3.1 Search strategy.  The following databases were searched 
systematically on September 18th, 2015: Medical Literature Analysis and 
Retrieval System Online (MEDLINE), Excerpta Medica Database (EMBASE), 
Mental Measurements Yearbook with Tests in Print, psycINFO, psycTEST and 
psycEXTRA. No limitations on publication year or language was used. All 
articles were in English except for one which was in French and was 
independently translated into English by two French speaking colleagues.  
 First, articles that described or used measures to identify and diagnose 
childhood internalising disorders were searched for. To identify relevant 
measures, pilot systematic searches were conducted. This revealed that most 
relevant measures could not be identified using methodological search terms. 
Consequently, a more comprehensive search strategy was developed. This 
involved a combination of text words and subject headings related to “childhood 
internal dis*” and “diagnostic measures”. On the basis of this search, a list of 
potentially relevant measures was developed and screened against inclusion 
criteria and exclusion criteria one and two (see below). Upon confirming the final 
list of measures, a combination of psychomet*, reliab*, valid* and the titles of all 
selected measures was used (see Table 3). A manual search was conducted and 
covered related reference lists and any additional resources identified. 
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Table 3.  
Systematic Review Search Terms  






“Diagnostic Infant and Preschool Assessment”  
“Research diagnostic criteria preschool age” 
“RDC-PA” 
“Preschool Age Psychiatric Assessment”  
 “The Child and Adolescent Psychiatric Assessment”  
 “Diagnostic interview schedule for children”  
 “Diagnostic Interview for Children and Adolescents” 
 “Kiddie-Schedule for Affective Disorders and Schizophrenia for School-Age 
Children-Present and Lifetime Version”  
"Schedule for Affective Disorders and Schizophrenia for School Aged 
Children" 
“K-SADS-PL” 
 “Structured Clinical Interview for DSM-IV Childhood Diagnoses” 
“KID-SCID”  
“the Mini International Neuropsychiatric Interview for Children and 
Adolescents” 
“MINI-KID” 
 “Children’s interview for psychiatric syndromes” 
“Interview Schedule for Children” 
“Diagnostic Infant and Preschool Assessment” 
“Children's Assessment Schedule” 
“Anxiety Disorders Interview Schedule for Children” 
“Development and Well-being Assessment” 
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5.3.2 Eligibility Criteria for Instrument Selection.  To be included in 
the review measures were required to be (1) structured or semi-structured 
diagnostic interviews; and (2) designed to enable a diagnosis of internalising 
(depressive and anxiety) disorders. Diagnostic interviews were considered 
structured if they used a fixed and systematic script wherein the interviewer was 
required to read questions word for word, in a precise sequence and record 
client’s responses without interpretation. Diagnostic interviews were considered 
semi-structured if there were pre-specified questions but also allowance for 
deviations and open questions to clarify the presence and severity of symptoms. 
Given the imperative to accurately diagnose internalising disorders as early as 
possible structured and semi-structured interviews were the focus as they are 
considered best-practice evidence based assessments and as a result are routinely 
used to diagnose childhood internalising disorders (Calinoiu & McClellan, 2004; 
Gutterman, O'Brien, & Young, 1987; Herrman, Maj, & Sartorius, 2009). 
Measures were excluded if (1) they were screening or self-report measures 
thereby eliminating measures unable to provide a true diagnosis; and (2) were 
designed for children older than 12 years. This exclusion criteria was set because 
pilot searches identified many measures that were used with adolescents or adults 
that were not suitable for children and thus could not accurately diagnose 
childhood internalising disorders (Calinoiu & McClellan, 2004). To prevent the 
inclusion of minimally used measures or those that have limited psychometric 
evidence, measures in which (3) there was no manual or full-text article 
describing or psychometrically evaluating the measure and those with (4) fewer 
than three peer-reviewed primary journal articles were excluded.  
Articles were considered if (a) they described the development, theoretical 
background, scale construction or application of the measure or (b) evaluated the 
psychometric quality of the measure (assessed validity, reliability, sensitivity 
and/or specificity).  
5.3.3 Measurement Selection and Data Extraction.  Titles and abstracts 
of the articles identified through the database searches were screened. If the 
abstract did not mention the name of the measure utilised, the full text article was 
examined. General information and psychometrics of the diagnostic interviews in 
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relation to internalising disorders were extracted, summarised and categorised 
into tables for comparison between studies.  
The general description of diagnostic interviews was extracted from the 
measures’ manual or authors’ description in the identified articles. Information 
regarding the measures’ name, citation, age range, source of information, 
interviewer, format, manual and training availability were extracted. Information 
regarding inter-rater reliability, test-retest reliability, concurrent validity, 
sensitivity and specificity were extracted from articles that psychometrically 
described or evaluated the included diagnostic interviews.  
 
5.4 Results 
The literature search generated 1174 articles, including 447 duplicates. Of 
the 725 eligible articles, 536 were excluded in the first screening phase and 72 in 
the second phase. Of the remaining articles, 103 were excluded in the data 
extraction phase, leaving 86 (see Figure 1).  
Figure 1. Prisma Flow Diagram 
ADHD AND MDD IN CHILDHOOD                                                           70 
 
Claire I Joseph Deakin University 210667098 
 
Thirteen diagnostic interviews were identified including; the National 
Institute of Mental Health Diagnostic Interview for Children and Adolescents 
(DICA; Herjanic et al., 1975), the Schedule for Affective Disorders and 
Schizophrenia for School-Age Children (K-SADS; Puig-Antich & Chambers, 
1978), the Diagnostic Interview Schedule for Children (DISC; Costello et al., 
1982), the Interview Schedule for Children (ISCA; Kovacs, 1974), the Children's 
Interview for Psychiatric Syndromes (ChIPS, Weller et al., 1999), the Diagnostic 
Infant Preschool Assessment (DIPA, Scheeringa & Haslett, 2010), the Mini 
International Neuropsychiatric Interview for Children and Adolescents (MINI-
KID; Sheehan et al., 1998), the Child and Adolescent Psychiatric Assessment 
(CAPA; Angold et al., 1995), the Structured Clinical Interview for DSM-IV, 
Childhood Diagnoses (KID-SCID; Matzner et al., 1994), the Preschool Age 
Psychiatric Assessment (PAPA; Egger, Ascher, & Angold, 1999), the Children's 
Assessment Schedule (CAS; Hodges et al., 1982), the Anxiety Disorders 
Interview Schedule for Children IV (ADIS-IV; Silverman & Albano, 1996) and 
the Development and Well-being Assessment (DAWBA; Goodman et al., 2000). 
As the ADIS-IV and DAWBA had insufficient information specific to the 
psychometric qualities in relation to internalising disorders/MDD they were 
excluded from the data synthesis. Specifically, the available research on the ADIS 
and DAWBA lacked information regarding the validity and reliability in detecting 
MDD specifically. Consequently, only 11 diagnostic interviews were included in 
the data synthesis.  
5.4.1 Client and study characteristics.  Studies reviewed were 
predominantly cross-sectional with sample sizes ranging between 38 and 260. 
Studies included community-based and clinical samples, a variety of nationalities 
(including Australian, Spanish and South African) and ages (3 to 18 years). 
5.4.2 Diagnostic Interviews Included 
This section will review the diagnostic interviews that were included within the 
systematic review; it will provide a general description of the measure/its origins, 
the number of disorders it covers, the versions available, information regarding 
the respondents and finally its use. The section following will then review the 
psychometrics of each diagnostic interview.  
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5.4.2.1 Structured Diagnostic Interviews 
ChIPS  
The ChIPS was designed to overcome the excessive length and use of age-
inappropriate language used in other diagnostic interviews. This was achieved 
through a research party, who, via the guidance of the DSM, designed shorter, 
simplified, age-appropriate questions enhancing comprehensibility and 
cooperation in children. The ChIPS has 15 sections assessing for the presence of 
20 DSM-IV disorders and an additional two sections evaluating psychosocial 
stressors. Each section begins with questions, regarding the ‘cardinal symptoms’, 
designed to screen for the presence of a disorder. If a ‘cardinal’ item is endorsed, 
the interviewer is required to administer all questions within that section. 
Questions are asked in a predetermined order and require yes-no answers. Whilst 
the caregiver and child versions differ in the use of pronouns and verbiage, the 
same structure and format is used. Results can be input into a computer which 
produces a one page summary with the diagnosis and related information. The 
ChIPS can be used within clinical and research settings.   
DISC  
The DISC was constructed from the adult version, the Diagnostic 
Interview Schedule. The DISC has undergone a number of revisions to parallel 
the revisions of international classification systems, improve the phrasing of 
questions and the reliability. The DISC is based on the ICD and DSM, is 
organized into six diagnostic sections and provides diagnostic assessment of 34 
disorders. The DISC consists of screening questions, questions designed to assess 
frequency, duration and intensity of symptoms and further questions designed to 
identify impairments in functioning, previous episodes and treatment. The DISC 
also covers three time frames (the past four weeks, past year and lifetime). 
Questions are asked in a predetermined order and require yes-no answers. The 
caregiver and child version are similar, though the caregiver version includes 
additional questions for disorders, such as schizophrenia, where the youth may 
not be able to reality check. The DISC can be used cross culturally with a variety 
of populations from various countries including Canada, China, Iceland, 
Germany, Netherlands, Scotland, South Africa, Venezuela and Spain. The DISC 
can be used within research and clinical settings and a computerised version is 
available. 
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5.4.2.2 Semi-structured Diagnostic Interviews 
K-SADS  
The K-SADS was constructed from the adult version, the Schedule for 
Affective Disorders and Schizophrenia. There are three versions: the K-SADS-P 
(present), the K-SADS-E (epidemiological) and the K-SADS-PL (current and 
entire life). The K-SADS is widely used to assess childhood internalising 
disorders and is capable of generating a diagnosis of 20 disorders according to the 
DSM. It does this via the use of a series of screening questions and then further 
questions designed to assess the endorsed symptoms. It does not assess symptom 
severity. Each item is rated on a 3-point scale, with 0 indicating there is no 
information available, 2 subthreshold presentation and 3 indicating the presence 
of symptoms. The caregiver and child versions are identical. The K-SADS can be 
used within research and clinical settings and is available online. 
ISCA  
The ISCA, originally named the Interview Schedule for Children, includes 
assessments of the client’s mental state, developmental milestones, global 
functioning, clinical impressions and behavioural observations. The ISCA is the 
only instrument designed specifically to assess childhood-onset mood disorders, 
though it can also diagnose 30 additional disorders. The ISCA is structured 
around symptoms as opposed to diagnostic categories. All questions are 
administered; it does not include a skip function. There is an intake version for the 
first assessment and a follow-up version to track symptom change over time. The 
ISCA begins with the caregiver interview and ends with the child, questions are 
undertaken in the same structure and format though multiple phrasings are offered 
for each item to provide standardised administration whilst ensuring interviewee 
comprehension. The interviewer determines summary ratings for the symptoms 
and combines the information to make a clinically informed diagnosis. The ISCA 
is mainly used in research. 
DICA  
The DICA was constructed according to the Diagnostic Interview 
Schedule and evolved from a structured interview to semi-structured interview. It 
has retained the structured wording though allows interviewers to deviate from 
the script and probe further. The DICA assesses lifetime and current disorders 
according to the DSM, psychosocial risk and protective factors and consists of 
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three distinct interviews; one specifically for children aged 6 to 12, another for 
adolescents aged 13 to 17, and one for caregivers. The two child versions only 
differ in the developmental level of the wording of questions. The DICA can be 
used within research and clinical settings. 
KID-SCID  
The KID-SCID was constructed from the adult version of the Structured 
Clinical Interview and is based on DSM-IV-TR criteria. It assesses 30 disorders 
and has a specific focus on childhood disorders. Clinical judgment plays a central 
role in guiding the interview and in scoring the symptoms. The caregiver and 
child are interviewed separately enabling the interviewer to evaluate the child’s 
symptoms and presentation from an independent point of view. The KID-SCID is 
designed to be used in research settings. 
DIPA   
The DIPA begins with the interviewer reading a scripted probe. This is 
followed-up with questions to obtain examples, and clarify answers until the 
interviewer is satisfied. All of the symptoms required to make a diagnosis are 
presented in the same order as listed in the DSM and functional impairment is 
assessed. The DIPA assesses all disorders within the DSM-IV. The DIPA is used 
with caregivers of children aged 6 or under and is worded so that symptoms can 
be applied to young children e.g., instead of school it queries about daycare. The 
DIPA can be used within research and clinical settings. 
MINI-KID  
The MINI-KID was based on the MINI-International Neuropsychiatric 
Interview. The MINI-KID provides current diagnoses of 28 disorders using DSM 
and ICD criteria. The MINI-KID begins with a screening interview including 
cardinal symptoms to determine which modules should be administered. This 
significantly reduces the number of questions asked and thus administration time. 
Questions are presented in a yes/no format and specific questions to assess 
suicidal ideation and rule out medical, organic or drug causes for the disorder are 
included. The caregiver and child are interviewed separately if children are over 
13 years and together with questions directed at the child for those under the age 
of 13. When assessing for MDD, it includes multiple symptoms within one 
prompt, reducing clinical clarity with regards to which actual symptom is present. 
The MINI-KID is used within research and clinical settings. 
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CAPA  
The CAPA includes a glossary whereby precise and detailed descriptions 
of symptoms in line with the disorders presented in the DSM, are provided in 
order to assist the interviewer to determine which probes to use. The CAPA 
assesses symptoms occurring in the past 3 months. Symptoms are assessed for: 
intensity, time-related severity and psychosocial impairment. First screening 
questions are asked verbatim. If endorsed, mandatory structured questions are 
asked, followed by suggested supplemental questions which gain further clarity. 
The CAPA includes a section on behaviours observed by the clinician during the 
interview, including motor behaviour, mood state and quality of interactions. The 
CAPA also includes assessment of psychosocial impairment. The CAPA is used 
within research and clinical settings. 
PAPA  
The PAPA was derived from the CAPA out of the recognition that there is 
no standardised or reliable method for assessing mental disorders in preschool 
aged children. The PAPA includes all DSM criteria relevant to younger children. 
Clear definitions of symptoms are provided in a glossary and the interviewer is 
expected to question until they can decide whether symptoms are present. The 
PAPA focuses on the 3 months immediately preceding the interview (primary 
period) and also enquires about significant events across the child’s lifetime like 
traumatic life events. The PAPA assesses disability resulting from symptoms, 
family environment, relationships and psychosocial problems. The PAPA is used 
within research and clinical settings. 
CAS  
The CAS was based on the Psychiatric Status Schedule and provides 
diagnostic information for all disorders within the DSM-III. The CAS was 
intended for use by experienced clinicians because interviewers are expected to 
clarify ambiguous answers and judge the presence or absence of symptoms based 
on the child’s reply. To develop rapport, information about the child’s hobbies, 
friends and family are probed for initially. Along with exploration of the presence 
of symptoms, onset and duration, interviewers are required to complete a series of 
observational assessments of the child. The CAS has a focus on clinical 
assessment in order to aid treatment planning and as such the CAS is 
predominantly used within clinical settings. 
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5.4.3 Characteristics of Structured Diagnostic Interviews.  As per 
Table 4, the ChIPS and DISC were the only structured diagnostic interviews, the 
remaining were semi-structured allowing for a more flexible interviewing 
approach. As many of these diagnostic interviews were initially developed for 
research, many could be administered by either clinician or trained interviewer, 
with the exception of the DIPA, ISCA and K-SADS which require administration 
by clinicians. Most of the identified diagnostic interviews were designed for 
children between 6 and 18 years of age, with only two (DIPA and PAPA) 
designed for pre-school aged children (age 0 to 6 years). All diagnostic interviews 
included a caregiver and child version, except the PAPA and DIPA which, due to 
the children’s age, is administered via caregiver by proxy. Generally, the 
caregiver is interviewed first and then the child. There were only three diagnostic 
interviews, the CAPA, DISC and MINI-KID which utilised both the DSM and 
ICD criteria to determine diagnosis, the rest were modelled on the DSM alone. 
The amount of training required varied widely, with the MINI-KID requiring the 
least (1 to 3 hours) and the CAPA (four weeks) the most amount of training. The 
instrument with the shortest administration time was the MINI-KID, followed by 
the ChIPS with it taking approximately 21 to 48 minutes. The rest had 
administration times longer than an hour. The number of studies specifically 
investigating the psychometric properties of each instrument tended to be between 
two and four studies. The most widely researched structured diagnostic interviews 
were the ChIPS, K-SADS and DISC.   
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Table 4.  
Characteristics of Identified Diagnostic Interviews  
 Author Format Age 
Range 
Source Interviewer Diagnostic 
criteria 
Manual Training Administration 
Time 




ChIPS Weller et al,, 
1999 
Weller et al., 
2000 
 




DSM-IV Published Required-length 
could not be 
determined 
20 to 50 15 
DISC  Costello et al., 
1982 
Schaffer et al., 
2000 
 






Published 2 to 3 days 70 to 120 23 
K-SADS Kaufman et al., 
1997 
Puig-Antich 






Clinician DSM-IV Published 2 weeks 180 in total;  
90 for 
caregivers 
 90 for child 
15 








Clinician DSM-IV Access via 
author 
Required- length 




60 for child 
2 












DSM-IV Published 2 to 4 weeks 
depending on 
qualification 
60 to 120 11 









DSM-IV Access via 
author 
31 hours- in person 
or via a DVD 
60 to 120 4 









DSM-IV Published 2 to 4 weeks 60 3 













1 to 3 hours 15 to 40 4 
CAPA Angold & 
Costello, 2000 













Intensive 4 week 
program; two weeks 
of theory and two 
weeks of observed 
practice 
60 to 150 
 
3 










DSM-IV Published 2 weeks 60 to 120 3 







Clinician DSM-IV Access via 
author 
2 days 45 to 60 3 
Note: The general information regarding the diagnostic interviewers was identified on September 18 2015 using MEDLINE, EMBASE, Mental Measurements Yearbook with Tests in Print, psycINFO, psycTEST and 
psycEXTRA; Angold & Costello, 2000; Egger et al., 2004; Garvey et al., 1989; Kaufman et al., 2000, 2004; Mattos et al., 2007; Reich, 2000; Rooney et al., 1999; Rourke & Reich., 2004; Shaffer et al., 2004; Sheehan et al., 1998, 
2010a; Weller et al., 1999, 2000.
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5.4.4 Psychometric Qualities.  The following psychometrics were 
examined: inter-rater reliability, test-retest reliability, validity, sensitivity and 
specificity. These were chosen because they were the most consistently and 
widely reported psychometrics available. As this study was focused on childhood 
internalising disorders, only the properties related to internalising disorders 
(depressive and anxiety related disorders) were recorded. Cohen’s kappa 
coefficient scores (k) which measures the inter-rater agreement of items and takes 
into account the possibility of agreement occurring by chance (Sim & Wright, 
2005) and intraclass correlation coefficient (ICC) which describes how strongly 
units within the same measure resemble each other (Koo & Li, 2016) were used. 
Kappa and ICC were utilised as these were the specific metrics presented within 
the studies reviewed. Converting the kappa and ICC scores into one standard 
measure was considered. However, it was decided against due to the lack of 
information presented within articles to enable accurate conversion. According to 
Koo and Li (2016) kappa and ICC scores below 0.50 are considered poor, 0.50 to 
0.75 moderate, 0.75 to 0.90 good and above 0.90 excellent. Sensitivity involves 
the proportion of actual positives that are correctly identified as positives whilst 
specificity measures the proportion of actual negatives that are correctly identified 
(Lalkhen & McCluskey, 2008). Both sensitivity and specificity were presented as 
percentages within the reviewed studies. The lowest and highest percentages for 
internalising disorders for each measure are presented below; 50% was 
considered poor, 50 to 70% moderate, 70 to 90% good and 90% was considered 
excellent (Lalkhen & McCluskey, 2008).  
As seen in Table 5, the inter-rater reliability of the CAS, ISCA and ChIPS 
across studies was relatively uniform, with kappa scores suggesting near perfect 
inter-rater reliability. The DISC, K-SADS, KID-SCID and DICA’s inter-rater 
reliability varied quite widely, with some studies suggesting there was moderate 
to substantial agreement and others near perfect agreement.  
Although test-retest reliability was widely studied, the time frames in 
which they were measured varied. Some studies used a standard 7 day week, 
whilst others investigated test-retest reliability after 3 months. Further, each 
instrument used varying information to determine test-retest reliability. For 
example, the CAPA and DICA assessed test-retest reliability by examining the 
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results from the child version, whereas the K-SADS and K-SCID synthetised both 
the caregiver and child’s interviews and finally the PAPA and DIPA utilised 
information obtained from the caregivers. Consequently, there should be some 
caution when comparing the diagnostic interviews and interpreting results. 
Nevertheless, studies suggest that caregiver versions for both clinical and 
community populations had better test-retest reliability. Overall, the MINI-KID, 
K-SADS and CAPA had the best test-retest reliability for internalising disorders 
whilst the PAPA, KID-SCID and DICA had among the poorest.  
Interestingly, most published studies focused on reliability over validation. 
No studies were identified assessing the validity of the CAPA, PAPA and ISCA. 
Within the studies reviewed, validity was generally assessed via the comparison 
with a diagnosis made by a clinician or another more established diagnostic 
interview, predominantly the DISC. Results obtained were fair to moderate, 
though DICA, DISC and CAS had substantial concordance. Poor to moderate 
concordance was found between caregiver and child reports. Overall, the 
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Table 5.  








CAPA κ = 0.50-0.88 κ = 0.64-0.90 N/A N/A N/A 
ChIPS κ = 0.89 κ = 0.20-0.66 κ = 0.41-0.65 80-88% 57-78% 
DICA κ = 0.75-0.90 κ = 0.48-0.63 κ = 0.84 61-88% 53-87% 
KID-SCID κ = 0.71-1 κ = 0.55 κ = 0.61 N/A N/A 
K-SADS κ = 0.65-0.96 κ = 0.58-0.87 κ = 0.47-0.74 42-60% 91-98% 
PAPA κ = 0.50-0.72 κ = 0.43-0.57 N/A 81% 79% 
DISC ICC 0.66-1 κ = 0.55-0.92 κ = 0.50-0.80 73-82% 66-75% 
DIPA ICC 0.77 κ = 0.48-0.76 κ = 0.40-0.70 N/A N/A 
ISCA ICC 0.80-0.95 N/A N/A N/A N/A 
MINI-KID κ = 0.7-0.81 κ = 0.68-95 κ = 0.38-0.1 60-81% 73-85% 
CAS κ = 0.92 ICC-0.57-0.78 κ = 0.68-0.82 78% 83% 
Note: N/A=not available 
Information obtained from Angold & Costello, 1995a, b; Apter et al., 1989; Bravo et al., 1993, 2001; Costello et al., 1985;  Cubo et al., 2011; de la Osa et al., 1996, 1997; Egger et al., 2006; Ezpeleta et al., 1997; Ezpeleta et al., 2011; Fisher et al., 
1993; Fristad et al., 1998a, b, c; Garvey et al., 1989; Ghanizad et al., 2006; Granero et al., 1998; Ho et al., 2005; Hodges et al., 1989; Jensen et al., 1995; Johnson et al., 1999; Kaufman et al.,1997; Kim et al., 2004; King et al., 1997; Kunst et al., 
2009; Liu et al., 2011; Moreno et al., 2006; Paing et al., 2010; Piacentini et al., 1993; Reich, 2000; Ribera et al., 1996; Roelofs et al., 2015; Rubio-Stipec et al., 1994; Scheeringa & Haslett, 2010; Schwab-Stone 1995; Schwab-Stone et al., 1993, 1994, 
1996; Shaffer et al., 1993, 1996; Shaffer et al., 2000; Shahrivar et al., 2010; Shanee et al., 1997; Sheehan et al., 1998; Sheehan et al., 2010b, c; Sherrill & Kovacs, 2000; Smith et al., 2005; Sylwia et al., 2014; Swenson et al., 2007; Teare et al., 1992; 
Teare et al., 1998a, b; Ulloa et al., 2006; Welner et al., 1987; Wood et al., 2002
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5.5 Discussion 
Structured diagnostic interviews represent best-practice assessment in 
assessing childhood internalising disorders (Calinoiu & McClellan, 2004). 
Despite this, to date, no systematic review identifying the available structured 
diagnostic interviews and their psychometric properties has been conducted. The 
lack of a resource for researchers and clinicians to refer to when attempting to 
decide which instrument is most suitable for their needs has led to confusion and 
the utilisation of inadequate tools such as screening measures (Cuijpers, Van 
Straten, Smits, & Smit, 2006; Stockings et al., 2015). This has also resulted in a 
failure to utilise symptom-based approaches within research which has 
subsequently limited the understanding of how childhood internalising disorders 
actually present. Consequently, the aim of this review was to identify and 
summarise the psychometric properties of existing structured and semi-structured 
diagnostic interviews designed to diagnose childhood internalising disorders. 
Currently, there are 11 diagnostic interviews available for clinicians and 
researchers to utilise when assessing childhood internalising disorders.  
Structured and semi-structured diagnostic interviews permit diagnostic 
assessment in accordance with systematic, specific criteria for mental disorders 
thereby reducing criterion and information variance (Gutterman, O'Brien, & 
Young, 1987). Structured and semi-structured formats are distinguished by the 
type of interchanges allowed between the interviewer and the respondent (Gray et 
al., 2009). Less structure allows more room for clinical judgment by allowing 
interviewers to deviate from the “script” (Gray et al., 2009). This provides greater 
potential for gathering richer and more accurate information, as the interviewer is 
allowed to engage in more of a dialogue and clarify responses as necessary 
(Calinoiu & McClellan, 2004; Reynolds, 1994). Likewise, however, there is more 
room for bias to distort assessment. Nevertheless, in comparison to screening 
measures and clinical interviews, structured and semi-structured interviews 
improve the diagnostic process by utilising standardised methods to organise and 
collect clinical data whilst eliminating biases (Gray et al., 2009).  
Whilst the basic characteristics of each instrument are similar, diagnostic 
interviews differ with regards to the structure (e.g., K-SADS-less structured and 
DISC-very structured), the diagnoses assessed (20 disorders versus 36), 
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administration requirements (trained lay interviewer versus clinician) and the 
manner in which questions are clustered (K-SADS versus ISCA; Gray et al., 
2009; Gutterman et al., 1987). All interviews use a branching format whereby 
additional items such as inquiries about the onset and duration are asked and 
recorded verbatim. Generally, interviews include extensive manuals and require 
some training, though as demonstrated the length and comprehensiveness of 
training varies. Most provide the opportunity for assessing depressive symptoms 
from the perspective of the caregiver and child. The PAPA and DIPA are the only 
diagnostic interviews designed for children younger than 6 and who make use of 
caregiver by proxy reporting alone.  
There was relatively high inter-rater reliability demonstrated across 
diagnostic interviews and studies. This is likely related to the use of criterion-
based questions which improves interrater diagnostic fidelity by ensuring 
homogeneity in how symptoms are defined, viewed and assessed (Calinoiu & 
McClellan, 2004). Further, due to the systematic nature in which information is 
collected, the variance related to personal characteristics of the interviewer is 
significantly reduced. Despite the ISCA having among the highest and most 
consistent inter-rater reliability, research regarding its validity, test-retest 
reliability, sensitivity and specificity is lacking and needs to be extended upon via 
a more comprehensive assessment of its psychometric quality.  
Overall, across diagnostic interviews test-retest reliability was considered 
relatively low. This may have occurred for a number of reasons including the 
child’s age, attention span, difficulties appreciating abstract criteria and the 
temporal nature of symptoms in children. Finally, the studies reviewed used 
varying time-frames to assess symptoms and impairment (7 days to 3 months). 
Nevertheless, the MINI-KID appears to have the best test-retest and concurrent 
reliability with near perfect results obtained in some studies. In terms of the time 
taken to administer the MINI-KID, the limited training required and the sound 
psychometrics, the MINI-KID appears to confer several advantages. However, it 
is limited to children over 6 years of age, there are only 4 studies on its 
psychometric quality, it does not include observations of the child, it is not widely 
used and it has not been assessed cross culturally.  
The DISC, one of the most widely utilised diagnostic interviews, although 
having the second highest inter-rater reliability had varying psychometric 
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properties with some studies suggesting its test-retest reliability and validity is as 
low as 0.50. Whilst these results suggest it is not as sound as initially believed, the 
vast amount of research investigating this instrument within varying countries and 
in varying languages as opposed to the average three studies for other diagnostic 
interviews may explain the lower numbers achieved. The DISC utilises both DSM 
and ICD criteria, is comprehensive and is the only instrument with research 
regarding its widespread use cross culturally. Consequently, despite the large 
variation in its psychometrics, the DISC is the most widely used and researched 
structured diagnostic interview for children and thus, at this point, should 
represent the assessment of choice.  
As discussed above, despite the great advances in the development of 
structured and semi-structured diagnostic interviews over the past 20 years, a 
number of weaknesses remain. Many have little consistent research available 
supporting their reliability and validity and most research is conducted by the 
authors of the measures, likely introducing some bias. Confounding this further is 
the inability to conduct nosological comparisons due to most available interviews, 
except the DISC, MINI-KID and CAPA, being tied to a single diagnostic system. 
Furthermore, the impact of ethnic, cultural, and socioeconomic differences on the 
outcomes of these diagnostic interviews has not been sufficiently studied, limiting 
the ability to determine if and which questions influence comprehension among 
these populations. 
The main limitation of this review was the heterogeneity (e.g., different 
age groups used, time elapsed) between studies assessing the psychometric 
properties of the diagnostic interviews as this makes direct comparisons between 
measures difficult (Cohen, O'Connor, Lewis, Velez, & Malachowski, 1987). A 
further limitation was the variation in the conceptualisation and measurement of 
depressive and anxiety disorders across structured diagnostic interviews. For 
example, some combined depressive and anxiety disorders into internalising 
disorders, others separated them to represent each depressive and anxiety related 
disorder that is present in the DSM, whilst others only recorded the disorders that 
occurred within the sample (e.g., social phobia and generalised anxiety disorder, 
dysthymia but not the other disorders that fall within the internalising disorders 
category).  
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Structured diagnostic interviews have many benefits and are, with 
increased understanding of childhood internalising disorders, becoming more 
applicable to childhood presentations. For example, irritability was made the 
focus of diagnosis for MDD within structured diagnostic interviews following 
findings that childhood MDD encompasses predominantly irritability (Luby et al., 
2014). At this point, the psychometric data available for these diagnostic 
interviews remains under established. Nevertheless, taken together, findings 
suggest that all diagnostic interviews, except the ISCA (lacks research) offer 
acceptable psychometrics and obtain a comprehensive range of information 
regarding symptom presentation. Though at this point the DISC confers the 
highest number of advantages. Studies reviewed commonly evaluated the 
psychometric properties of these diagnostic interviews individually but not 
comparatively. Consequently, more research, particularly that which looks at 
directly comparing each instrument’s psychometric qualities to one another is 
required. To increase clinical utility and thus use within clinical settings, the 
lengthy assessment processes could be reduced by identifying the symptoms that 
are key in the presentation of childhood disorders.  
With the findings from this systematic review it is clear that the DISC is 
the most widely used and researched instrument and offers a culturally sensitive 
and largely psychometrically sound tool for a symptom-based investigation of 
depressive symptoms. Achieving an understanding of how depressive symptoms 
present in children with ADHD versus children without ADHD will provide 
knowledge that will enable a move towards a more proficient and accurate 
diagnostic and treatment process. Consequently, the following two studies sought 
to achieve this via a cross-sectional and longitudinal investigation into depressive 
symptoms in children with and without ADHD. 
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6. Children’s Attention Project Method 
Data for study two and three were collected as part of the Children’s Attention 
Project (Sciberras et al., 2013). The Children’s Attention Project had four primary 
aims; 
1. To describe ADHD symptoms across the early years of primary 
school.  
2. To evaluate the extent to which children with ADHD have elevated 
risks of poor academic, social and mental health outcomes and quality 
of life when compared to non-ADHD controls.  
3. To assess the impact ADHD presentations, symptom severity, 
comorbidity and other child, family, school and socioeconomic factors 
have on these functional outcomes.  
4. To evaluate the extent to which caregivers of children with ADHD 
have elevated risks for poor mental health and quality of life. 
See the protocol paper (Sciberras et al., 2013) for further information. 
 
6.1 Ethics  
Ethics approval (see Appendix C) was obtained from the Human Research 
Ethics Committees of the Royal Children’s Hospital, Melbourne (#31056), the 
Victorian Department of Education and Early Childhood Development 
(#2011_001095) and Deakin University, Australia (#2016-396). School principals 
and teachers were required to provide consent at baseline. Caregivers (biological, 
step, foster or other legal guardians) were required to provide consent for 
participation at each stage of the study; baseline and follow up.  
 
6.2 Design 
The Children’s Attention Project is a community-based longitudinal 
cohort study of non-referred children with ADHD and matched non-ADHD 
controls (Sciberras et al., 2013). Baseline data collection commenced in 2011 and 
was collected over two consecutive years. Participants were then followed 18 
months and 3 years post-recruitment.Data from baseline and 3 year follow up 
were utilised for the present thesis due to the inclusion of the DISC-IV/the 
assessment of depressive symptoms at these two points. To aid with 
understanding, these time points are referred to as age 7 (baseline) and age 10 (3 
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year follow up). Study two used cross-sectional data at age 7, while study three 
used longitudinal data from age 7 to age 10. 
 
6.3 Setting and Location  
The Children’s Attention Project was coordinated by a research team at 
the Murdoch Children's Research Institute, located at The Royal Children’s 
Hospital, Melbourne, Australia (Sciberras et al., 2013). 
Children were recruited from 43 mainstream government (inclusive) 
primary schools in the Western and Eastern regions of metropolitan Melbourne, 
Australia. The region was chosen due to its representation of a diverse range of 
socioeconomic communities as recorded in the administrative departmental 
database using the Index of Community Socioeconomic Advantage (mean = 
1000, SD = 100; Barnes, 2011).  
 
6.4 Participants  
6.4.1 Inclusion criteria.  Participants included children aged 6 to 8 years,  
in their second year of formal schooling (Grade 1), the parent who identified as 
the primary caregiver and the child’s current school teacher. This age group was 
chosen as the recruitment point as research suggests this is the developmental 
stage where diagnosis is common and functional impairments related to 
symptoms of ADHD begin to manifest (Barkley, 2014; Sciberras et al., 2013). 
Consequently, sampling of younger age groups would have resulted in missed 
cases, whilst later sampling may have increased caseness and reduced 
opportunities to reliably record and track key early influences on developmental 
trajectories (Sciberras et al., 2013).  
6.4.2 Exclusion criteria.  Children with an intellectual disability (IQ<70), 
a serious medical condition, moderate to severe sensory impairment, neurological 
problem or a genetic disorder were excluded from the study. As were those whose 
caregivers lacked sufficient English to complete study questionnaires and 
interviews. Those whose ADHD caseness were not confirmed via the DISC-IV 
were excluded from the study. See the measures section for further information 
regarding the assessment of exclusion criteria.  
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6.4.3 Sample size.  
At baseline, the sample consisted of a total of 391 participants; 179 with a 
with a normal, paediatric, medical diagnosis of ADHD  (ADHD group) and 212 
children without a diagnosis of ADHD (the non-ADHD control group; see Figure 
2). Within the 
 ADHD group 124 were males and 55 females. The mean age for the children 
with ADHD was 7.29 years. The non-ADHD control group consisted of 135 
males and 77 females, with a mean age of 7.32 years at baseline. 
At follow up, the sample consisted of a total of 266 participants (see 
Figure 3). Of the 128 within the ADHD group, 85 children continued to have a 
with a normal, paediatric, medical diagnosis of ADHD whilst 43 no longer met 
criteria for ADHD. Despite no longer meeting criteria, the decision to retain these 
cases within the ADHD group, due to their initial diagnosis of ADHD and the 
potential for there to be functional impacts, was made. Within the non-ADHD 
control group, 4 children received a normal, paediatric, medical diagnosis of 
ADHD at follow up whilst 138 did not meet criteria for ADHD. Those who met 
criteria for ADHD within the non-ADHD control group were excluded from 
longitudinal analyses. The mean age at follow up for the children within the 
ADHD group and the non-ADHD control group was 10.49 years. 
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Figure 2. Screening and Diagnostic Process at Baseline, Age 7.
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Figure 3. Re-assessment and Diagnostic Process at Follow up, Age 10 
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6.5 Measures 
Caregiver- and teacher- completed measures were assessed at age 7 and 
10. As seen in Table 6, measures assessed a range of factors including 
inclusion/exclusion criteria, family characteristics, ADHD, depressive symptoms, 
MDD and other comorbidities, and functional outcomes (i.e. social, behavioural, 
academic functioning and quality of life). The measures included in the study are 
widely used in Australia and internationally and all were considered to possess 
sound psychometric properties.  
 
Table 6.  
Summary of the Measures Included within Study Two and Three 






C •   
ADHD symptoms 
 
Conners 3AI Caregiver & 
Teacher ADHD index 
 









Strengths and Difficulties 
Questionnaire (SDQ) 
 







C, T •  •  
Quality of Life Pediatric Quality of Life 
Inventory (Peds QL) 
 
C •  •  
α C= Caregiver-reported measures, T = Teacher-reported measures. 
Specific information regarding the measures used in study two and three 
are detailed below. 
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6.5.1 Demographic Measures.  Demographic information was collected 
at age 7, during the initial screening phase, via a caregiver questionnaire (see 
Appendix D and E). The questionnaire contained brief demographic details about 
the child (e.g., date of birth and sex), a question regarding previous diagnoses and 
medical conditions and direct questions assessing exclusion criteria. Contact 
details, if caregivers consented to follow up, were also collected within this 
questionnaire. 
The caregivers recruited into the study completed a more detailed baseline 
questionnaire, which included questions regarding the caregivers’ relationship to 
the child (biological, step, foster or other legal guardian), their sex (male or 
female), their relationship status (has a partner; yes/no), the caregiver’s education 
level (highest education achieved; year 9 or less, yes 10 or 11, year 12, completed 
a university degree; yes/no) and current family income (below 3$0,000 per year, 
$30,001-$60,000, $60,001-$90,000 or above $90,001 per year) . All variables, 
except child sex, were reassessed at age 10.  
6.5.2 ADHD Identification and Diagnosis 
6.5.2.1 Screener for ADHD; Conners 3rd Edition ADHD Index (Conners 
3AI).  The presence of ADHD symptomatology was assessed at age 7 via the 10-
item Conners 3AI caregiver and teacher form (see Appendix F and G; Conners, 
2007). The Conners 3AI was utilised as it can be completed within 10 minutes, 
does not pose a large burden to raters and covers inattention, hyperactivity and 
impulsivity symptoms.  
The Conners 3AI uses the rater’s response (ether caregiver or teacher) to 
determine whether a child is more similar to children with a diagnosis of ADHD 
or children without a diagnosis. The Conners 3AI does this by providing a 
composite measure of the full spectrum of symptoms of ADHD. Items are rated 
on a 4-point scale from “not true at all” to “very much true”. Teacher report via 
the Conners 3AI was utilised to provide further, independent information 
regarding whether or not children were symptomatic across settings. Teachers 
completed the Conners 3AI within school hours while caregivers completed the 
Conners 3AI at home. 
The Conners 3AI is a validated measure in children, has excellent internal 
reliability and good sensitivity and specificity (Conners, Sitarenios, Parker, & 
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Epstein, 1998; DuPaul, 1991; Erhart, Döpfner, Ravens-Sieberer, & Bella Study 
Group, 2008; Gallant, 2007). 
Cut off scores for the Conners 3AI points were based on the pilot study 
which was conducted by Sciberras and colleagues (unpublished) in 2009/2010 
with nine schools and 389 families. Pilot data indicated that the best 
correspondence with diagnostic criteria for this population occurred at the 75th 
percentile for males and 80th for females. A higher cut off point, indicating the 
presence of more symptoms, was used for females as the pilot study demonstrated 
that it resulted in better correspondence with diagnostic criteria.  
Children were considered to have screened positive for ADHD and were 
eligible for inclusion in the ADHD group, if they did not meet the exclusion 
criteria, had a caregiver reported diagnosis of ADHD and/or they met cut off 
scores for the Conners 3AI on both the caregiver and teacher report. Children 
were considered to have screened negative for ADHD and were eligible for 
inclusion in the non-ADHD group, if they did not meet the exclusion criteria, they 
had no caregiver reported diagnosis of ADHD and if scores on both caregiver and 
teacher Conners 3AI were less than the 75th percentile for age for males and less 
than the 80th percentile for age for females. 
6.5.2.2 Confirmation of ADHD and assessment of comorbid disorders; 
DISC-IV.    The diagnosis of ADHD was assessed/confirmed and comorbid 
internalising and externalising disorders identified via the DISC-IV at age 7 and 
age 10 (Shaffer et al., 2000). The DISC-IV is a caregiver-completed structured 
diagnostic interview designed to assess for the presence of 34 childhood 
psychiatric disorders.  
Diagnoses are separated into 26 diagnostic sections that are arranged into 
six modules of related disorders. These include mood disorders (MDD, 
dysthymia, mania, hypomania), anxiety disorders (agoraphobia, generalised 
anxiety, panic, social phobia, post-traumatic stress disorder), disruptive disorders 
(conduct, oppositional defiant disorder), schizophrenia, ADHD, eating disorders 
(bulimia, anorexia nervosa) and substance use disorders (alcohol, marijuana and 
other substance disorders).  
The DISC-IV ascertains the presence or absence of symptoms and 
includes all the information needed, as specified by the DSM and ICD, to arrive at 
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a diagnosis for each module. The DISC-IV assesses for the presence of disorders 
across three different time points; present (past 4 weeks), past year and whole life. 
The DISC-IV has approximately 3,000 questions including; stem questions, 
contingent questions, age of onset questions and impairment questions, treatment 
questions and whole life questions (Fisher et al., 2006). There are 358 stem 
questions that are asked of every respondent. They describe the essential aspects 
of a disorder in broad terms and are overly sensitive. There are 1300 contingent 
questions which are asked if a stem or previous contingent question has been 
answered positively. Contingent questions help determine whether an endorsed 
symptom meets frequency, duration and intensity criteria and thus contingent 
questions reduce the administration time. Age of onset and impairment questions 
are only asked if a clinically significant number of symptoms (half or more of 
those required for a diagnosis) have been endorsed. Age of onset questions help 
determine the age of the child when the symptoms first appeared, the age at which 
the current symptoms presented and whether there has been more than one 
episode. Impairment questions are uniform across all diagnosis and form a two-
part question structure; the first determining whether impairment is present and 
the next the degree to which the symptoms/diagnoses cause distress, impairment 
or impact academic and social functioning. Treatment questions assess whether 
any appointment about the condition has been made, who it was, what was 
diagnosed and what treatment was prescribed. Answers in the DISC-IV are 
mainly in the form of “yes”/“no”, though there are some impairment questions 
which provide the following response choices; “somewhat”, “refuse to answer”, 
“not applicable”, “do not know” and “a lot of the time/very bad”, “some of the 
time/bad” or “hardly ever/not too bad”. As no hierarchical scoring rules are 
applied, diagnostic sections can be dropped without impacting the scoring of 
other included diagnosis. The dropping of sections reduces the time taken to 
complete the DISC-IV and increases willingness to participate. The 
administration of the DISC-IV took between 90 and 120 minutes to complete and 
was completed within one sitting. The DISC-IV was completed by parents and 
there were no signs of fatigue across the administration.  
Version N algorithms were used to confirm ADHD status and the presence 
of other disorders. Children were considered to have ADHD if they met all 
criteria for the disorder according to the DSM-IV. Specifically, children had to 
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experience six or more symptoms of inattention and/or six or more symptoms of 
hyperactivity/impulsivity. A persistent pattern of symptoms, that occurred prior to 
7 years of age and that were more severe than other children at a comparable level 
of development, was required. Finally, children needed to experience clinically 
significant impairment across settings.  
Children were classified as having an internalising disorder if they met 
criteria according to the DSM-IV for separation anxiety disorder, social phobia, 
generalized anxiety disorder, post-traumatic stress disorder, obsessive-compulsive 
disorder, dysthymic, hypomania, or manic episode. Children were classified as 
having an externalising disorder if they met DSM-IV criteria for oppositional 
defiant disorder or conduct disorder. 
The DISC-IV was initially developed for use in large-scale 
epidemiological studies of children and adolescents, though is now widely and 
commonly used in clinical studies and service settings (Shaffer et al., 1993; 
Shaffer et al., 2000). As outlined within the systematic review in chapter 5, in 
comparison to other structured diagnostic interviews assessing childhood 
internalising disorders, the DISC-IV offers a widely researched, culturally 
sensitive and comprehensive measure that aligns with both the ICD and DSM. 
Consequently, the DISC-IV was the chosen measure due to the large number of 
studies supporting its positive psychometric qualities and its ability to accurately 
identify symptoms and diagnose ADHD and childhood internalising disorders 
including childhood MDD (Bravo et al., 2001; Ho et al., 2005; Shaffer et al., 
1993; Shaffer et al., 2000).  
6.5.3 Symptom-based Assessment of MDD; DISC-IV.  Depressive 
symptomatology and the presence of MDD was measured at age 7 and 10 using 
the DISC-IV (details about the DISC-IV were provided above). As can be seen in 
Table 7, depressive symptoms assessed included criterion a1-presence of 
depressed or irritable mood, criterion a2-diminished interest or pleasure, criterion 
a3-weight loss/gain or appetite change, criterion a4-insomnia or hypersomnia, 
criterion a5-psychomotor agitation or retardation, criterion a6 fatigue or loss of 
energy, criterion a7 worthlessness or guilt, criterion a8-diminished ability to think 
or concentrate and criterion a9-thoughts of death, suicidal ideation and suicide. 
Items included “In the last month, was there a time when the child was often 
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grouchy, irritable or in a bad mood, when even little things would make the child 
mad?” To meet each criterion, caregivers were required to endorse one of the 
symptoms within the specific criterion as well as any five of the other criteria. For 
example, to meet criterion 1 participants were required to experience either a sad 
or irritable mood along with diminished interest, changes in sleep, psychomotor 
changes, suicidal ideation and diminished ability to concentrate or think. This 
meant that participants could endorse items across the criterion whilst still not 
reaching the threshold for the overall criterion. 
Children were considered to have MDD if they met all criteria according 
to the DSM-IV. Specifically, children had to experience depressed or irritable 
mood and/or a loss of interest or pleasure in daily activities for most of the day, 
nearly every day for at least two weeks. Additionally, they had to experience at 
least four of the symptoms within Table 7 nearly every day. The symptoms had to 
represent a change from the child’s baseline and cause distress or impair 
functioning.  
In accordance with the DISC-IV which states that for a diagnosis of 
subthreshold MDD at least half of the criteria must be met and/or impairment 
from symptoms indicated, children were considered to have subthreshold MDD 
and labelled as having MDD if they presented with depressive symptoms 
(whether or not symptoms were part of a MDD or dysthymia presentation) but 
failed to meet the stringent cut off, for example, they experienced four and not 
five symptoms.  
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Table 7. 
Depressive Symptoms Assessed Using the DISC-IV 
Depressive Symptoms Required for diagnosis of MDD 
according to the DSM 
Assessed 
Criterion 1:  Depressed or irritable mood √ 
     Sad/depressed √ 
     Grumpy/irritable √ 
  
Criterion 2: Diminished interest or pleasure √ 
     Didn't enjoy anything/not interested √ 
  
Criterion 3: Weight loss/gain or appetite changes √ 
     Loss of weight √ 
     Loss of appetite √ 
     Gained weight √ 
     Felt hungrier/ate more √ 
  
Criterion 4: Change in Sleep  √ 
     Trouble sleeping (Insomnia) √ 
     Slept more (Hypersomnia) √ 
  
Criterion 5: Psychomotor agitation or retardation √ 
     Slowed down walking/talking √ 
     Felt restless  √ 
  
Criterion 6: Fatigue or loss of energy √ 
     Less energy than usual √ 
     Doing little things made them tired  √ 
     Felt as if their arms and legs were heavy √ 
  
Criterion 7: Worthlessness or guilt √ 
     Blamed self for bad things  √ 
     Felt bad about self √ 
  
Criterion 8: Thinking or concentration problems or indecision √ 
     Inability to think as clearly/fast √ 
     Trouble keeping focused √ 
     Difficulty making decisions √ 
  
Criterion 9: Thoughts of death, suicidal ideation, suicide √ 
     Often thought about death/dying √ 
     Thought seriously about killing self √ 
     Tried to kill self √ 
 
 
6.5.4 Functional Outcome Measures.  A number of measures were 
utilised to assess children’s functioning at age 7 and age 10.  
6.5.4.1 Strengths and Difficulties Questionnaire (SDQ; Goodman, 
1997). Social and behavioural functioning at age 7 and 10 was assessed using the 
caregiver- and teacher-reported versions of the SDQ at age 7 and age 10 (see 
 Appendix H). The SDQ is a brief behavioural screening questionnaire for  
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completion by caregivers and teachers of children aged 3 to 16 years old.  
Items are divided into five subscales: emotional problems (five items, e.g., 
easily scared), conduct problems (five items, e.g., often lies or cheats), 
hyperactivity/inattention (five items, e.g., cannot stay still for long), peer 
problems (five items, e.g., gets along better with adults than other children) and 
prosocial behaviour (five items, e.g., considerate of peoples’ feelings). The 
conduct problems, peer problems and prosocial behaviour subscales were used 
within study three. Ratings were based on the child’s behaviour over the previous 
six months. Answers were scored on a three point scale; either “not true”, 
“somewhat true” or “certainly true”. For each subscale the scores ranged from 0 
to 10.  Higher scores were considered indicative of poorer functioning on the 
peer and conduct problems subscales, and indicative of better functioning on the 
prosocial behaviour subscale. The SDQ was sent home with caregivers to 
complete in their own time and teachers completed it during school time. It took 
approximately 10 minutes to complete. 
The SDQ has been normed on a random sample consisting of 910 
individuals aged 7 to 17 years from government schools across Melbourne, 
Australia (Mellor, 2005). Additionally, a large study (N = 1359) of Australian 
children aged 4 to 9 assessed the internal consistency, stability and externality 
validity of the caregiver report SDQ (Hawes & Dadds, 2004). The internal 
reliability across the subscales was α = 0.66 for conduct problems, α = 0.59 for 
peer problems and α = 0.70 for prosocial behaviour.  Subscales were found to be 
strongly related to each other (adequate validity). Moderate external validity was 
evidenced in the correlations between the SDQ subscales and diagnostic 
interviews (ranging between 0.42 and 0.79). The SDQ was also able to adequately 
detect changes across a 12 month period; conduct problems r = 0.65, peer 
problems r = 0.61 and prosocial behaviour r = 0.64. A further study seeking to 
validate the SDQ for teachers in children with a mean age of 7 found very good 
internal consistency within the SDQ teachers version (α = 0.64 for conduct 
problems, α = 0.60 for peer problems and α = 0.81 for prosocial behaviour; van 
den Heuvel et al., 2017). The SDQ was also found to have good sensitivity (90%) 
and specificity (94%). Overall, the psychometric qualities of the SDQ appear 
sound, with reliability moderate and validity good (Goodman, 2001; Hawes & 
ADHD AND MDD IN CHILDHOOD                                                                97 
 
   
Claire I Joseph Deakin University 210667098 
 
Dadds, 2004; Lundh, Wangby-lundh, & Bjarehed, 2008; Muris, Meesters, & van 
dan Berg, 2003; Stone et al., 2010; van den Heuvel et al., 2017; Yao et al., 2009).  
6.5.4.2 Social Skills Improvement System (SSIS; Gresham & Elliott, 
2008).   Academic functioning was assessed at age 7 and 10 via the SSIS 
Academic Competence subscale (see Appendix I). It is a scale suitable for children 
aged 3 to 18 years. This measure is completed by teachers and assesses 
motivation to learn and reading and math achievement. The SISS asks teachers to 
rate the child based on comparisons to same aged peers using a scale of 1 to 5, 
with 1 being the student is in the lowest 10% of the class and 5 being the student 
is in the highest 10% of the class. Raw scores were converted to standard scores 
(M = 100, SD = 15) based on the child’s age. The SSIS was completed during 
school hours by the child’s primary teacher and took approximately 5 minutes to 
complete.  
The norms for the SSIS were based on the 2006 American census 
involving 4,700 children aged 3 to 18, 2,800 caregivers and 385 teachers 
(Gresham & Elliott, 2008). The academic competence scale of the SSIS is widely 
used within the ADHD literature and has high internal consistency (α = 0.97), 
test-retest reliability (0.87) and moderate inter-rater reliabilities (0.48-0.69; 
Gresham & Elliott, 2008; Gresham, Elliott, Vance, & Cook, 2011; Klaussen, & 
Rasmussen, 2013). Content, internal structure and convergent validity are all 
considered sufficient (Gresham & Elliott, 2008; Gresham, Elliott, Cook, Vance, & 
Kettler, 2010; Klaussen, & Rasmussen, 2013).   
6.5.4.3 Pediatric Quality of Life Inventory (PedsQL; Varni, Seid, & 
Kurtin, 2001).   The PedsQL was utilised to assess the child’s quality of life at 
age 7 and age 10 (see Appendix J). The PedsQL is a brief assessment that 
measures the core dimensions of health as delineated by the World Health 
Organisation (Varni et al., 2001). The inventory presents a list of 23 items 
covering potential difficulties and is responsive to clinical changes across time. 
The PedsQL asks caregivers to rate, on a scale from 0 (never a problem) to 4 
(almost always a problem), how much of a problem each item has been over the 
past month. Quality of life subscales include social (5 items, e.g., getting along 
with others, α = 0.81), school (5 items, e.g., keeping up with school work, 
α = 0.75), physical (8 items, e.g., participating in spots activity or exercise, 
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α = 0.87), and emotional (5 items, e.g., feeling sad or blue, α = 0.79; Varni et al., 
2001). Item scores are reverse coded and converted to a 100-point scale. Scale 
scores are computed as the sum of the items divided by the number of items 
answered. From the four core scales, three standardised summary scores can be 
calculated; total quality of life score (23 items-all items), physical health 
summary score (8 items, based on the physical functioning items) and 
psychosocial quality of life summary score (15 items, combining emotional, 
social and school items). Scores range from 0 to 100, with higher scores 
indicative of better quality of life. The PedsQL was completed by caregivers in 
their own time and takes approximately five minutes to complete.  
The PedsQL 4.0 is the only empirically validated generic pediatric 
measure of quality of life that spans the age range of 5 to 18 years (Varni, 
Burwinkle, Seid, & Skarr, 2003). The PedsQL has good internal consistency, α = 
0.90-0.92 for caregiver-reported total scale QoL (Varni et al., 2001; Varni et al., 
2003). Research suggests that the PedsQL is able to accurately distinguish 
between children with chronic conditions and healthy children (Varni et al., 2001; 
Varni et al., 2003). A study aiming to assess the psychometric properties of the 
PedsQL in a child psychiatric population found internal consistency of the 
PedsQL was α = 0.87 for caregiver report; Bastiaansen, Koot, Bongers, Varni, & 
Verhulst, 2004). Significant correlations between the PedsQL and measures of 
psychopathology indicate good convergent validity. Good criterion related 
validity was demonstrated with significantly lower scores (i.e. poorer quality of 
life) for children with a psychiatric problem in comparison to non-referred 
children. Overall, the PedsQL is believed to be a valid instrument for measuring 
quality of life in children referred for psychiatric conditions (Bastiaansen et al., 
2004; Varni et al., 2001; Varni et al., 2003).  
 
6.6 Procedure 
6.6.1 Recruitment.  Schools within the Western and Eastern regions of 
metropolitan Melbourne (see Sciberras et al., 2013) were invited to attend an 
information session during regional network meetings.  
Following information sessions school principals who indicated an interest 
in the study were visited by the lead investigator and further information was 
provided. Meetings to discuss project details with teachers were also arranged 
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during this visit. Schools were accepted into the study if teachers indicated 
support and principals signed a research agreement form regarding the school’s 
contribution to data collection. Forty three schools agreed to participate. Plain 
language statements and consent forms were provided (see Appendix K-P).  
To facilitate data collection, enable teachers to complete questionnaires 
during work hours and compensate schools for teacher participation, teacher relief 
funding was provided. A school prize for the school with the highest proportion 
of caregiver consent forms returned (both accepted and declined) was supplied 
each year. 
6.6.2 Screening.  With caregiver consent, all Grade 1 children (aged 6 to 
8) in 2011 and 2012 in participating schools were screened for ADHD symptoms 
using a two-stage screening process; completion of the questionnaire including 
the Conners 3AI and completion of the DISC-IV. The questionnaire and 
information sheets were sent home with children for caregivers to complete in 
their own time. Upon completion, caregivers were asked to return the 
questionnaire in sealed envelopes via classroom collection boxes or via reply-paid 
mail. Upon receipt of caregivers consent forms and questionnaires, teachers were 
asked to complete the Conners 3AI.  
At two and four weeks after the initial distribution, reminder letters and 
replacement questionnaires were re-sent home to all those who did not decline to 
participate but had not returned the questionnaire. A school nominated liaison 
personnel was made responsible for following up outstanding teacher 
questionnaires. 
Sixty three percent of all those approached had completed caregiver and 
teacher screening questionnaires available. No significant differences (assessed 
using t-test and chi squared tests) with regards to age and sex were found between 
responders and non-responders, though responders tended to come from more 
socially advantaged areas (Green et al., 2015).   
As cross-situational impairment is a key requirement for a diagnosis of 
ADHD, children were considered to have screened positive for ADHD if: scores 
on both caregiver and teachers Conners 3AI were equal to or above the designated 
percentile cut off point for age and sex (see the measures section for further 
information) or caregivers reported a diagnosis of ADHD. All children who 
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screened positive, who did not meet exclusion criteria and where consent for the 
next stage was provided, were allocated to the ADHD group.  
Children were considered to have screened negative for ADHD and were 
eligible for inclusion as non-ADHD controls if; scores on both caregiver and 
teacher Conners 3AI were below the cut off and they had no caregiver reported 
diagnosis of ADHD. All children who screened negative, who did not meet 
exclusion criteria and where consent for the next stage was provided were 
allocated to the non-ADHD control group.  
Assessment occurred at baseline, the 18 month point and 36 month point. 
As diagnostic information was only collected at baseline and the 36 month follow 
up, these data points were the focus of the present thesis. However, it is to be 
noted that contact with participants was made and maintained across the time 
period.  
6.6.3 Diagnostic case confirmation and age 7 data collection.  Each 
child screening positive for ADHD was randomly matched on sex and school to a 
negative screen. Caregivers of these children were telephoned and invited to 
participate in the longitudinal component of the Children’s Attention Project. All 
caregivers who provided consent underwent an extensive assessment process. 
Age 7 assessment included; diagnostic interviews via the DISC-IV with 
caregivers to assess ADHD, depressive symptoms, MDD and other mental health 
conditions, and surveys to assess functioning (SDQ, SSIS, PedsQL). Teachers 
also completed surveys to assess the child’s functioning (SDQ, SSIS).  
The DISC-IV was administered by trained interviewers who had at least a 
four year under-graduate degree in psychology, were comprehensively trained in 
all procedures and were blind to the participants’ screening status and any 
previous diagnoses like MDD. Interviewers were trained in DISC-IV 
administration by a Clinical Psychologist during a full day workshop and then 
completed three practices before commencing fieldwork. All interviewers 
attended fortnightly supervision meetings to discuss issues around DISC-IV 
administration and to provide an opportunity to debrief. 
No staff member undertook both caregiver and child assessments in order 
to ensure that interviewers were blind to the participants diagnostic status. The 
DISC-IV was conducted face to face with caregivers, at home or at the child’s 
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school, in accordance with preference. No feedback was given to caregivers or 
teachers regarding the child's screening status prior to completion of the 
assessment.  
6.6.4 Study three data collection.   Caregivers of children from both the 
ADHD and non-ADHD control groups who participated at age 7 were contacted 3 
years later and invited to participate at age 10. The follow up assessment process 
enabled tracking of outcomes through the cusp of puberty (9-11 years), a critical 
developmental transition point, particularly with regards to the development of 
depressive symptoms.   
Age 10 assessments were conducted across 2014 and 2015. Blinding was 
maintained at follow up. Caregiver and teacher completed assessments and 
interviews that were administered at age 7 including the DISC-IV, SDQ, SISS 
and PedsQL were re-administered with the caregiver and the child’s current 
teacher at age 10. The procedure for the collection of age 10 data was the same as 
above. As some participants were reluctant to participate at age 10, due to the 
time involved, the option was given to complete certain components of the 
follow-up (i.e. sections only as opposed to the full DISC-IV interview) in an 
attempt to increase participation rates.   
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7. Statistical Method 
7.1 Overview 
This section describes the statistical methods and analyses used for studies 
two and three. This section first outlines the assumptions related to the analyses 
and how these were assessed. Secondary analyses were conducted using Stata 
13.0 (StataCorp, 2013). Although the risk of Type 1 errors were increased by the 
number of statistical tests performed, in accordance with Howell (2002) 
correction for multiple comparisons were not warranted as a priori predictions 
were made. For all analyses an alpha level of 0.05 was used as the cut off for 
significance and exact p values are reported where appropriate. Effect sizes 
(Cohen’s d) were calculated and reported where relevant, with 0.20 indicating 
small effect sizes, 0.50 medium and 0.80 large effect sizes (Cohen, 1992). For 
analyses reporting associations between MDD and functioning, both 
unstandardized and standardised coefficients are reported, as well as confidence 
intervals and Adjusted R2.  
 
7.2 Assumptions 
7.2.1 Missing data.  All questionnaires were visually inspected for 
missing data. For sections that appeared to have been overlooked, the respondent 
was contacted and the section was completed over the phone with willing 
participants. Visual inspection for missing or anomalous data was conducted on 
the dataset. For any analysis that included missing data, Stata automatically 
deleted them listwise. Total N ranges are summarised in footnotes under each 
results table.  
7.2.2 Outliers.  An outlier is an extreme value which can unduly influence 
results (Tabachnick & Fidell, 2007). To examine the distribution of the data and 
identify outliers scatter plots were generated. There were no outliers identified by 
inspection or as indicated by Cooks d values greater than 1 for study two.  
Within study three one outlier within the ADHD group with regards to 
depressive symptoms at age 7 and 10 was identified (see Figure 4 and 5). To 
address this and ensure that it was not unduly influencing results, analyses were 
run with and without the outlier. As results were similar suggesting that it was not 
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unduly influencing results, the outlier was included in all reported analyses. See 
Appendix Q for a summary of the results excluding the outlier.  
 
 
Depressive symptoms in the ADHD group at age 7  
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7.2.3 Normality.   Normality assumes that the spread of data are 
symmetric around the centre and follow a normal bell-shaped distribution 
(Tabachnick & Fidell, 2007). As linear and logistic regression rely on the 
assumption of normality, this was examined. Continuous outcome variables were 
visually examined for normality using histograms, followed by formal tests in the 
form of the Univariate kernel density and Shapiro–Wilk W test for normality.   
These tests indicated that the data from the following variables were non-
normal; depressive symptoms at age 7 and age 10, SDQ prosocial behaviour, peer 
problems and conduct problems, quality of life at age 7 and 10. However, the 
large sample size meant data was robust to this violation (Lumley, Diehr, 
Emerson, & Chen, 2002).  
7.2.4 Linearity.  Linearity refers to the relationship between the 
independent variables and the dependent variable forming a straight line 
(Tabachnick & Fidell, 2007). Linearity was assessed via the examination of 
scatter plots. There was evidence that the residuals for teacher reported peer and 
conduct problems, caregiver reported peer problems and prosocial behaviour and 
quality of life were somewhat non-linear. Given the large sample size data were 
considered robust to the violation of linearity.  
7.2.5 Multicollinearity.  Multicollinearity exists when two or more 
independent variables are highly correlated/linearly related (Tabachnick & Fidell, 
2007). Multicollinearity was assessed via the variance inflation factor. Several 
depressive symptoms were multicollinear at 0.69. As this value does not suggest a 
perfect relationship and given that depressive symptoms are expected to be related 
this multicollinearity is to be expected. Consequently, analyses continued and no 
correction to the individual symptoms were made. Several criteria were,  
however, due to significant multicollinearity with the symptoms that made each 
criterion up, automatically omitted from analyses and thus no results relating to 
those criteria were available.   
7.2.6 Homoscedasticity.   The assumption of homoscedasticity occurs 
when the error term is the same across all values of the independent variables 
(Tabachnick & Fidell, 2007). The violation of homoscedasticity, called  
heteroscedasticity, means that the size of the error term differs across the 
independent variable (Tabachnick & Fidell, 2007). When homoscedasticity is 
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violated the cases with larger distributions and errors have more weight than other 
observations which then biases results (Tabachnick & Fidell, 2007). 
Heteroscedasticity with clear patterns of values falling on either the far left or 
right side was detected in study three. The syntax “robust” was used as this 
computes a robust variance estimator and accounts for the impact of 
heteroscedasticity. Results prior to this correction and following it were similar, 
indicating that heteroscedasticity had little impact on the outcome. Nevertheless 
results both prior to and after correcting for heteroscedasticity are reported in the 
result section for study three (from page 164).   
7.2.7 Confounding variables.  Whilst an adjusted linear regression 
including confounding variables was planned for study two, due to the small 
number of participants endorsing each of the depressive symptoms (N ranged 
from 0 to 26) this was not possible.  
Potential confounding variables, as determined by previous research and 
current analyses which outlined the variables that were significantly different 
between the ADHD and non-ADHD groups, were controlled for within study 
three. Child sex was controlled for due to previous research which has 
consistently found sex differences in the frequency of ADHD and MDD (Arcia & 
Conners, 1998; Brunsvold et al., 2008; Gaub & Carlson, 1997b; Ghada et al., 
2012; Neuman et al., 2001; Rucklidge & Tannock, 2001; Turgay et al., 2005; 
Yang et al., 2011; Yoshimasu et al., 2012). The presence of externalising 
comorbidities were controlled for as previous research has suggested that the co-
occurrence of externalising disorders with any other disorder significantly impacts 
functioning (Burt, Krueger, McGue, & Iacono, 2003; Kusche, Cook, & 
Greenberg, 1993; Renouf Kovacs & Mukerji, 1997). Medication use was 
controlled for due to its goal of reducing learning, behavioural and emotional 
difficulties and improving functioning. In addition to the significant difference 
within the sample, research has demonstrated that caregiver education, 
relationship status and mental health greatly impacts the outcomes of children 
(Amato & Keith, 1991; Blanden & Gregg, 2004; Brown, 2004; Chevalier, 
Harmon, O’Sullivan, & Walker, 2013; Mayer, 1997; Smith, 2004; Stallard, 
Norman, Huline-Dickens, Salter, & Cribb, 2004; Wills, McNamara, & Vaccaro, 
1995). Consequently, adjusted analyses controlled for child sex, the presence of 
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an externalising comorbidity at age 7 and/or age 10, use of medication at age 7 
and/or age 10, caregiver education level, caregiver relationship status at age 7 and 
clinical levels of caregiver mental health difficulties at age 7 and/or 10. 
7.2.8 Addressing the low number of cases with MDD.  Due to the small 
number of children who experienced depressive symptoms (N = 26), Fisher’s 
exact, an exact measure of statistical significance that takes into account small 
cell counts and ensures maximal accuracy, was utilised and presented in order to 
ensure accuracy.  
7.2.9 Type 1 error vs Type 2 error. Multiple comparisons across groups 
and within groups were made. Whilst this increases the potential for Type 1 errors 
a correction such as a Bonferroni correction was not made as this would have 
reduced the power of the study and increased the potential for Type 2 errors 
(Ranstam, 2016). 
 
7.3 Study Two Analyses  
7.3.1 Descriptive Statistics.  To understand the sample characteristics of 
each group and determine whether they differed, two sets of analyses were 
undertaken. For continuous data (i.e., age), differences between groups were 
examined using t-tests with means and standard deviations reported. For 
categorical data (all other data), chi square analyses were used with number and 
percentages were reported.  
7.3.2 Aim 1: Examine whether the measurement of MDD is 
represented similarly across those with ADHD relative to non-ADHD 
controls.  A confirmatory factor analysis was used to assess the measurement 
invariance of all depressive symptoms in children with ADHD relative to non-
ADHD controls. As the data were binary a standard factor analysis using Stata 
could not be performed accurately. Consequently, analyses were conducted using 
Mplus version 7.2 (Muthén & Muthén, 1998-2017). 
The minimum amount of data for factor analysis was satisfied, with a final 
sample size of 391, providing a ratio of over 17 cases per variable (Tabachnick & 
Fidell, 2007). The weighted least squares mean and variance adjustment estimator 
were used within the analysis due to the ordered categorical nature of the item 
scaling on the MDD measure (Muthén & Muthén, 1998-2010). These estimation 
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methods and THETA paramterisation were used to estimate all models as these 
are robust estimation methods that account for violations to the assumptions of 
factor analyses (Brown, 2014; Muthén & Muthén, 1998-2012). Model fit was 
evaluated in accordance with Hu and Bentler (1999); non-significant goodness-of-
fit test (p > .05), comparative fit index (CFI) ≥ 0.95, and root-mean-square-error 
of approximation (RMSEA) ≤ 0.06. 
Invariance of the measurement of MDD across the two groups (i.e., 
ADHD vs non-ADHD control) was examined using a three step approach 
outlined in detail in Muthén and Muthén (1998-2010). Step one was conducted to 
determine whether the factor structure was invariant across the ADHD and non-
ADHD control group, that is, whether the two groups conceptualised MDD in the 
same way and whether the same number of factors for MDD were observed 
across groups. Step one involved leaving the thresholds and factor loadings free to 
vary across groups whilst fixing the residual variances to one and factor means to 
zero for both the ADHD and non-ADHD control group. Step two assisted with 
determining whether the ADHD and non-ADHD control group responded to the 
depressive items in the same way (i.e. full metric invariance). Step two involved 
constraining the thresholds and factor loadings to be equal across groups. The 
residual variances and factor means for the ADHD group were left free to vary 
whilst in the non-ADHD control group the residual variances were fixed to one 
and factor means to zero. Step three was used to determine whether partial metric 
invariance held. Step three involved inspecting the modification indices and 
leaving those with the largest source of misfit free to vary. Nested model 
comparisons were conducted using a chi-square difference test implemented with 
the DIFFTEST function in Mplus which adjusts analyses when using weighted 
least squares mean and variance adjustment estimator.  
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7.3.3 Aim 2: Determine whether children with ADHD have elevated 
depressive symptoms relative to non-ADHD controls and whether depressive 
symptoms in children with ADHD differ according to key clinical 
characteristics (i.e., ADHD presentation and comorbidity status).  An 
unadjusted linear regression in which total depressive symptoms were regressed 
on to a grouping variable (i.e., ADHD versus non-ADHD control) was used to 
determine whether children with ADHD have elevated depressive symptoms 
when compared to non-ADHD controls. In this analysis, depressive symptoms 
were the dependent variable and ADHD status (ADHD/control) the independent 
variable.   
Analysis of Variance was used to compare depressive symptoms across 
the three ADHD presentations: Combined, Inattentive, Hyperactivity/Impulsivity, 
while linear regression was used to examine whether depressive symptoms 
differed in children with ADHD by comorbid anxiety and externalising disorder 
status. In order to determine whether children with ADHD only experienced more 
depressive symptoms those with ADHD and MDD, those with MDD were 
excluded and analyses investigating individual symptoms re-run. 
7.3.4 Aim 3: Examine the profile of depressive symptoms in children 
with ADHD relative to non-ADHD controls and identify which depressive 
symptoms, if any, discriminate ADHD and non-ADHD samples. To examine 
group differences at a symptom level, a series of unadjusted and adjusted logistic 
regressions (adjusting for child sex, medication use, caregiver relationship status, 
income and education) were planned. However, due to the low number of 
children with depressive symptoms (N=26), these were not possible. 
Consequently, the frequency of the occurrence of the depressive symptoms, both 
in numbers and percentages, was calculated and presented. Additionally, chi-
square analyses comparing the prevalence of each depressive symptom across the 
groups were conducted and presented.  
In order to ensure that symptoms experienced in children with ADHD 
were not due to the use of medication, the frequency of each symptom in those 
using medications versus those who were not using was compared via chi-square 
analyses.  
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7.4 Study Three Analyses  
In order to be included in study three, assessment of depressive symptoms 
using the DISC-IV at both time points was required. Consequently, those who did 
not complete the full ADHD and MDD sections of the DISC-IV at both time 
points were excluded from analyses.  
7.4.1 Descriptive Statistics.  A similar approach to study two to 
understand the sample characterises and determine whether they differed was 
used (see above, 7.3.1 Descriptive statistics for further information).  
Analyses comparing descriptive statistics in those with complete versus 
incomplete data was conducted in order to examine the potential impact of 
attrition on results. 
Given the low numbers of children meeting the full criteria for MDD, 
children who met both full and subthreshold MDD were combined into one 
group. Two new variables which included those with subthreshold and threshold 
depressive symptoms at age 7 and age 10 were created. The above descriptive 
analysis were then undertaken again on those with ADHD and MDD versus those 
with ADHD only. The persistence of ADHD from age 7 to age 10 was 
investigated via a chi square analysis.  
7.4.2 Aim 1. Understand the presentation of depressive symptoms and 
MDD in children with and without ADHD across 3 years, at age 7 and 10.  
For all regressions, the F-test was used. R-squared was reported and used to 
determine how much variance in the dependent variable was accounted for by the 
independent variable. Due to the small number of participants endorsing 
depressive symptoms adjusted analyses were not possible. 
7.4.2.1 Determine whether depressive symptoms at age 7 were associated 
with depressive symptoms at age 10 in children with ADHD and non-ADHD 
controls.  Separate linear regressions were conducted to determine whether 
depressive symptoms at age 7 were associated with depressive symptomatology at 
age 10. Analyses were run within the ADHD and non-ADHD control group 
separately. Depressive symptoms at age 7 were the independent variable and 
depressive symptoms at age 10 the dependent variable.   
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7.4.2.2 Determine whether depressive symptoms at age 7 were associated 
with MDD at age 10 in children with ADHD and non-ADHD controls.  Separate 
logistic regressions were conducted to determine whether depressive symptoms in  
children aged 7 with ADHD were associated with MDD (subthreshold and 
threshold symptoms of MDD) at age 10. Analyses were run within the ADHD 
and non-ADHD control group separately. Depressive symptoms at age 7 were the 
independent variable and MDD at age 10 dependent variable.   
7.4.2.3 Determine which depressive symptoms at age 7 were associated 
with MDD at age 10 in children with ADDH and non-ADHD controls.    For 
each symptom a frequency matrix was produced which identified those with 
MDD at age 10 who did or did not endorse the depressive symptom at age 7 and 
those without MDD at age 10 who did or did not endorse the depressive symptom 
at age 7. Each depressive symptom at age 7 was the independent variable and 
MDD the dependent variable.   
Individual logistic regressions were conducted on each symptom in order 
to determine which depressive symptoms were significantly associated with MDD 
in children aged 10. Due to the small number of participants who had MDD 
within the non-ADHD control group analyses on individual depressive symptoms 
for this group were not possible. 
7.4.3 Aim 2. Examine the association between depressive symptoms at 
age 7 and functioning (social, behavioural and academic functioning and 
quality of life) at age 10 in children with ADHD and non-ADHD controls.  
Summary statistics for all functional outcomes of interest were undertaken. A 
series of linear regression analyses were used to examine the association between 
depressive symptoms at age 7 and functioning at age 10 in children with and  
without ADHD separately. Adjusted analyses were also conducted. See “Section 
7.2.7 Confounding variables” for further information regarding what was 
controlled for. Analyses were also conducted with a group by interaction term to 
see if the association between depressive symptoms and functioning was different 
across the two groups. Depressive symptoms at age 7 were the independent 
variable and functioning at age 10 the dependent variable.    
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8. Characterisation of Depressive Symptoms in Young Children 
with and without Attention Deficit Hyperactivity Disorder 
8.1 Abstract 
8.1.1 Background.  Depressive symptoms and ADHD are prevalent and 
commonly co-occur in childhood. To assist with early identification of MDD in 
children with ADHD, we aimed to: 1) use factor analysis to determine whether 
the construct of MDD is measured consistently in those with and without ADHD; 
and 2) determine whether overall depressive symptoms and specific depressive 
symptoms were elevated in young children with ADHD relative to controls. 
8.1.2 Method.  Participants comprised a community-based sample of 179 
children with ADHD (51% Combined, 35% Inattentive, 12% Hyperactive) and 
212 non-ADHD controls aged 6 to 8 years. Participants were screened for ADHD 
and underwent a structured diagnostic interview which confirmed ADHD status 
and assessed depressive symptoms. 
8.1.3 Results. The factor structure of depressive symptoms was similar, 
enabling comparisons between the two groups to be made. Eighteen children with 
ADHD (10%) and three non-ADHD control participants (1%) experienced either 
MDD or subthreshold MDD. Children with ADHD experienced significantly 
more depressive symptoms than non-ADHD controls (Cohen’s d = 1.19, p<.001), 
with the following symptoms elevated in children with ADHD relative to non-
ADHD controls: sadness (32% versus 14%, p<.001), irritability (52% versus 
19%, p<.001), insomnia (56% versus 22%, p<.001), psychomotor agitation (53% 
versus 9%, p<.001), feeling bad about oneself (50% versus 24%, p<.001), 
difficulty concentrating (75% versus 14%, p<.001) and making decisions (56% 
versus 17%, p<.001). 
8.1.4 Conclusion.  This study provides support for the occurrence of 
depressive symptoms in children with ADHD as young as six and highlights the 
importance of early assessment for depressive symptoms in children with ADHD. 
  
  
ADHD AND MDD IN CHILDHOOD                                                                112 
 
   
Claire I Joseph Deakin University 210667098 
 
8.2 Introduction  
ADHD is the most prevalent neurodevelopmental disorder, affecting 
approximately 5% of children worldwide (Polanczyk et al., 2014). It is estimated 
that children with ADHD are four times more likely than the general population 
to experience MDD, with lifetime prevalence estimates of depressive disorders in 
children with ADHD ranging from 2 to 32% (Australian Government Department 
of Health, 2000; Barkley, 1998; Pliszka, 1998; Spencer, Biederman, & Wilens, 
1999). Those with comorbid ADHD and MDD experience greater impairment, 
morbidity and poorer treatment outcomes when compared to those with either 
condition alone (Biederman et al., 1998; Biederman et al., 2008; Bertha & Balázs, 
2013; Chronis-Tuscano et al., 2010; Freuchen et al., 2012; Georgiades et al., 
2006). Similarly, subthreshold depressive symptoms have been found to have a 
significant impact on emotional, adaptive and psychosocial functioning, suicide 
risk and MDD recurrence (Biederman et al., 1998; Biederman et al., 2008; Bertha 
& Balázs, 2013; Chronis-Tuscano et al., 2010; Freuchen et al., 2012; Georgiades 
et al., 2006). To date, the majority of empirical studies in ADHD have focused on 
investigating the co-occurrence of MDD from a diagnostic level, i.e. the presence 
or absence of MDD (for example, Chronis-Tuscano et al., 2010), with fewer 
studies in young samples of children with ADHD examining their overlap using a 
symptom-based approach. Consequently, it is unclear how depressive symptoms 
present in young children with ADHD and whether this presentation differs from 
children without ADHD. Possessing this information will inform the assessment 
and subsequent management of depressive symptoms in young children with 
ADHD.   
Studies are yet to investigate whether the presentation and expression of 
depressive symptoms on measurement tools is invariant (i.e. the same) across 
children with and without ADHD. Although not specifically investigated, the 
non-specific overlapping symptoms of ADHD and MDD and the side effects of 
medications used to treat ADHD which mimic depressive symptoms (Biederman 
et al., 1998; Pliszka, 1998, Spencer et al., 1999), suggests that measurement 
variance (i.e. differences) across children with and without ADHD is likely. The 
failure to investigate measurement invariance is a glaring omission given that 
measurement invariance is essential when comparing groups, such as those with 
ADHD versus controls, as it ensures that the same underlying construct is being 
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measured and that observed differences are not due to group specific 
measurement effects.  
Understanding differences in depressive symptoms between those with 
and without ADHD is important given that there are approximately 1,000 unique 
symptom combinations that qualify for a diagnosis of MDD (Fried & Nesse, 
2015b). An example of the large variation in the presentation of depressive 
symptoms is the most widely used measure of childhood MDD, the CDI, which 
assesses a broad range of symptoms in order to identify MDD. These are 
externalising including misbehaviour, disobedience and aggression; dysphoria 
including negative affectivity, sadness, irritability; self-deprecation including self-
hate, negative body image and feeling unloved, school problems including decline 
in school performance and social problems including social withdrawal and a lack 
of friendships (Craighead et al., 1998; Hodges et al., 1983). Given the large range 
of symptoms and symptom combinations, it is possible that, in comparison to 
children without ADHD, children with ADHD experience a heterogeneous 
pattern of depressive symptoms. If this is the case, then comparisons across 
groups are likely to be flawed. 
To our knowledge only one previous community-based study has 
compared depressive symptoms in children with (n = 34, mean age = 10) and 
without ADHD (n = 34, mean age = 9.5; LeBlanc & Morin, 2004). This study, 
using the CDI found that children with ADHD experienced significantly more 
depressive symptoms than those without ADHD (12.15 ± 5.38 vs. 6.50 ± 3.74, p 
< .001). Anhedonia was the most common symptom in both groups, though those 
with ADHD experienced significantly more anhedonia than those without ADHD 
(3.89 ± 2.28 vs. 2.53 ± 1.64, p < .001). Negative mood (2.82 ± 1.90 vs. 1.53 ± 
1.31, p < .001), feelings of ineffectiveness (3.09 ± 1.73 vs 1.38 ± 1.56, p < .001) 
and negative self-esteem (1.53 ± 1.46 vs. 1.76 ± 0.70, p < .001) were more 
frequently reported in the ADHD group when compared to the controls. 
Additionally, 15% of children with ADHD endorsed the statement ‘I want to kill 
myself’, with no children from the control group endorsing this item. Whilst this 
study provides evidence of depressive symptoms in ADHD, the sample was small 
and the symptoms examined were from the CDI as opposed to a diagnostic 
instrument.  
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Diler and colleagues (2007), used a clinical sample, the K-SADS-PL and 
the Mood and Feelings Questionnaire to investigate which depressive symptoms 
best discriminated young people aged 5 to 17 with ADHD and MDD (n = 18) 
from those with ADHD only (n = 93). They found that social withdrawal (67% vs 
32%), anhedonia (89% vs. 40%), all 14 depressive cognitions (e.g., could never 
be as good as others 90% vs 56%, felt unloved 94% vs 43%, felt no good 
anymore 89% vs 42%), psychomotor retardation (67% vs 27%) and suicidal 
ideation (61% vs 15%) occurred more frequently in children with ADHD and 
MDD than those with ADHD only. Depressed mood (100% vs 80%), irritability 
(100% vs. 85%), concentration difficulties (94% vs 86%) and appetite (61% vs 
56%) and sleep changes (72% vs 57%) did not significantly differ across the two 
groups. These results are limited by the lack of reference to a typically developing 
comparison group reducing the opportunity to comment on whether depressive 
symptoms differ between those with ADHD and those without (Buitelaar, 2012; 
Luby et al., 2014).  
This study aimed to improve understanding of comorbid depressive 
symptoms in children with ADHD. Using a community-based sample of young 
children aged 6 to 8 years, the research sought to i) first demonstrate 
measurement invariance across groups and then ii) investigate whether children 
with ADHD have elevated depressive symptoms compared to non-ADHD 
controls and whether depressive symptoms in children with ADHD differed 
according to key clinical characteristics (i.e. ADHD presentation, comorbidity 
status; and iii) determine the profile of depressive symptoms in children with 
ADHD, relative to non-ADHD controls by identifying which depressive 
symptoms, if any, discriminated ADHD and non-ADHD samples. It was  
hypothesised that children with ADHD would experience significantly more 
depressive symptoms than non-ADHD controls and that a higher proportion of 
children with ADHD would endorse each depressive symptom compared to non-
ADHD controls. 
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8.3 Method 
8.3.1 Design.  This cross-sectional study involved secondary analysis  
which used baseline data from The Children’s Attention Project, a community-
based longitudinal study of children with and without ADHD (Sciberras et al., 
2013). Ethics approval was obtained from The Royal Children’s Hospital 
(#31056), the Victorian Department of Education and Early Childhood 
Development (#2011_001095) and Deakin University, Melbourne, Australia 
(#2016-396). Schools were recruited via the Victorian Government Department of 
Education and Early Child Development. Baseline data were collected across two 
consecutive years (2011-2012). The methodology has been previously described 
(Sciberras et al., 2013). 
8.3.2 Participants and Procedures.  With caregiver consent, all children 
aged 6 to 8, in Grade 1 were screened for ADHD, as per procedures outlined 
below. Children with an intellectual disability (IQ<70), serious medical condition, 
moderate-severe sensory impairment, neurological problem or genetic disorder 
were excluded, as were those whose caregivers lacked sufficient English to 
complete study questionnaires. All other children in Grade 1 were eligible. This 
age group was chosen as the recruitment point as this is the developmental stage 
where diagnosis is common (Barkley, 2014; Sciberras et al., 2013). 
Caregivers and teachers across the 43 participating schools completed the 
10-item Conners 3AI (Conners, 2008). As cross-situational impairment is a 
requirement for a diagnosis of ADHD, children were considered to have screened 
positive for ADHD if scores on both caregiver and teacher ADHD Indices were 
equal to or above the percentile cut off point for age and sex (≥75th percentile for 
males and ≥80th for females). Any child reported by caregivers as having 
received a diagnosis of ADHD was regarded as a positive screen. Children were 
considered to have screened negative for ADHD and eligible for inclusion into 
the non-ADHD control group if scores on the caregiver and teacher ADHD 
Indices were less than the percentile cut off point, exclusion criteria were not met 
and there was no reported diagnosis of ADHD. Consenting caregivers of all 
children who screened positive and negative and who did not meet exclusion 
criteria were invited to participate. For each positively screened child, a 
negatively screened child matched on sex and school was randomly selected.  
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To confirm ADHD status in both groups, consenting caregivers completed 
the Diagnostic Interview Schedule for Children-IV (DISC-IV; Shaffer et al., 
2000), which included the MDD module. It was completed either at home or at 
the child’s school according to preference. The DISC-IV was conducted by field 
staff who had at least a four year undergraduate degree in psychology, were 
comprehensively trained and blind to the child’s diagnostic status. Interviewers 
were trained in DISC-IV administration by a Clinical Psychologist during a full 
day workshop and then completed three practices before commencing fieldwork. 
All interviewers attended fortnightly supervision meetings to discuss issues 
around DISC-IV administration and to provide an opportunity to debrief. 
The final sample comprised 179 children with ADHD (124 male, 55 
female, mean age 7.30) and 212 children without ADHD (135 male, 77 female, 
mean age 7.33).  
8.3.3 Measures.  
8.3.3.1 Socio-demographic Survey; included questions assessing 
demographic details of the child (e.g. age, sex, diagnostic status and medication 
use) and family characteristics (e.g. respondent’s relationship to the child, 
respondent’s sex, marital status, employment, education and income). 
  The Conners 3AI (Conners, 2008) screened for ADHD symptom severity 
across the last month via 10-items rated on a 4-point scale ranging from ‘not true 
at all’ to ‘very much true’. Both caregiver and teacher report were used. The 
measure has excellent psychometric properties (Conners, 2008).  
8.3.3.2 The DISC-IV (Shaffer et al., 2000); using caregiver report, 
assessed ADHD diagnostic status, identified depressive symptoms and any 
comorbid mental disorders according to DSM-IV criteria. Depressive 
symptoms assessed included depressed or irritable mood (Criterion A1), 
diminished interest or pleasure (Criterion A2), weight loss/gain or appetite change 
(Criterion A3), insomnia or hypersomnia (Criterion A4), psychomotor agitation or 
retardation (Criterion A5), fatigue or loss of energy (Criterion A6), worthlessness 
or guilt (Criterion A7), thinking or concentration problems (Criterion A8), 
thoughts of death (Criterion A9) across the last month. The exact questions that 
assessed the above criteria are listed in Table 7 within chapter 6. Symptoms were 
either endorsed as ‘yes’ or ‘no’. To meet each criterion, caregivers were required 
ADHD AND MDD IN CHILDHOOD                                                                117 
 
   
Claire I Joseph Deakin University 210667098 
 
to endorse one of the symptoms within the specific criterion as well as any five of 
the other criterion. For example, to meet criterion 1 participants were required to 
experience either a sad or irritable mood along with diminished interest, changes 
in sleep, psychomotor changes, suicidal ideation and diminished ability to 
concentrate or think. This meant that participants could endorse items across the 
criterion whilst still not reaching the threshold for the overall criterion. A 
diagnosis of MDD was given if children met criteria for MDD according to the 
DSM-IV. Specifically, they had to experience five or more symptoms across the 
last two weeks that represented a change of functioning and caused impairment or 
significant distress and were not due to other conditions. A diagnosis of 
subthreshold MDD was made in accordance to the DISC-IV algorithms which 
states that at least half of the criteria must be met and/or impairment from 
symptoms indicated. The DISC-IV is widely used and has sound psychometric 
qualities (Shaffer et al., 2000). 
 
8.4 Data Analysis 
To examine whether the measurement of MDD is represented similarly 
across those with and without ADHD, a factor analysis was used to assess the 
measurement invariance of all depressive symptoms in children with ADHD 
relative to non-ADHD controls. Factor analysis was conducted in Mplus v7.11 
(Brown, 2014; Muthén & Muthén, 1998-2010). The weighted least squares mean 
and variance adjustment estimator was used for analysis due to the ordered 
categorical nature of the item scaling on the MDD measure (Muthén & Muthén, 
1998-2010). Model fit was evaluated in accordance with Hu and Bentler (1999); 
non-significant goodness-of-fit test (p > .05), CFI ≥ 0.95, and RMSEA ≤ 0.06. 
Invariance of the measurement of MDD across the two groups (i.e., ADHD vs 
non-ADHD control) was examined using a three step approach (with THETA 
parameterisation) outlined in detail in Muthén and Muthén (1998-2010) and 
reviewed in detail in Putnick and Bornstein (2016) and Mutchen and Asparouhov 
(2002). Briefly, step one involved examining whether the same number of factors 
were observed across groups (i.e., thresholds and factor loadings were left free 
across groups, fixing residual variances to one and factor means to zero in both 
groups). Step two investigated whether the two groups responded to each specific 
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item in the same way (i.e., full metric invariance; involved constraining 
thresholds and factor loadings to be equal across groups). Step three involved 
relaxing parameters found to be different between the groups (i.e., partial metric 
invariance modification indices that identified the largest source of misfit).  
Nested model comparisons were compared using the DIFFTEST function in 
Mplus. Due to the stringent procedure for managing missing data, whereby 
participants were contacted and the missing information completed, there was no 
missing data within the final dataset.  
A linear regression, in which total depressive symptoms were regressed on 
to a grouping variable (i.e., ADHD versus non-ADHD control), was used to 
examine whether children with ADHD experienced elevated depressive 
symptoms compared to non-ADHD controls. Analysis of Variance was used to 
compare depressive symptoms across the three ADHD presentations: Combined, 
Inattentive, Hyperactivity/Impulsivity, while linear regression was used to 
examine whether depressive symptoms differed in children with ADHD by 
comorbid anxiety and externalising disorder status.  
To examine group differences at the symptom level, a series of logistic 
regressions and adjusted regressions (adjusting for child sex, medication use, 
caregiver relationship status, income and education) were planned. However, due 
to the low number of children with depressive symptoms, these were not possible. 
Consequently, chi-square analyses comparing the prevalence of each depressive 
symptom across the groups were conducted. Fishers exact tests were used to 
ensure accuracy despite the small cell counts. Analyses were repeated excluding 
children with ADHD who met MDD criteria to determine whether depressive 
symptoms are more prevalent in ADHD irrespective of MDD diagnosis. Analyses 
specifically comparing depressive symptoms between children with ADHD by 
medication use status were also repeated. Standard significant tests, set at 0.05, 
were used for t-tests analyses. Cohen's d was used to report effect sizes, with 0.20 
indicating a small relationship, 0.50 indicating a moderate relationship, and 0.80 
indicating a strong relationship (Cohen, 1977). Regression analyses were 
conducted using Stata 13.0 (StataCorp, 2013). 
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8.5 Results 
8.5.1 Sample Characteristics  
Compared to non-ADHD controls, children with ADHD were more likely 
to experience internalising (25% ADHD versus non-ADHD 5%) and externalising 
(54% versus 8%) disorders (see Table 8). Fifteen participants in the ADHD group 
met subthreshold criteria for MDD and three met criteria for MDD, compared to 
two who met subthreshold criteria for MDD and only one child who met criteria 
for MDD in the non-ADHD control group. Twenty one percent of the ADHD 
group were taking medication for behavioural or emotional difficulties compared 
with none in the non-ADHD control group. Only one participant was using an 
antidepressant; SSRI Citalopram. Although other family characteristics were 
relatively similar across the groups, more caregivers in the non-ADHD control 
group than in the ADHD group had completed high school (85% versus 69%) and 
university (67% versus 46%). Further, more caregivers in the non-ADHD control 
group earnt more than $90,000 per year (46% versus 23%). 
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Table 8.  
Study Two Sample Demographic Characteristics 
Sample Characteristics 
ADHD 
n =  179 
Freq (%) 
Non-ADHD 
controls n = 212 
Freq (%) 
p 
    
Age, M (SD) 7.30 (0.45) 7.33 (0.38) .41£ 
Sex (n) - - .28€ 
     Male 124 (69%) 135 (63%) - 
     Female 55 (30%) 77 (36%) - 
Diagnosis    
     ADHD Combined 93 (51%) - - 
     ADHD Hyperactive 22 (12%) - - 
     ADHD Inattentive 64 (35%) - - 
     MDD  3 (2%) 1 (0%) - 
     Subthreshold MDD  15 (8%) 2 (1%) < .001€ 
     Comorbid Internalising Disorders 44 (25%) 10 (5%) < .001€ 
     Comorbid Externalising Disorders 97 (54%) 17 (8%) < .001€ 
Medication use 36 (21%) 1 (0%) < .001€ 
     Methylphenidate 23 (14%) 0 < .001€ 
     Clonidine 6 (3%) 0 .008€ 
     Risperidone 3 (1%) 0 .09€ 
     Melatonin 5 (2%) 0 .02€ 
     Other¥ 3 (1%) 0 .09€ 
Family Characteristics    
     Respondent’s relationship to child   .60£ 
          Biological Parent 162 (97%) 198 (98%) - 
          Foster Parent 1 (0%) 0 - 
          Other Legal Guardian 4 (2%) 4 (1%) - 
     Respondent’s Sex   .23£ 
          Male 8 (4%) 16 (7%) - 
          Female 159 (95%) 186 (92%) - 
     Primary caregiver has partner 132 (79%) 184 (92%) < .001€ 
     Respondent’s Education Level - - - 
          Completed high school 116 (69%) 173 (85%) < .001€ 
          Completed university 52 (46%) 107 (67%) < .001€ 
     Income - - < .001€ 
          Below $30,000 per year 28 (17%) 22 (11%) - 
          $30,001-$60,000 per year 44 (26%) 38 (19%) - 
          $60,001-$90,000 per year 45 (27%) 46 (23%) - 
          Above $90,001 per year 47 (28%) 93 (46%) - 
        £ standard significance test for independent t-tests        
        € fisher’s exact p value  
        ¥ 1 SSRI (Citalopram), 1 Lovan, 1, 1 anxiety tablet (not specified) 
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8.5.2 Factor structure and invariance of depressive symptoms in those 
with ADHD versus non-ADHD controls  
Step one of the invariance testing demonstrated that a single MDD  
factor fit the individual depressive symptom items in both the ADHD and non- 
ADHD control group, χ2 (340) = 371.78, p = .11, RMSEA = 0.02, CFI = 0.96 and 
TLI = 0.96. Moving beyond the number of factors underlying the data, step two of 
the analysis demonstrated that restricting the factor loadings and item thresholds 
to full equivalence across both groups resulted in a significantly worse fit, χ2 
(359) = 459.91, p = .00, RMSEA = 0.04, CFI = 0.89 and TLI = 0.88; χ2difftest (19) 
=104.02, p < .001. Consequently, full metric invariance did not hold between the 
ADHD and the non-ADHD control group. Step three explored whether there was 
partial metric invariance between the groups by examining which items were 
causing model misfit and then allowing parameters involving these items to vary 
freely between groups. After inspection of modification indices, the thresholds of 
items ‘grumpy/irritable’, ‘didn’t enjoy anything’, ‘insomnia’, ‘hypersomnia’, 
‘restlessness’, ‘trouble keeping mind on school work’ and ‘difficulty making 
decisions’ were allowed to vary freely between groups. After freeing these 
parameters, the partial metric invariance model was found to have good fit, χ2 
(352) = 386.13, p = .10, RMSEA = 0.02, CFI = 0.96 and TLI = 0.96, and was not 
significantly different from the model presented in Step 1, χ2difftest (12) = 16.39, p 
= .17. These analyses demonstrated partial metric invariance between the ADHD 
and non-ADHD control group (see Table 9) and thus it was appropriate to 
conduct further analysis on the presentation of symptoms across the two groups 
and interpret any group differences in symptoms (‘grumpy/irritable’, ‘didn’t enjoy 
anything’, ‘insomnia’, ‘hypersomnia’, ‘restlessness’, ‘trouble keeping mind on 
school work’ and ‘difficulty making decisions’) as representing true group 
differences on the latent MDD variable.  
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Table 9.  
Factor Loadings Demonstrating Measurement Invariance for Each Depressive 
Symptom in Children with ADHD and non-ADHD Controls. 
Diagnostic Criterion and related Depressive Symptoms 
ADHD 
n = 179 
Non-ADHD 
controls 
n = 212 
Criterion 1:  Depressed or irritable mood   
     Sad/depressed 0.97 0.97 
     Grumpy/irritable 0.75 0.75 
   
Criterion 2: Diminished interest or pleasure   
     Didn't enjoy anything/not interested 2.12 2.12 
   
Criterion 3: Weight loss/gain or appetite changes   
     Loss of weight 0.70 0.70 
     Loss of appetite 1.14 1.14 
     Gained weight 0.42 0.42 
     Felt hungrier/ate more 0.74 0.74 
   
Criterion 4: Change in Sleep    
     Trouble sleeping (Insomnia) 0.44 0.44 
     Slept more (Hypersomnia) 1.43 1.43 
   
Criterion 5: Psychomotor agitation or retardation   
     Slowed down walking/talking 0.90 0.90 
     Felt restless  0.64 0.64 
   
Criterion 6: Fatigue or loss of energy   
     Less energy than usual 1.11 1.11 
     Doing little things made them tired  1.44 1.44 
     Felt as if their arms and legs were heavy 0.77 0.77 
   
Criterion 7: Worthlessness or guilt   
     Blamed self for bad things  - - 
     Felt bad about self 0.81 0.81 
   
Criterion 8: Thinking or concentration problems or indecision   
     Inability to think as clearly/fast 1.17 1.17 
     Trouble keeping focused 0.57 0.57 
     Difficulty making decisions 0.62 0.62 
   
Criterion 9: Thoughts of death, suicidal ideation, suicide   
     Often thought about death/dying 0.50 0.50 
     Thought seriously about killing self 1.62 1.62 
     Tried to kill self - - 
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8.5.3 Prevalence of depressive symptoms in children with ADHD 
versus those without 
When regressing depressive symptoms on to group (unadjusted), it was 
found that children with ADHD experienced more depressive symptoms (M = 5.6, 
SD = 3.5, Range = 0-17) than non-ADHD controls (M = 2.0, SD = 2.5, Range = 0-
16; F(1,389) = 136.61, p < .001) with an R2 of 0.26 and mean difference of -3.58, 
95% CI -4.19; -2.98 between the two groups. A large between groups effect size 
(Cohen’s d = 1.19) was also found. 
Although mean depressive symptoms were highest in the ADHD 
combined presentation (M = 6.0, SD = 3.5), followed by Inattentive (M = 5.3, SD 
= 3.6) and Hyperactivity/Impulsivity (M = 4.9, SD = 3.5) presentations, 
differences between groups were non-significant [F(2, 176) = 1.24, p = .29). 
Depressive symptoms were higher in children with ADHD and an anxiety 
disorder (M = 8.0, SD = 3.9) compared to children with ADHD without an 
anxiety disorder (M = 4.8, SD = 3.1; p < .001). Similarly, depressive symptoms 
were higher in children with ADHD with an externalising disorder (M = 6.7, SD = 
3.6) compared to children with ADHD without an externalising disorder (M = 4.3, 
SD = 3.1; p < .001). 
8.5.4 Presentation of depressive symptoms in those with ADHD and 
non-ADHD controls  
As per Figure 6 and Table 10, a number of depressive symptoms were 
elevated in children with ADHD compared with non-ADHD controls. 
Sadness/depressed mood (32% versus 14%, p < .001), grumpy/ irritability (53% 
versus 20%, p < .001), insomnia (57% versus 23%, p < .001), feeling restless 
(53% versus 9%, p < .001), trouble keeping focused (75% versus 14%, p < .001) 
and difficulty making decisions (57% versus 18%, p < .001) were the highest 
occurring depressive symptoms in children with ADHD and were significantly 
different to controls. Anhedonia, loss of weight and appetite, heaviness of limbs, 
blaming self for bad thing, thoughts about dying and suicidal ideation also 
significantly differed across the two groups. 
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Table 10.  
Frequency of Depressive Symptoms in Children with ADHD and non-ADHD 
Controls 
Diagnostic Criterion and related Depressive Symptoms 
ADHD 









exact p  
 
Criterion 1:  Depressed or irritable mood 11(6%) 1 (1%) .002 
     Sad/depressed 58 (32%) 29 (14%) < .001 
     Grumpy/irritable 94 (53%) 42 (20%) < .001 
    
Criterion 2: Diminished interest or pleasure 5 (3%) 1 (1%) .09 
     Didn't enjoy anything/not interested 29 (16%) 16 (8%) .01 
    
Criterion 3: Weight loss/gain or appetite changes 4 (2%) 0 .04 
     Loss of weight 18 (10%) 4 (2%) .001 
     Loss of appetite 31 (17%) 15 (7%) .002 
     Gained weight 6 (3%) 7 (3%) 1.00 
     Felt hungrier/ate more 46 (26%) 43 (20%) .23 
    
Criterion 4: Change in Sleep  1 (1%) 0 .46 
     Trouble sleeping (Insomnia) 102 (57%) 48 (23%) < .001 
     Slept more (Hypersomnia) 5 (3%) 5 (2%) 1.00 
    
Criterion 5: Psychomotor agitation or retardation - - - 
     Slowed down walking/talking 5 (3%) 2 (1%) .25 
     Felt restless  95 (53%) 20 (9%) < .001 
    
Criterion 6: Fatigue or loss of energy 1 (1%) 0 .46 
     Less energy than usual 27 (15%) 17 (8%) .04 
     Doing little things made them tired  16 (9%) 7 (3%) .03 
     Felt as if their arms and legs were heavy 23 (13%) 4 (2%) < .001 
    
Criterion 7: Worthlessness or guilt 2 (1%) 1 (1%) .59 
     Blamed self for bad things  30 (17%) 12 (6%) < .001 
     Felt bad about self 91 (51%) 51 (24%) < .001 
    
Criterion 8: Thinking or concentration problems or indecision 1 (1%) 0 .46 
     Inability to think as clearly/fast 27 (15%) 8 (4%) < .001 
     Trouble keeping focused 135 (75%) 30 (14%) < .001 
     Difficulty making decisions 102 (57%) 38 (18%) < .001 
    
Criterion 9: Thoughts of death, suicidal ideation, suicide 2 (1%) 0 .21 
     Often thought about death/dying 50 (28%) 29 (14%) .001 
     Thought seriously about killing self 10 (6%) 1 (1%) .003 
     Tried to kill self 3 (2%) 0 .01 
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When those with MDD were excluded from the analysis the following 
depressive symptoms were no longer significantly different; criterion 1 (from p = 
.002 to p = .379), anhedonia (p = .0001 to p = .08), less energy than usual (p =.04 
to p = .251) and fatigue after doing little (p = .03 to p = .056). Attempts at suicide 
became significant (p = .095 to p = .048).  
As can be seen in Table 11, whether symptoms in children with ADHD 
differed between those on medication versus those who were not was also 
examined. These analyses suggested that the prevalence of depressive symptoms 
did not differ by medication use, with the exception of “often thinking about 
death/dying” which was higher in the medication group (50%) compared to the no 
medication group (22%). 
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Table 11.  
Frequency of Depressive Symptoms in Children with ADHD by Medication Status 
(yes/no) 
Diagnostic Criterion and related Depressive 
Symptoms  
ADHD not using 
Medication 




n = 36 
Freq (%) 
Fisher’s 
exact p  
 
Criterion 1:  Depressed or irritable mood 9 (7%) 1 (3%) 0.36 
     Sad/depressed 41 (31%) 12 (33%) 0.82 
     Grumpy/irritable 64 (49%) 24 (67%) 0.06 
    
Criterion 2: Diminished interest or pleasure 3 (2%) 1 (3%) 0.87 
     Didn't enjoy anything/not interested 19 (15%) 8 (22%) 0.27 
    
Criterion 3: Weight loss/gain or appetite changes 2 (2%) 1 (3%) 0.62 
     Loss of weight 9 (7%) 6 (17%) 0.07 
     Loss of appetite 20 (15%) 9 (25%) 0.17 
     Gained weight 4 (3%) 0 0.29 
     Felt hungrier/ate more 35 (27%) 5 (14%) 0.11 
    
Criterion 4: Change in Sleep  0 1 (3%) 0.06 
     Trouble sleeping (Insomnia) 71 (54%) 22 (61%) 0.46 
     Slept more (Hypersomnia) 3 (2%) 2 (6%) 0.31 
    
Criterion 5: Psychomotor agitation or retardation -  - 
     Slowed down walking/talking 2 (2%) 1 (3%) 0.62 
     Felt restless  66 (50%) 22 (61%) 0.25 
    
Criterion 6: Fatigue or loss of energy 1 (1%) 0 0.56 
     Less energy than usual 22 (17%) 3 (8%) 0.21 
     Doing little things made them tired  11 (8%) 3 (8%) 0.99 
     Felt as if their arms and legs were heavy 16 (12%) 4 (11%) 0.86 
    
Criterion 7: Worthlessness or guilt 2 (2%) 0 0.46 
     Blamed self for bad things  20 (15%) 10 (27%) 0.08 
     Felt bad about self 68 (52%) 19 (53%) 0.93 
    
Criterion 8: Thinking or concentration problems or 
indecision 
0 1 (3%) 0.06 
     Inability to think as clearly/fast 19 (15%) 5 (14%) 0.93 
     Trouble keeping focused 99 (76%) 28 (78%) 0.78 
     Difficulty making decisions 74 (56%) 22 (61%) 0.62 
    
Criterion 9: Thoughts of death, suicidal ideation, 
suicide 
2 (2%) 0 0.46 
     Often thought about death/dying 30 (22%) 18 (50%) 0.001 
     Thought seriously about killing self 8 (6%) 2 (6%) 0.90 
     Tried to kill self 1 (1%) 2 (6%) 0.06 
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8.6 Discussion  
This study builds upon the limited body of research examining depressive 
symptoms in children with ADHD by extending findings to a large, community-
based sample of young, pre-adolescent children with and without ADHD. The 
factor structure of depressive symptoms was found to be similar across the two 
groups. We found strong evidence of elevated depressive symptoms in young 
children with ADHD compared to non-ADHD controls, with irritability, 
insomnia, psychomotor agitation, feeling bad about oneself, difficulty 
concentrating and making decisions the most common symptoms experienced by 
young children with ADHD.  
Findings indicated that the factor structure of MDD is similar for children 
with and without ADHD. Specifically, we found that a one factor structure was 
observed in both groups, and that partial measurement invariance was 
demonstrated across groups. This provides evidence that the presentation of MDD 
for children aged 6 to 8 with and without ADHD is unidimensional and that items 
are being interpreted similarly by both groups. This is an important first step 
when comparing groups across symptoms such as MDD as it ensures that it is not 
simply measurement error that is influencing group differences. As such, 
demonstration of partial metric invariance provides a strong basis for group 
comparisons across depressive symptoms. 
The present study sought to determine whether young children with 
ADHD have elevated depressive symptoms compared to non-ADHD controls. As 
expected, results confirm that young children, across all three presentations of 
ADHD experienced more depressive symptoms than those without ADHD. This 
is consistent with previous research findings that suggest that children with 
ADHD compared to those without experience greater depressive symptoms 
(Biederman et al., 2004; Kitchens, Rosen, & Braaten, 1999; LeBlanc & Morin, 
2004). We extend previous research by indicating that children with ADHD as 
young as 6 years old are more likely to experience depressive symptoms than 
their non-ADHD counterparts, highlighting the need for screening for MDD in 
children with ADHD from a young age. We also demonstrate that in young 
children with ADHD the occurrence of anxiety and externalising disorders is 
associated with an increase in depressive symptoms relative to those with ADHD 
only. This finding suggests that there is a subpopulation of children with ADHD 
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who are at a higher risk of developing depressive symptoms. Whilst previous 
research indicates that the occurrence of MDD is not due to “false positives” 
(Biederman et al., 1998), given the increase in the presentation of depressive 
symptoms in those with multiple disorders, future research should investigate 
whether the presence of depressive symptoms is due to the demoralisation that 
many children with ADHD and co-occurring disorders experience. This research 
would also benefit from investigating associated risk trajectories and functional 
impairment using a longitudinal design.  
In comparison to non-ADHD controls, children with ADHD experienced 
many elevated depressive symptoms including depressed mood, irritability, 
anhedonia, loss of weight and appetite, restlessness, fatigue, loss of energy and 
insomnia. They also experienced more concentration difficulties, depressive 
cognitions such as blaming oneself and feeling bad about oneself and more 
suicidal ideation. The non-ADHD control group did not experience any symptoms 
at a higher rate than the ADHD group, though this is likely explained by the near 
absence of MDD within the non-ADHD group. These findings provide support 
for LeBlanc and Morin (2004) who also found that the depressive symptoms that 
occurred more frequently in children with ADHD included depressed or irritable 
mood, anhedonia, feeling bad about oneself along with thoughts about killing 
oneself. Whilst the children with ADHD across both studies experienced more 
thoughts about killing oneself than those without ADHD, only 5% of the current 
sample endorsed this item in comparison to 15% within the LeBlanc and Morin 
sample. This is likely due to the wider age range included in LeBlanc and Morin. 
Findings within this study extend on LeBlanc and Morin by indicating that 
somatic symptoms such as fatigue and loss of appetite are also more common in 
children with ADHD than those without. Interestingly, across both studies, 
gaining weight, feeling hungrier or eating more, sleeping more and psychomotor 
retardation along with suicide attempts were not found to discriminate those with 
and without ADHD, indicating that they may not be as important when assessing 
for MDD in young children.  
A noteworthy limitation in all research investigating the co-occurrence of 
ADHD and MDD is the overlapping symptoms of ADHD and MDD and more 
specifically the inability to determine which disorder they apply to. Whilst 
difficulty keeping focused, making decisions and restlessness were among the 
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most common occurring symptoms in children with ADHD, there were a number 
of depressive symptoms, such as sadness and irritability, independent of ADHD 
criteria, which were elevated in children with ADHD suggesting that the 
comorbidity is not due to overlapping symptoms. Further, whilst some of the 
depressive symptoms may have been attributable to treatment side effects, 
findings suggest that medication had little impact on the presentation of 
symptoms. The results suggest that the above symptoms are important in 
discriminating depressive symptoms in children with ADHD and thus should be 
assessed in clinical assessment of young children with ADHD.  
This is the first study to specifically examine which depressive symptoms 
occur more frequently in young children aged 6 to 8 with and without ADHD. 
This study incorporates the use of gold standard assessment, structured diagnostic 
interviews, which align with DSM and ICD diagnosis of MDD. Despite these 
strengths, there are a number of weaknesses. The cross-sectional nature of the 
study limits the ability to draw conclusions regarding the temporal course of 
depressive symptoms in children with and without ADHD. Despite the potential 
impact of caregiver’s mental health difficulties on reports, this was not controlled 
for. Future research would benefit from adjusting for caregiver mental health as 
this would ensure results are not skewed by caregivers’ mental state. A further 
limitation was the relatively small number of females within the sample. Whilst 
research suggests that males experience ADHD at a higher rate than females, the 
higher prevalence of MDD within females suggests that symptom-based 
investigation of MDD in a sample containing more females is necessary. Finally, 
most of the sample presented with no or mild depressive symptoms, thus results 
may only generalise to this community-based age group and those with less 
severe MDD.  
This research contributes to an understanding of the presentation of 
depressive symptoms in children with and without ADHD. The factor structure 
was found to be unidimensional across both groups, indicating that the same 
assessment tools for depressive symptoms can be utilised for children with and 
without ADHD. This study highlights the co-occurrence of depressive symptoms 
in those with ADHD, above that found in matched peers without ADHD as well 
as the young age at which depressive symptoms present. This research also 
highlights the depressive symptoms that may be of particular importance in 
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children with ADHD, including sadness, anhedonia, psychomotor agitation, 
thoughts about killing oneself and feeling bad and blaming oneself. 
Understanding how MDD presents in children with ADHD, even at an early age, 
provides opportunities for early identification and treatment.  
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9. Outcomes Associated with Depressive Symptoms in Children 
with and without Attention Deficit Hyperactivity Disorder. 
Although previous research has indicated that depressive symptoms 
predict later experiences of MDD (Horwath, Johnson, Klerman, & Weissman, 
1992; Luby et al., 2004; Pine, Cohen, Cohen, & Brook, 1999) no research has 
investigated whether this association with early depressive symptoms and later 
MDD holds within a population of children with ADHD.  
Children with ADHD present with multiple impairments in functioning 
including higher rates of comorbid disorders, peer and conduct problems, 
academic difficulties and poorer quality of life, when compared to children 
without ADHD (Efron, Hazell, & Anderson, 2011; Sciberras, Fulton, Efron, 
Oberklaid, & Hiscock, 2011; Sciberras, Lycett, Efron, Mensah, Gerner, & 
Hiscock, 2014; Sciberras et al., 2014; Sciberras, Roos, & Efron, 2009). Similar 
impairments in functioning have been noted in children with MDD when 
compared to children without MDD (Herrman, Maj, & Sartorius, 2009; Lépine & 
Briley, 2011; Lynch & Clarke, 2006; Rhode et al., 2013; Richards, 2011; Wulsin, 
Vaillant, & Wells, 1999). Despite the high co-occurrence of ADHD and MDD 
and the multiple impairments associated with each disorder alone, no studies have 
sought to investigate whether these impairments are, at least in part, associated 
with comorbid depressive symptoms. The studies that have investigated the 
functional impact of ADHD and depressive/anxiety symptoms have produced 
mixed findings, with some suggesting functioning (social, behavioural, academic 
and quality of life) is impacted and others suggesting it is not.  
Determining the association between early symptoms and later 
symptoms/MDD and understanding whether depressive symptoms were 
associated with impaired functioning in children with ADHD represents a crucial 
next step within the literature. It will assist in determining whether depressive 
symptoms should become a focus within the assessment and treatment process for 
children with ADHD. It will also, through increased focus on MDD, assist in 
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Study three from the Children’s Attention Project aimed to  
1. Understand the presentation of depressive symptoms and MDD in 
children with and without ADHD across 3 years. To do this the 
study aimed to: 
a. Determine whether depressive symptoms at age 7 were 
associated with depressive symptoms at age 10 in children 
with ADHD and non-ADHD controls. 
b. Determine whether depressive symptoms at age 7 were 
associated with MDD at age 10 in children with ADHD 
and non-ADHD controls. 
c. Determine which depressive symptoms at age 7 were 
associated with MDD at age 10 in children with a ADHD 
and non-ADHD controls.  
2. Examine the association between depressive symptoms at age 7 
and functioning (social, behavioural, academic and quality of life) 
at age 10 in children with ADHD and non-ADHD controls. 
  
It was hypothesised that 
a. Depressive symptoms at age 7 would be positively 
associated with depressive symptoms at age 10 in children 
with ADHD and non-ADHD controls.  
b. Depressive symptoms at age 7 would be positively 
associated with MDD at age 10 in children with ADHD 
and non-ADHD controls.  
c. As this is the first study to examine whether specific 
depressive symptoms were associated with MDD at age 10, 
no specific hypothesis regarding the association of 
depressive symptoms was developed.   
2. Depressive symptoms would be associated with poor functioning 
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9.1 Persistence of ADHD from age 7 to age 10 
Of the 128 within the ADHD group, 85 children (66%) continued to have 
a normal, paediatric, medical diagnosis of ADHD at age 10 whilst 43 (34%) no 
longer met criteria. Those no longer meeting criteria for ADHD continued to be 
included within the ADHD group. Consequently, the ADHD group represented 
children with a childhood history of ADHD.   
Of the 142 within the non-ADHD control group that participated at age 
10, 4 (3%) children met criteria for ADHD and as described previously (see 6.4.3 
Sample size) were excluded from all subsequent analyses in order to ensure 
specificity of results.  
 
9.2 Occurrence, resolution and persistence of MDD 
At age 7 and age 10, more children with ADHD (n = 10, 8%; n = 26, 
20%) than non-ADHD controls (n = 1, 1%; n = 2, 1%) experienced MDD [X2 (2, 
N = 266) = 10.05, p < .001; X2 (2, N = 266) = 25.21, p < .001].  
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Figure 7 shows the persistence of MDD in the entire sample (i.e. 
combining children with ADHD and non-ADHD controls) from age 7 to age 10 
years. This figure demonstrates that MDD persisted in 50% of the cases from age 



















Figure 7. Patterns of MDD Occurrence, Resolution and Persistence across 3 years 
(overall sample, N = 266).  
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Figure 8 shows the persistence of MDD in the ADHD group from age 7 to 
age 10 years. This figure demonstrates that MDD persists in 60% of cases from 
age 7 to age 10. Nearly 1 in 5 (17%) of children without MDD at age 7, met 




Figure 8. Patterns of MDD Occurrence, Resolution and Persistence across 3 years 
(ADHD group, n = 128). 
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Figure 9 shows the persistence of MDD in the non-ADHD control group 
from age 7 to age 10 years. This figure demonstrates that the single case of MDD 
at age 7 did not continue experiencing MDD at age 10 and that two new cases 
developed. Only 1% of children without MDD at age 7, met criteria for MDD at 
age 10. Given the small number of children who experienced MDD within the 




Figure 9. Patterns of MDD Occurrence, Resolution and Persistence across 3 years 
(non-ADHD control group, n = 138). 
 
 
9.3 Sample Characteristics  
Of the 391 eligible children, 270 participants (n = 128 with ADHD, n = 
142 non-ADHD controls) consented to participate in study three. Those within the 
non-ADHD control group who subsequently met criteria for ADHD at age 10 (n = 
4) were dropped from the analyses. Consequently, the final sample consisted of 
266 participants (n = 128 with ADHD, n = 138 without ADHD). Table 12 
presents sample characteristics for both the ADHD and non-ADHD control group 
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at age 7 and age 10. As can be seen, the sample consisted of predominately males 
(70% ADHD, 60% non-ADHD). The sex composition between the ADHD and 
non-ADHD control group did not significantly differ (p = .09). 
9.3.1 Sample Characteristics at age 7.  At age 7, the majority of the 
ADHD group had ADHD combined presentation (50%). Children with ADHD 
experienced higher rates of internalising (23% versus 5%, p < .001) and 
externalising disorders (54% versus 7%, p < .001) than the non-ADHD control 
group. Likewise, more children with ADHD used medication for learning, 
behavioural and emotional difficulties (n = 26 versus n = 0, p < .001). 
Medications included Methylphenidate (14%), Clonidine (3%), Risperidone (1%) 
and Melatonin (2%).  
With regards to both groups the majority of the respondents were 
biological parents to the children and most were female. More caregivers within 
the non-ADHD control group were in a relationship (91% versus 80%, p = .01), 
had completed tertiary education (56% versus 32%, p < .001) and were receiving 
incomes over 60,000 (74% versus 58%, p = .01). 
9.3.2 Sample Characteristics at age 10.  At age 10, half of the ADHD 
group experienced ADHD inattentive presentation which rose from 39% to 50% 
whilst the ADHD combined presentation dropped from 50% to 43%. The 
presence of internalising and externalising disorders remained fairly consistent 
across the 3 years. Significantly more children with ADHD than non-ADHD 
controls experienced internalising (24% versus 7%, p < .001) and externalising 
disorders (51% versus 9%, p < .001) at age 10. Likewise, more children with  
ADHD than the non-ADHD control group used medication for learning, 
behavioural and emotional difficulties (30% versus 1%, p < .001). The percentage 
of children within the ADHD group using medications for learning, behavioural 
and emotional difficulties rose from 21% to 30%. The medications used included 
Methylphenidate (25%), Clonidine (5%), Risperidone (3%), Atomoxetine (2%) 
and Melatonin (10%). Whilst the percentage of participants using these specific 
medications remained fairly stable across the 3 years, the percentage of 
participants with ADHD using Methylphenidate and Melatonin increased by 8%. 
Dexamphetamine was not used by any participants at age 7 or 10. At age 10, one 
child within the non-ADHD control group reported using melatonin. 
ADHD AND MDD IN CHILDHOOD                                                                139 
 
   
Claire I Joseph Deakin University 210667098 
 
As was the case at age 7, at age 10 the majority of the respondents from 
both groups were biological parents to the children and most were female. Whilst 
more caregivers within the non-ADHD control group continued to receive 
incomes over 60,000 (73% versus 60%), the percentage of caregivers within the 
ADHD group with incomes over 60,000 increased by 4% across the 3 years.   
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Table 12.  










Age 7 Baseline     
Child characteristics    
Child age in years, M (SD) 7.31 (0.47) 7.34 (0.39) .52 
Sex - - .09 
       Male, n (%) 90 (70) 83 (60) - 
       Female, n (%) 38 (30) 55 (40) - 
ADHD DISC-IV presentation, n (%) - - - 
       ADHD-combined 64 (50) - - 
       ADHD-inattentive 50 (39) - - 
       ADHD-hyperactive/impulsive  14 (11) - - 
DISC-IV diagnosis other than ADHD and MDD, n (%) - - - 
       Internalising disorders  30 (23) 7 (5) < .001 
       Externalising disorders 69 (54) 10 (7) < .001 
Medication use, n (%) 26 (21) - < .001 
Family characteristics    
Respondent’s relationship to child, n (%) - - .51 
       Biological Parent 121 (97) 134 (99) - 
       Step Parent - - - 
       Foster Parent 1 (1) - - 
       Other Legal Guardian 3 (2) 2 (1) - 
Respondent’s Sex, n (%) - - .42 
       Male 5 (4) 9 (7) - 
       Female 120 (96) 127 (93) - 
Primary caregiver has a partner, n (%) 100 (80) 121 (91) .01 
Primary caregiver education, n (%) - - - 
       Completed high school 85 (68) 110 (81) .06 
       Completed university 36 (32) 69 (56) < .001 
Income, n (%) - - .01 
       Below $30,000 per year 18 (15) 15 (11) - 
       $30,001-$60,000 per year 34 (27) 20 (15) - 
       $60,001-$90,000 per year 34 (27) 31 (23) - 
       Above $90,001 per year 38 (31) 68 (51) - 
    
Age 10 Follow up    
Child characteristics    
Child age in years, M (SD) 10.49 (0.57) 10.49 (0.47) .96 
ADHD DISC-IV presentation, n (%) - - - 
       ADHD-combined 37 (43) - - 
       ADHD-inattentive 42 (50) - - 
       ADHD-hyperactive/impulsive  6 (7) - - 
DISC-IV diagnoses other than ADHD or MDD, n (%) - - - 
       Internalising disorders 31 (24) 10 (7) < .001 
       Externalising disorders 65 (51) 12 (9) < .001 
Medication use, n (%) 36 (30) 1 (1) < .001 
Family characteristics    
Respondent’s relationship to child, n (%) - - .35 
       Biological Parent 113 (97) 127 (98) - 
       Step Parent - 1 (1) - 
       Foster Parent - - - 
       Other Legal Guardian 3 (3( 1 (1) - 
Respondent’s Sex, n (%) - - .45 
       Male 6 (5) 10 (8) - 
       Female 110 (95) 119 (92) - 
Primary caregiver has a partner, n (%) 88 (100) 112 (100) - 
Primary caregiver education, n (%) - - - 
       Completed high school 86 (74) 106 (83) .21 
       Completed university 42 (40) 69 (56) .02 
Income, n (%) - - .05 
       Below $30,000 per year 20 (17) 9 (7) - 
       $30,001-$60,000 per year 25 (21) 24 (19) - 
       $60,001-$90,000 per year 23 (20) 22 (17) - 
       Above $90,001 per year 49 (42) 71 (56) - 
‡ n ranged from 88 to 128.  
£ n ranged from 112 to 138. 
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9.3.3 Sample Characteristics in those with follow up data versus those 
without.  As seen in Table 13, those with complete data did not significantly 
differ from those with incomplete data on sample characteristics measured at age 
7.  
 
Table 13.  
Study Three Sample Demographic Characteristics at Age 7 between those with 









Age 7 Baseline    
Child characteristics    
Child age in years, M (SD) 7.33 (0.43) 7.29 (0.38) .40 
Sex - - .56 
       Male, n (%) 173 (65) 83 (69) - 
       Female, n (%) 93 (35) 38 (31) - 
ADHD DISC-IV Diagnosis 128 (48) 51 (42) - 
ADHD DISC-IV presentation, n (%) - - .29 
       ADHD-combined 64 (50) 29 (57) - 
       ADHD-inattentive 50 (39) 14 (27) - 
       ADHD-hyperactive/impulsive  14 (11) 8 (16) - 
DISC-IV diagnosis other than ADHD and MDD, n 
(%) 
- - - 
       Internalising disorders 37 (14) 17 (14) 1.00 
       Externalising disorders 79 (30) 34 (28) .81 
Medication use, n (%) 27 (10) 10 (10) 1.00 
Family characteristics    
Respondent’s relationship to child, n (%) - - .78 
       Biological Parent 255 (98) 101 (97) - 
       Step Parent - - - 
       Foster Parent 1 (0) - - 
       Other Legal Guardian 5 (2) 3 (3) - 
Respondent’s Sex, n (%) - - .24 
       Male 14 (5) 9 (9) - 
       Female 247 (95) 95 (91) - 
Primary caregiver has a partner, n (%) 221 (86) 91 (89) .49 
Primary caregiver education, n (%) - - - 
       Completed high school 195 (74) 69 (66) .24 
       Completed university 105 (45) 29 (34) .10 
Income, n (%) - - .25 
       Below $30,000 per year 33 (13) 17 (17) - 
       $30,001-$60,000 per year 54 (21) 27 (27) - 
       $60,001-$90,000 per year 65 (25) 26 (26) - 
       Above $90,001 per year 106 (41) 31 (31) - 
‡N ranged from 128 to 266.  
£N ranged from 115 to 121. 
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9.3.4 Sample Characteristics in those with ADHD + MDD versus those 
with ADHD only   
Table 14 presents the demographic characteristics, at age 7 and age 10, of 
those with ADHD and MDD versus those with ADHD only. As can be seen in 
section 9.3 a number of diagnoses of MDD resolved by age 10. Consequently, 
classification of groups was based on the diagnosis of MDD at age 10.  
As can be seen, those with ADHD and MDD did not differ from those 
with ADHD only in terms of age, sex, respondent’s relationship to the child and 
the caregivers’ relationship status.  
Although the ADHD presentations differed between the two groups at age 
7 (p = .01), this was not the case at age 10 (p = .70). Across both time points, the 
combined presentation was the most common presentation within the ADHD and 
MDD group (n = 20, 77% at age 7; n = 12, 50% at age 10). In contrast, the 
inattentive presentation was the most predominant within the ADHD only group 
(n = 46, 45% at age 7; n = 32, 52% at age 10). 
At age 7 and 10, 50% of children with ADHD and MDD experienced 
comorbid internalising disorders compared to 18% within the ADHD only group 
(p = .001). At age 7, there were no significant differences in externalising 
disorders or use of medication across the two groups. At age 10, children with 
ADHD and MDD experienced more externalising disorders (n = 20, 77% versus n 
= 45, 44%, p = .004) and had higher rates of medication use (n = 24, 55% versus 
n = 12, 25%, p = .01) compared to children with ADHD only.  
Whilst there were more male respondents in the ADHD and MDD group 
at age 7 (2% versus 12% at age 7, p = .05), caregivers’ sex did not differ at age 10 
(p = .08). At age 7 and 10 more children with ADHD only than children with 
ADHD and MDD came from families earning more than $60,000 per year (n = 
66, 66% versus n = 6, 24%, p = .001 at age 7 and n = 65, 68% versus n = 7, 32%, 
p = .01 at age 10).   
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Table 14.  
Study Three Sample Demographic Characteristics at Age 7 and 10 for the ADHD 
Only Group versus the ADHD+MDD Group 
 ADHD only 
n = 102‡ 
ADHD/ MDD 
n = 26£ 
p  
Age 7 Baseline    
Child characteristics    
Child age in years, M (SD) 7.30 (0.45) 7.33 (0.53) .81 
Sex - - .63 
       Male, n (%) 73 (72) 17 (65) - 
       Female, n (%) 29 (28) 9 (35) - 
ADHD DISC-IV presentation, n (%) - - .01 
       ADHD-combined 44 (43) 20 (77) - 
       ADHD-inattentive 46 (45) 4 (15) - 
       ADHD-hyperactive/impulsive  12 (11) 2 (8) - 
DISC-IV diagnosis other than ADHD and MDD, n (%) - - - 
       Internalising disorders 17 (17) 13 (50) .001 
       Externalising disorders 52 (51) 17 (65) .27 
Medication use, n (%) 18 (18) 8 (32) .17 
Family characteristics    
Respondent’s relationship to child, n (%) - - 1.00 
       Biological Parent 96 (96) 25 (100) - 
       Step Parent - - - 
       Foster Parent 1 (1) - - 
       Other Legal Guardian 3 (3) - - 
Respondent’s Sex, n (%) - - .05 
       Male 2 (2) 3 (12) - 
       Female 98 (98) 22 (88) - 
Primary caregiver has a partner, n (%) 82 (82) 18 (72) .27 
Primary caregiver education, n (%) - - - 
       Completed high school 72 (72) 13 (52) .12 
       Completed university 33 (37) 3 (14) .07 
Income, n (%) - - .001 
       Below $30,000 per year 11 (11) 7 (29) - 
       $30,001-$60,000 per year 23 (23) 11 (46) - 
       $60,001-$90,000 per year 29 (29) 5 (20) - 
       Above $90,001 per year 37 (37) 1 (4) - 
    
Age 10, Follow up    
Child characteristics    
Child age in years, M (SD) 10.48 (0.54) 10.55 (0.69) .61 
Persistence of ADHD (%) 85% 
ADHD DISC-IV presentation, n (%)α - - .70 
       ADHD-combined 25 (40) 12 (50) - 
       ADHD-inattentive 32 (52) 11 (46) - 
       ADHD-hyperactive/impulsive  5 (8) 1 (4) - 
DISC-IV diagnoses other than ADHD or MDD, n (%) - - - 
       Internalising disorders 18 (18) 13 (50) .001 
       Externalising disorders 45 (44) 20 (77) .004 
Medication use, n (%) 24 (25) 12 (55) .01 
Family characteristics    
Respondent’s relationship to child, n (%) - - 1.00 
       Biological Parent 91 (97) 22 (100) - 
       Step Parent - - - 
       Foster Parent - - - 
       Other Legal Guardian 3 (3) - - 
Respondent’s Sex, n (%) - - .08 
       Male 3 (3) 3 (14) - 
       Female 91 (97) 19 (86) - 
Primary caregiver has a partner, n (%) 73 (100) 15 (100) - 
Primary caregivers education, n (%) - - - 
       Completed high school 73 (78) 13 (59) .11 
       Completed university 37 (43) 5 (26) .21 
Income, n (%) - - .01 
       Below $30,000 per year 14 (15) 6 (27) - 
       $30,001-$60,000 per year 16 (17) 9 (41) - 
       $60,001-$90,000 per year 20 (21) 3 (14) - 
       Above $90,001 per year 45 (47) 4 (18) - 
‡ n ranged from 86 to 100. £ n ranged from 19 to 26. 
α ADHD presentation for those who met criteria at follow up.  
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9.3.5 Attrition 
Of those who participated at age 7, 69% participated at age 10. Whilst an 
attrition rate of 32% may be considered high, rigorous attempts were used to 
collect data from families. Further, no significant differences between those with 
complete and incomplete data were found. However, the attrition rate should be 
considered when interpreting results.   
 
9.4 Aim 1. Understand the presentation of depressive symptoms and MDD in 
children with and without ADHD across 3 years.  
9.4.1 Are depressive symptoms at age 7 associated with depressive 
symptoms at age 10? 
9.4.1.1 Children with ADHD.  For children with ADHD, depressive 
symptoms at age 7 were associated with depressive symptoms at age 10 [Adjusted 
R² = 0.21, F(1, 126) = 34.49, p < .001]. Results which controlled for 
heteroscedasticity were similar [Adjusted R² = 0.21, F(1,126) = 23.32, p < .001]. 
For children with ADHD, depressive symptoms at age 7 explained 21% of 
the variance in depressive symptoms at age 10. For each one point increase in 
depressive symptoms at age 7, there was a 0.56 increase (coefficient = 0.56, β = 
0.46) in depressive symptoms at age 10.  
9.4.1.2 Children without ADHD.  For children in the non-ADHD control 
group, depressive symptoms at age 7 were also associated with depressive 
symptoms at age 10 [Adjusted R² = 0.24, F(1, 136) = 44.93, p < .001]. Results 
which controlled for the heteroscedasticity were similar [Adjusted R² = 0.25, 
F(1,136) = 33.30, p <  .001].  
Within the non-ADHD control group depressive symptoms at age 7 
explained 25% of the variance in depressive symptoms at age 10. For each one 
point increase in depressive symptoms at age 7, there was a 0.52 increase 
(coefficient = 0.52, β = 0.67) in depressive symptoms at age 10. 
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9.4.2 Are depressive symptoms at age 7 associated with MDD at age 
10?   
9.4.2.1 Children with ADHD.  As per Table 15, in children with ADHD, 
depressive symptoms at age 7 were associated with increased odds for MDD at 
age 10. Results indicated that a one unit increase in depressive symptoms at age 7 
was related to a 1.36 unit increase in the odds of experiencing MDD at age 10.  
 
Table 15.  
Association between Depressive Symptoms at Age 7 with MDD at age 10 in 
Children with ADHD  
n = 128 OR 95% CI  p  
Unadjusted  1.36 1.17 to 1.57 < .001 
Adjusted (robust) 1.36 1.18 to 1.56 < .001 
 
9.4.1.2 Children without ADHD.   As only two children within the non-
ADHD control group experienced MDD the analysis seeking to determine the 
association between depressive symptoms at age 7 and MDD at age 10 in children 
without ADHD could not be conducted 
9.4.3 Which depressive symptoms at age 7 were associated with MDD 
at age 10? 
9.4.2.1 Children with ADHD.   Table 16 presents all the depressive 
symptoms that make up the DSM-5 criteria for a diagnosis of MDD. Table 16 
details whether or not the depressive symptom was present at age 7 by MDD 
status at age 10. Odds ratios, confidence intervals, standard errors, and p values 
are also presented. Due to the small number of children with MDD, obtained 
confidence intervals were sometimes wide and thus results should be interpreted 
with some caution.  
In children with MDD depressed mood (criterion 1), sadness, 
irritability/grouchiness, anhedonia, loss of weight and appetite, increased hunger, 
insomnia, psychomotor agitation, blaming oneself and indecisiveness at age 7 was 
associated with MDD at age 10.  
As seen in Table 16, of those with MDD at age 10, 19% endorsed 
depressed mood at age 7 compared to 2% without MDD at age 10. Of those with 
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MDD at age 10, 46% endorsed sad or depressed mood at age 7 compared to 23% 
without MDD at age 10. Similarly, 42% of those with MDD at age 10 endorsed 
criterion 2 at age 7 versus 8% of those without MDD at age 10. Of those with 
MDD at age 10, 27% and 38% respectively endorsed loss of weight or appetite at 
age 7 compared to 5% and 10% without MDD at age 10. Forty two percent of 
those with MDD at age 10 endorsed increased hunger at age 7 whilst 19% of 
those with MDD did not endorse increased hunger at age 7. For those with MDD 
at age 10, 69% endorsed psychomotor agitation at age 7 and 46% did not. Of 
those with MDD at age 10, 35% and 77% blamed themselves for things going 
wrong or experienced indecisiveness at age 7 respectively compared to 10% and 
48% of those without MDD at age 10.  
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Table 16.  
Association between Depressive Symptoms Endorsed at Age 7 and MDD Status at 














Criterion 1: Depressed Mood 19 2 11.90 2.16 to 65.56 10.36 .004 
    Sad 46 23 2.98 1.21 to 7.33 1.37 .02 
    Grouchy 73 47 3.11 1.20 to 8.03 1.51 .01 
       
Criterion 2: Markedly diminished interest 
or pleasure+  
8 0 - - - - 
    Anhedonia 42 8 8.62 2.98 to 24.90 4.67 .00 
       
Criterion 3: Change in weight or appetite 8 1 8.42 0.73 to 96.70 10.48 .09 
    Lost weight 27 5 7.15 2.05 to 24.91 4.55 .002 
    Lost appetite 38 10 5.75 2.06 to 16.02 3.01 .001 
    Gain weight 8 1 8.42 0.73 to 96.70 10.48 .09 
    Hunger  42 19 3.20 1.27 to 8.07 1.51 .01 
       
Criterion 4: Changes in sleep+ 0 0 - - - - 
    Insomnia 77 53 2.96 1.10 to 7.99 1.50 .03 
    Hypersomnia 4 2 2.00 0.17 to 22.95 2.49 .58 
       
Criterion 5: Psychomotor changes+   0 0 - - - - 
    Psychomotor retardation+    0 1 - - - - 
    Psychomotor agitation 69 46 2.63 1.05 to 6.60 1.24 .04 
       
Criterion 6: Fatigue or loss of energy+   0 1 - - - - 
    Less energy 12 13 0.89 0.23 to 3.40 0.61 .87 
    Tired  12 5 2.53 0.56 to 11.36 1.94 .23 
    Heavy limbs 19 11 1.97 0.62 to 6.28 1.16 .25 
       
Criterion 7: Feelings of 
worthlessness/inappropriate guilt+   
0 1 - - - - 
    Blamed oneself 35 10 4.87 1.72 to 13.76 2.58 .003 
    Felt bad about oneself 65 46 2.21 0.90 to 5.42 1.01 .08 
       
Criterion 8: Diminished cognitive ability+   0 0 - - - - 
    Inability to think clearly 23 13 2.05 0.69 to 6.06 1.13 .19 
    Difficulty with school work 81 73 1.59 0.55 to 4.62 0.86 .40 
    Indecisiveness 77 48 3.60 1.34 to 9.72 1.82 .01 
       
Criterion 9: Recurrent suicidal ideation 4 1 4.04 0.24 to 66.85 5.78 .33 
   Attempted suicide+ 0 2 - - - - 
    Experienced thoughts of death  31 25 1.30 0.51 to 3.34 0.63 .59 
Note. Bolding denotes significant result. 
+ Criterions that were perfectly associated with the subset of symptoms and thus logistic regressions could not be computed, that is, there 
were no changes between age 7 and age 10 in terms of those variables.  
 
9.4.2.1 Children without ADHD.  As only two participants within the 
non-ADHD control group met criteria for MDD at age 10, examination of which 
depressive symptoms at age 7 were associated with MDD at age 10 was not 
possible. 
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9.5 Aim 2. The association between depressive symptoms at age 7 and 
functioning at age 10 in children with ADHD and non-ADHD controls.  
Whilst only a small number of children experienced MDD, a number of 
children, within both the ADHD and non-ADHD control group, experienced 
depressive symptoms. Research indicates that subthreshold depressive symptoms 
impact functioning (Biederman et al., 1998; Biederman et al., 2008; Bertha & 
Balázs, 2013; Chronis-Tuscano et al., 2010; Freuchen et al., 2012; Georgiades et 
al., 2006). Consequently, this section focused on the association between 
depressive symptoms and functioning, as opposed to MDD and functioning.  
The mean and standard deviations of all functional outcomes assessed are 
presented in Table 17. As can be seen, children with ADHD had greater peer 
problems, displayed less prosocial behaviour, greater conduct problems, 
experienced poorer academic functioning and poorer quality of life compared 
with controls. 
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Table 17.  




n = 251‡ 
ADHD 
Mean (SD) 




n = 130£ 
p 
Social Functioning     
       SDQ: Peer problems - caregiver report 2.01 (2.23) 3.10 (2.40) 1 (1.47) < .001 
       SDQ: Peer problems - teacher report 1.54 (1.88) 2.25 (2.08) 0.90 (1.39) < .001 
       SDQ: Prosocial behaviour – caregiver report 7.72 (2.05) 6.74 (2.05) 8.62 (1.59) < .001 
       SDQ: Prosocial behaviour – teacher report 7.43 (2.29) 6.60 (2.43) 8.18 (1.86) < .001 
Behavioural Functioning     
       SDQ: Conduct problems - caregiver report 2.40 (2.37) 3.85 (2.38) 1.05 (1.35) < .001 
       SDQ: Conduct problems - teacher report 1.42 (2.11) 2.33 (2.53) 0.61 (1.15) < .001 
Academic Functioning     
       SSIS Academic functioning – teacher report 96.42 (15.04) 88.72 (13.98) 103.27 (12.46) < .001 
Quality of life     
       PedsQL: Overall functioning 64.84 (20.09) 51.76 (16.80) 77.02 (14.47) < .001 
‡ n ranged from 223 to 251. £ n ranged from 118 to 130.  ¥ n ranged from 105 to 121.  
 
  
ADHD AND MDD IN CHILDHOOD                                                                150 
 
   
Claire I Joseph Deakin University 210667098 
 
9.5.1 The association between depressive symptoms at age 7 and 
functioning at age 10 in children with ADHD.   
The association between depressive symptoms at age 7 and functioning at 
age 10 in children with ADHD is presented in Table 18. 
9.5.1.1 Unadjusted analysis.  Prior to adjustments, depressive symptoms 
at age 7 in children with ADHD were associated with greater peer and conduct 
problems at age 10 as reported by caregivers (Adjusted R2 = 0.03, β = 0.20, p = 
.03; Adjusted R2 = 0.06, β = 0.26, p = .003) but not teachers (p = .53; p = .27). 
Depressive symptoms at age 7 were also associated with poorer academic 
functioning (Adjusted R2 = 0.03, β = -0.19, p = .04) and reduced quality of life 
(Adjusted R2 = 0.09, β = -0.32, p < .001) at age 10. There was some evidence that 
depressive symptoms at age 7 were associated with reduced prosocial behaviour 
in children with ADHD by both caregiver and teacher report, although these 
findings fell short of statistical significance (p = .06). 
 9.5.1.2 Adjusted analysis.   The association between depressive 
symptoms at age 7 and caregiver reported peer (Adjusted R2 = 0.10, β = 0.16, p < 
.001), academic (Adjusted R2 = 0.16, β = -0.10, p < .001) and conduct (Adjusted 
R2 = 0.31, β = 0.11, p < .001) problems and poorer quality of life (Adjusted R2 = 
0.22, β = -0.23, p = .001) at age 10 in children with ADHD held even after 
adjustments for child sex, externalising comorbidities, medication use, caregiver 
education level, caregiver relationship status and clinical levels of caregiver 
mental health difficulties. Following adjustments the relationship between 
depressive symptoms at age 7 and prosocial behaviour as reported by caregivers 
at age 10 strengthened (Adjusted R2 = 0.06, β = -0.08, p = .02).  
9.5.1.3 Confounding variables.  A number of the confounding variables 
were independently associated with functioning. Use of medication was  
associated with higher caregiver reported peer problems (p = .01), conduct 
problems (p = .01), academic functioning (p = .01) and quality of life (p = .01). 
Externalising comorbidities were associated with worse prosocial behaviour (p = 
.02) and higher conduct problems (p < .001 caregiver reported; p = .03 teacher 
reported). Caregiver relationship status (partner/no partner) was associated with 
higher levels of peer p = .04) and conduct problems (p = .03), lower academic 
functioning (p = .002) and lower quality of life (p = .01).
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Table 18.  
The Association between Depressive Symptoms at Age 7 and Functioning at age 10 in Children with ADHD  
Outcomes Unadjusted analyses (n = 121
‡) Adjusted analyses (n = 119£) 
 Coefficient 95% CI Beta p 
Adjusted 
R2 
Coefficient 95% CI Beta p 
Adjusted 
R2 
Social Functioning           
       SDQ: Peer problems - caregiver report 0.15 0.02 to 0.27 0.20 .03 0.03 0.12 -0.02 to 0.25 0.16 < .001 0.10 
       SDQ: Peer problems - teacher report 0.04 -0.08 to 0.15 0.06 .53 -0.01 0.03 -0.07 to 0.14 0.05 .06 0.04 
       SDQ: Prosocial behaviour – caregiver report -0.10 -0.21 to 0.00 -0.17 .06 0.02 -0.05 -0.17 to 0.06 -0.08 .02 0.06 
       SDQ: Prosocial behaviour – teacher report -0.13 -0.27 to 0.01 -0.18 .06 0.02 -0.10 -0.25 to 0.04 -0.14 .33 0.02 
Behavioural Functioning           
       SDQ: Conduct problems – caregiver report 0.18 0.06 to 0.31 0.26 .003 0.06 0.08 -0.03 to 0.19 0.11 < .001 0.31 
       SDQ: Conduct problems - teacher report 0.08 -0.06 to 0.23 0.11 .27 0.00 0.01 -0.15 to 0.17 0.02 .11 0.00 
Academic Functioning           
       SSIS Academic functioning – teacher report -0.79 -1.54 to -0.05 -0.19 .04 0.03 -0.44 -1.19 to 0.31 -0.10 < .001 0.16 
Quality of life           
       PedsQL: Overall functioning -1.62 -2.50 to -0.75 0.31 < .001 0.09 -1.16 -1.95 to -0.37 -0.23 < .001 0.22 
‡ n ranged from 105 to 121.  
£ n ranged from 99 to 119.
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9.5.2 The association between depressive symptoms at age 7 and 
functioning at age 10 in non-ADHD controls  
The association between depressive symptoms at age 7 and functioning at 
age 10 in non-ADHD controls is presented in Table 19. 
9.5.2.1 Unadjusted analysis.    Prior to adjustments, the presence of 
depressive symptoms at age 7 was associated with poor quality of life (Adjusted 
R2 = 0.04, β = -0.21, p = .03) at age 10 in the non-ADHD control group.  
Depressive symptoms at age 7 were not associated with any other significant 
changes in functioning at age 10 in the non-ADHD control group.  
9.5.2.2 Adjusted analysis.  The association between depressive symptoms 
at age 7 and poorer quality of life (Adjusted R2 = 0.07, β = -0.17, p = .02) at age 
10 in the non-ADHD control group held even after adjusting for child sex, 
externalising comorbidities, use of medication, caregiver education level, 
caregiver relationship status and clinical levels of caregiver mental health 
difficulties. Following adjustments, depressive symptoms at age 7 in the non-
ADHD control group were associated with poorer prosocial behaviour (Adjusted 
R2 = 0.07, β = -0.15, p = .01) and increased conduct problems (Adjusted R2 = 
0.16, β = 0.09, p = .01) as reported by caregivers. Peer problems as reported by 
teachers approached significance (Adjusted R2 = 0.05, β = -0.03, p = .09) in the 
adjusted model, while the association between depressive symptoms at age 7 and 
academic functioning at age 10 remained unchanged. 
9.5.2.3 Confounding variables.  A number of the confounding variables 
were independently associated with outcomes. Child sex was negatively 
associated with prosocial behaviour (p = .03) and conduct problems (p = .03) at 
age 10 in the non-ADHD control group.  Use of medication was associated with 
more peer problems (p < .001) as reported by teachers. Caregiver education was 
associated with poorer quality of life (p = .01). 
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Table 19.  
The Association between Depressive Symptoms at Age 7 and Functioning at Age 10 in non-ADHD Controls 
Outcomes 
Unadjusted analyses (n = 130‡) Adjusted analyses (n = 123£) 
Coefficient 95% CI Beta p Adjusted R2 Coefficient 95% CI Beta p Adjusted R2 
Social Functioning           
       SDQ: Peer problems - caregiver report** 0.11 -0.03 to 0.25 0.19 .11 0.03 0.10 -0.03 to 0.22 0.17 .11 0.06 
       SDQ: Peer problems - teacher report** -0.04 -0.16 to 0.07 -0.06 .48 -0.00 -0.02 -0.17 to 0.12 -0.03 .09 0.05 
       SDQ: Prosocial behaviour – caregiver 
report** 
0.09 -0.21 to 0.03 -0.15 .14 0.01 -0.09 -0.18 to 0.00 -0.15 .01 0.07 
       SDQ: Prosocial behaviour – teacher report** -0.05 -0.21 to 0.12 -0.05 .58 -0.01 0.00 -0.17 to 0.18 0.00 .57 -0.01 
Behavioural Functioning           
       SDQ: Conduct problems - caregiver report 0.12 -0.01 to 0.24 0.22 .07 0.04 0.05 -0.07 to 0.16 0.09 .01 0.16 
       SDQ: Conduct problems - teacher report 0.01 -0.07 to 0.09 0.02 .78 -0.01 -0.36 -0.13 to 0.06 -0.07 .17 0.03 
Academic Functioning           
       SSIS Academic functioning – teacher report -0.33 -1.43 to 0.77 -0.06 .55 -0.01 -0.23 -1.39 to 0.92 0.04 .39 0.00 
Quality of life           
       PedsQL: Overall functioning -1.20 -2.30 to -0.10 -0.21 .03 0.04 -0.94 -1.99 to 0.11 -0.17 .02 0.07 
‡N ranged from 118 to 130.  
£N ranged from 105 to 123. 
** Caregiver clinical levels of mental health difficulties omitted due to 0 participants within the non-ADHD control group meeting the clinical cut off.  
 
ADHD AND MDD IN CHILDHOOD                                                                154 
 
   
Claire I Joseph Deakin University 210667098 
 
9.5.3 The association between depressive symptoms at age 7 and 
functioning 3 years later in children with ADHD versus non-ADHD controls.  
There was no interaction effect between depressive symptoms and peer problems 
(caregiver reported p = .44, teacher reported p = .36), conduct problems 
(caregiver reported p = .35, teacher reported p = .47), prosocial behaviour 
(caregiver reported p = .94, teacher reported p = .34), academic functioning (p = 
.42) or quality of life (p = .45) across groups. This suggested that the strength of 
the association between depressive symptoms and functioning was similar for 
children with ADHD and non-ADHD controls.
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10. General Discussion and Thesis Conclusion 
10.1 Principal Findings and Interpretation in light of Previous Research 
10.1.1 Structured Diagnostic Interviews of Childhood Internalising 
Disorders: A Systematic Review. Due to the importance of early identification 
and intervention for childhood internalising disorders, the systematic review 
aimed to identify, describe and compare existing structured diagnostic interviews 
used in assessing childhood internalising disorders. Eleven diagnostic interviews 
were reviewed. Despite the difficulty with directly comparing existing diagnostic 
interviews due to the heterogeneity across interviews and studies, findings suggest 
that all 11 identified diagnostic interviews were suitable for assessing childhood 
internalising disorders in accordance with established diagnostic criteria. Whilst 
all diagnostic interviews included manuals that were either published or available 
via the author, the training and administration time varied widely. For example, 
training was four weeks for the CAPA and one to three hours for the MINI-KID, 
administration was up to 180 minutes for the K-SADS and up to 40 minutes for 
the MINI-KID. The diagnostic interviews reviewed tended to be limited to 
children over 6 years of age. Findings suggest that all diagnostic interviews 
offered acceptable psychometrics, though the DISC was the most widely utilised 
and researched diagnostic interview for children and thus had a considerable 
evidence base. The DISC utilises both DSM and ICD criteria and is the only 
instrument with significant research regarding its widespread use cross culturally. 
Consequently, the DISC appears to confer the highest number of advantages 
relative to other interviews.  
The results from the systematic review suggested that the psychometric 
properties across interviews varies considerably. Specifically, inter-rater 
reliability across interviews was ordinary to excellent, test-retest reliability 
ordinary, validity fair to moderate and sensitivity and specificity mostly good. A 
key finding from this systematic review was the limited psychometric data 
available, particularly with regards to validity. Most diagnostic interviews only 
had two to three studies investigating their psychometrics. Much of the research 
sought to investigate the psychometrics in relation to all mental disorders assessed 
by the measure as opposed to individual disorders. This meant that understanding 
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how the diagnostic interviews perform in relation to a specific disorder, such as 
MDD, was difficult.  
Despite the importance of the clinical utility of diagnostic measures, very 
few studies investigated the diagnostic interviews within clinical settings. 
Nevertheless, although previous research has suggested that structured diagnostic 
interviews lack clinical utility (David, 2013; Eisman et al., 1998; Turret, 2016) 
this review has provided evidence for the clinical utility of some diagnostic 
interviews such as the ChIPS and MINI-KID which require less training, less 
administration time and allow for clinical input (Angold & Costello, 2000; Egger 
et al., 2004; Garvey et al., 1989; Kaufman et al., 2000, 2004; Mattos et al., 2007; 
Reich, 2000; Rooney et al., 1999; Rourke & Reich., 2004; Shaffer et al., 2004; 
Sheehan et al., 1998, 2010a; Weller et al., 1999, 2000). Increased awareness about 
the clinical utility of diagnostic interviews, as achieved within this thesis, should 
assist with increasing the application of these best-practice, evidence based 
assessments within clinical practice thereby ensuring standardised, systematic and 
comprehensive diagnosis processes.     
The ultimate aim of this systematic review was to assist clinicians and 
researchers to make an informed decision when seeking to investigate childhood 
internalising disorders including MDD. Whilst diagnostic interviews provide a 
wealth of knowledge and aid in effective assessment of childhood internalising 
disorders, they are far from optimal and large variation across diagnostic 
interviews and related research is common. Consequently, future research is 
required to enhance the format, utility and psychometric quality of these 
diagnostic interviews. Overall, findings suggest that if a researcher or clinician 
has the time and resources and the aim is to comprehensively investigate a range 
of disorders whilst being culturally sensitive, then the DISC represents a sound 
choice. 
10.1.2 Characterisation of Depressive Symptoms in Children with and 
without ADHD.  Utilising the findings from study one, study two sought to 
examine depressive symptoms using the DISC-IV in children with and without  
ADHD. Prior to comparing depressive symptoms in children with and without 
ADHD it was essential to determine whether the underlying MDD construct was 
the same across the groups as this ensured that any observed differences in 
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symptoms were due to true group differences as opposed to being a result of 
measurement effects. Findings indicated that symptom specific comparisons 
across children with and without ADHD were possible as the measurement of 
childhood MDD was similar and unidimensional in both the ADHD and non-
ADHD samples. Findings indicated that Australian children aged 6 to 8 years 
with ADHD are more likely to experience substantially higher levels of 
depressive symptoms than their non-ADHD counterparts. In relation to specific 
depressive symptoms, sadness, irritability, insomnia, psychomotor agitation, 
feeling bad about oneself, difficulty concentrating and making decisions were 
elevated in children with ADHD relative to non-ADHD controls.  
Very little research has examined the factor structure of depressive 
symptoms and MDD in young children. Nevertheless, the finding that MDD in 
young children with and without ADHD is similar and consists of one factor 
contrasts previous research on the CDI which has suggested that childhood MDD 
is made up of five separate factors (Craighead et al., 1998; Hodges et al., 1983). 
The contrasting findings are likely due to the differences in the assessment tools 
used; a structured diagnostic interview versus a screening measure. Specifically, 
the DISC-IV only includes the depressive symptoms required for a diagnosis of 
MDD, whilst the CDI includes a range of additional symptoms found to be 
associated with MDD in childhood (e.g., behavioural outbursts). Consequently, it 
is believed that the findings from study two more accurately represent the factor 
structure of depressive symptoms. Nevertheless, as both the CDI and the DISC-IV 
are among the most widely used measures of childhood MDD, investigating the 
factor structure and measurement invariance of MDD utilising both measures 
would assist with determining whether findings hold. Utilising screening measure 
of MDD such as the CDI may be more feasible in clinical practice and therefore 
its suitability for use in children with ADHD should be established.   
Given the participants’ age and thus absence of severe depressive 
symptoms, it is likely that the factor structure within the ADHD and non-ADHD 
control group is modelled at the milder end of the MDD continuum. Similarly, it 
is possible that the factor structure of MDD may change in children with ADHD 
as they get older, particularly in adolescence. Consequently, it is important to 
investigate the factor structure in children with ADHD with more severe cases of 
MDD and at later stages of development in order to determine if 
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unidimensionality holds. Possessing this knowledge will help determine whether 
MDD presents similarly during a time point in which MDD is more likely to 
emerge (i.e., adolescents; Chrisman et al., 2006). It will also assist with 
understanding whether the current tools utilised to measure MDD in adolescents 
are adequate or whether, in fact, a different tool modelling the specific factor 
structure of MDD in adolescents with ADHD needs to be developed.  
As hypothesised, findings confirmed that young Australian children with 
ADHD, across all three presentations of ADHD, experience more depressive 
symptoms than their non-ADHD counterparts. A large effect size difference 
between the groups was found, indicating that there are substantial differences in 
the presence of depressive symptoms between groups. The higher occurrence of 
depressive symptoms in children with ADHD is consistent with previous research 
and supports the claims that ADHD and depressive symptoms commonly co-
occur (Angold et al., 1999; Biederman et al., 2008; Chronis-Tuscano et al., 2010). 
Findings from this study extend previous research to demonstrate that risk for 
MDD can be detected in children with ADHD from as young as 6 years of age.  
Consistent with previous research that indicated that children and 
adolescents with ADHD are four to six times more likely to experience depressive 
symptoms than those without ADHD (Daviss, 2008; Gilberg et al., 2004), 
findings indicated that young children with ADHD were three and a half times 
more likely to experience depressive symptoms than their same aged counterparts 
who did not have ADHD. Although this is slightly lower than in previous 
research, the differences likely reflect that this study examined young children 
before the peak of MDD emergence whereas previous research has tended to 
examine adolescents across a large age range. The present sample was 
community-based whereas the previous research has predominantly recruited 
clinical samples. Given the tendency for clinical samples to experience a 
significantly higher proportion of mental health difficulties, the higher prevalence 
of MDD within previous studies is also likely accounted for, at least in part, by 
the sample characteristics (i.e. more males, more comorbidities, more 
impairments/experience of demoralisation). This finding advances the field by 
highlighting the higher likelihood of children with ADHD developing MDD and 
thus the clinical importance of assessing for depressive symptoms in young 
children with ADHD.  
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As outlined within the literature review the aetiology of ADHD and MDD 
and the reason for its high co-occurrence is largely unknown. However, there 
have been claims that comorbid MDD may be due to the demoralisation that 
children with ADHD experience (Biederman et al., 1998; Posner et al., 2014). 
Specifically, children with ADHD are more likely to experience social and 
academic failures as well as familial tensions which may contribute to negative 
self-esteem, demoralisation and ultimately MDD (Biederman et al., 1998; Posner 
et al., 2014). Although this is not well supported in the literature as research has 
suggested that ADHD and MDD have independent and distinct courses 
(Biederman et al., 1998), it is possible that the increased likelihood of developing 
MDD in children with ADHD is related to demoralisation. It is suspected that 
there may be a bidirectional relationship between MDD and demoralisation in 
children with ADHD whereby children with ADHD develop MDD which then 
contributes to demoralisation, which further perpetuates the MDD and the 
likelihood of experiencing it. An alternative hypothesis regarding the relationship 
between ADHD and MDD is the shared hippocampal anomalies, as these their 
effects i.e., impulsivity, hyperactivity and inattention, may make children with 
ADHD vulnerable to depressive symptoms and thus MDD (Posner et al., 2014). 
This was supported in a study demonstrating that, in comparison to children 
without ADHD (n = 33), children with ADHD (n = 32) aged 6 to 13 have reduced 
hippocampal volumes and reduced connectivity between the left hippocampus 
and orbitofrontal cortex (Posner et al., 2014). Within this sample, these 
hippocampal anomalies were also found to be associated with depressive 
symptoms. This suggests that there is a relationship between hippocampal 
anomalies and a susceptibility to developing MDD in individuals with ADHD, 
though further research investigating the mechanisms underlying this co-
occurrence is required.  
Finally, as predicted, children with ADHD endorsed a number of 
depressive symptoms at higher rates than non-ADHD controls. Consistent with 
previous research a higher proportion of children with ADHD than non-ADHD 
controls endorsed depressed mood, irritability, anhedonia, loss of weight and 
appetite, insomnia, psychomotor agitation, fatigue, loss of energy, difficulty 
concentrating and making decisions, depressive cognitions such as blaming 
oneself and feeling bad about oneself and suicidal ideation (Diler et al., 2007; 
ADHD AND MDD IN CHILDHOOD                                                                160 
 
   
Claire I Joseph Deakin University 210667098 
 
LeBlanc & Morin, 2004). This consistency across studies is interesting given the 
varying populations used. Specifically, Diler and LeBlanc utilised clinical 
samples with a large age range, whereas a community-based sample with a 
specific and narrow age range was used in this study. The consistency adds to the 
confidence that MDD symptoms are indeed elevated in children with ADHD and 
consequently, when undertaking assessments, findings suggest that these 
symptoms should be routinely assessed in this population.  
Consistent with previous research on children and adolescents with 
ADHD and MDD, suicidal ideation occurred at a higher rate within the ADHD 
group when compared to the non-ADHD control group (Barkley & Fischer, 2005; 
Biederman et al., 2008; Diler et al., 2007; LeBlanc & Morin, 2004; Monuteaux, 
Faraone, Gross, & Biederman, 2007). Given the young age of participants and 
previous findings which indicated that suicidal ideation in children and 
adolescents with ADHD predicted future MDD and suicide attempts (Barkley & 
Fischer, 2005), this finding is of clinical importance. The importance of this 
finding is also highlighted when considering previous research which has 
indicated that youth with comorbid ADHD and MDD are three times more likely 
to complete suicide than those with either disorder alone (James et al., 2004). 
Findings from this thesis indicate that thoughts about wanting to die begin early in 
the life of children with ADHD and thus should be assessed, addressed and 
monitored from a young age.  
The occurrence of anxiety and externalising disorders was higher in 
children with ADHD and MDD relative to those with ADHD only. Despite mean 
depressive symptoms being highest within the combined ADHD presentation, 
there was no significant differences between groups, suggesting that all ADHD 
presentations are impacted by depressive symptoms. These findings advance the 
field by confirming the importance of considering depressive symptoms in young 
children across all ADHD presentations and highlighting the early impact of 
comorbid disorders in childhood. Findings also suggest that if anxiety or 
externalising disorders are detected in children with ADHD, assessment for 
depressive symptoms is important.  
MDD in childhood tends to be recurrent and impairing (Biederman et al., 
1998). Consequently, early identification of depressive symptoms and accurate 
diagnosis of MDD in children with ADHD is vital for effective prevention and 
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intervention. To our knowledge, study two is the first study to specifically 
examine depressive symptoms in children aged 6 to 8 with and without ADHD 
using the DISC-IV - a gold standard assessment - which aligns with the DSM and 
ICD. It validated previous research which has compared depressive 
symptoms/MDD across children with and without ADHD by confirming that 
comparisons were accurate and that the factor structure of depressive symptoms is 
the same across the two groups. It highlighted the young age at which differences 
in depressive symptoms can be detected in children with ADHD compared to 
controls. This study contributed to the understanding of the presentation of 
depressive symptoms by demonstrating the importance of specific depressive 
symptoms, including suicidal ideation, in children with ADHD. This informs 
assessment processes and facilitates early identification of depressive symptoms 
in children with ADHD.  
10.1.3 Outcomes Associated with Depressive Symptoms in Children 
with and without ADHD.  ADHD and depressive symptoms in childhood are 
common, though a longitudinal examination of the presentation of depressive  
symptoms in children with ADHD has yet to be undertaken. Consequently, study 
three aimed to understand the association between depressive symptoms at age 7 
and depressive symptoms and MDD at age 10. It also aimed to examine the 
association between depressive symptoms at age 7 and functioning at age 10 in 
children with and without ADHD. Depressive symptoms at age 7 were associated 
with depressive symptoms at age 10 in children with and without ADHD. 
Depressive symptoms at age 7 were also associated with MDD at age 10 in 
children with ADHD. Depressed mood, sadness, irritability/grouchiness, 
anhedonia, loss of weight and appetite, increased hunger, insomnia, psychomotor 
agitation, indecisiveness and blaming oneself at age 7 were associated with MDD 
at age 10 in children with ADHD. Depressive symptoms at age 7 were associated 
with poorer functioning across multiple domains in both the ADHD and non-
ADHD control groups.  
Study three is the first longitudinal study to examine the association 
between depressive symptoms and MDD across time in children with ADHD. As 
hypothesised, depressive symptoms at age 7 were positively associated with 
depressive symptoms at age 10 in children with ADHD and non-ADHD controls. 
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Similarly, as hypothesised, depressive symptoms at age 7 were positively 
associated with MDD at age 10 in children with ADHD. This suggests that the 
early presence of depressive symptoms in children with ADHD are not benign 
and rather predict ongoing depressive difficulties over a three year period. Thus 
depressive symptoms should be a central focus of ADHD assessment and 
management.  
The findings are consistent with a previous community-based longitudinal 
study of 9,900 adults which found that individuals who experienced depressive 
symptoms were 4.4 times more likely than those with depressive symptoms to 
develop MDD a year later (Horwath, Johnson, Klerman, & Weissman, 1992) and 
an epidemiological study which indicated that in 776 typically developing 
adolescents subclinical depressive symptoms predicted a two to three fold greater 
risk for MDD in adulthood (Pine, Cohen, Cohen, & Brook, 1999). Furthermore, 
the findings are also consistent with a recent study investigating the naturalistic 
course of depressive symptoms in 804 adults with MDD which suggested that 
across a two year period depressive symptoms were the best predictor of later 
MDD (Dinga et al., 2018). Findings extend this research by demonstrating that 
associations between early and later assessments of depressive symptoms also 
hold in children with ADHD.  
Despite depressive symptoms at age 7 being associated with MDD at age 
10, depressive symptoms only explained 35% of the variance. Although there is 
no research directly investigating factors that may be associated with later MDD 
in children with ADHD, previous research investigating the factors that contribute 
to the development of MDD suggests that female sex, family history of MDD, 
comorbid internalising and externalising disorders, premorbid neuroticism, and 
demoralisation/the impact of impairments may be contributors (Lewinsohn et al., 
2000; Penninx et al., 2011; Scott, Eccleston, & Boys, 1992). Further research is 
needed to examine the role of such factors in predicting the developmental course 
of MDD in children with ADHD.  
Six of the 11 children who experienced MDD at age 7 continued to 
experience MDD at age 10, providing support for previous research suggesting 
that depressive symptoms do not necessarily spontaneously remit (Achenbach et 
al., 1995; Ezpeleta et al., 2001; Kovacs & Paulauskas, 1984; Kovacs et al., 1984a, 
b; Lewinsohn et al., 1994; Luby et al., 1996). It is also interesting to note that 
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some new cases of MDD emerged over time. This finding suggests that in 
children with ADHD clinicians need to be monitoring depressive symptoms over 
time as new cases may develop over time.   
Study three is the first to outline the specific depressive symptoms that are 
associated with MDD 3 years later in children with ADHD. These included 
depressed mood (criterion 1), sadness, irritability/grouchiness, anhedonia, loss of 
weight and appetite, increased hunger, insomnia, psychomotor agitation, blaming 
oneself and indecisiveness. Findings were consistent with Eaton and colleagues 
(1995) who found that feelings of sadness, worthlessness and guilt, sleep 
difficulties and weight loss and gain were associated with MDD in adolescents. 
Given the association of these symptoms with later MDD, it would be worthwhile 
for clinicians to specifically screen for and target the above symptoms in clinical 
practice. As mentioned previously, early intervention approaches are likely 
important in breaking the longitudinal association between early depressive 
symptoms and later depressive symptoms/MDD in children with ADHD. The 
findings from this section of the study, specifically the identification of the 
symptoms associated with later MDD will be used to advocate for early 
intervention approaches to identifying depressive symptoms in children with 
ADHD and will inform how to best intervene to improve depressive symptoms in 
this population.  
The need to consider intervention approaches for depressive symptoms is 
confirmed by the findings that depressive symptoms at age 7 were associated with 
a host of poorer outcomes (quality of life, peer, academic and conduct problems) 
at age 10 in children with ADHD even when considering potential confounding 
variables such as ADHD symptom severity and parent mental health difficulties. 
This finding extends previous research by suggesting that depressive symptoms 
are substantially associated with poor functioning across all four domains.  
Although the mechanisms connecting depressive symptoms to poorer 
functional outcomes are unknown, based on previous research there are several 
possible explanations. The impairments in social functioning (i.e. peer problems 
and prosocial behaviour) may be due to the nature of depressive symptoms such 
as anhedonia and irritability as they, in addition to the core symptoms of ADHD, 
may make withdrawal and/or fights more commonplace. They may also impair 
the child’s ability to cope with the significant social changes experienced during 
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this age (Gifford-Smith & Brownell, 2003; LeBlanc & Morin, 2004; Pellegrini & 
Long, 2002). Although no research has investigated the role of executive 
functioning in social and academic functioning in children with ADHD and 
MDD, previous research has suggested that; children with ADHD have impaired 
executive functioning, children with MDD have impaired executive functioning, 
depressive symptoms impair executive functioning and deficits in executive 
functioning are associated with social and academic abilities (Biederman et al., 
2006; Chandler, 2010; Clark et al., 2002; Diamantopoulou et al., 2007; Riggs, 
Blair, & Greenberg, 2003;  Willcutt et al., 2005a,b). As both disorders are already 
characterised by executive functioning deficits it is possible that the co-
occurrence results in increased deficits in executive functioning which then 
impairs social and academic functioning. Specifically, those with comorbid 
ADHD and MDD may have added difficulty planning possible actions, inhibiting 
inappropriate actions and recalling required information during a social 
interaction making it difficult for children with ADHD and MDD to maintain peer 
relationships. This theory is indirectly supported by several studies, which have 
suggested that deficits in executive functioning are associated with deficits in 
social and academic functioning in typically developing children, children with 
ADHD and children with MDD (Barkley, 1997; Barry, Lyman, & Klinger, 2002; 
Biederman et al., 1996; Hinshaw, 1992; Hinshaw et al., 2002; Kofler et al., 2011; 
Marazziti et al., 2010; Miller & Hinshaw, 2010; Rapport, Scanlan, & Denney, 
1999; Rinsky & Hinshaw, 2011; Uekermann et al., 2010). Further research should 
seek to directly investigate the role executive functioning has in the association 
between depressive symptoms and reduced social and academic functioning in 
children with ADHD.  
Previous research has found an association between conduct problems and 
impulsivity and conduct problems and deficits in the ability to express thoughts 
and feelings (Dodge & Price, 1994; Frick et al., 1991; Kazdin, Siegel, & Bass, 
1992; Sturge, 1982; WebsterStratton & Hammond, 1997). Consequently, the 
association between depressive symptoms at age 7 and conduct problems at age 
10 may be due to children with ADHD’s difficulty with expressing their 
depressive symptoms/how they are feeling and thus their use of behaviours to 
illustrate these feelings. For example, a child may feel sad, not know how to 
express it and so impulsively kicks a child to try communicate to others they are 
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not coping. This finding is also consistent with the cross-sectional results and may 
reflect that children with ADHD and depressive symptoms are a group of children 
with a more severe set of symptoms across both internalising and externalising 
domains. The finding that depressive symptoms at age 7 were associated with 
conduct problems at age 10 in children with ADHD is of clinical significance as 
conduct problems at such a young age tend to predict conduct disorder in 
adolescence (Mannuzza, et al., 2004).  
No previous research has sought to investigate the functional impact of 
depressive symptoms in children with ADHD versus controls. Nevertheless, the 
poorer outcomes observed are consistent with previous research on each disorder 
alone demonstrating that both ADHD and MDD are associated with  poorer 
outcomes compared to those without the disorder (Faraone, Biederman, 
Monuteaux, Doyle, & Seidman, 2001; Herrman, Maj, & Sartorius, 2009; Lépine 
& Briley, 2011; Lynch & Clarke, 2006; Ohan & Johnston, 2007; Rhode et al., 
2013; Richards, 2011; Sciberras, Roos, & Efron, 2009).  
Above the independent contribution that depressive symptoms at age 7 
made to age 10 outcomes has been outlined, however, this research demonstrates 
that a number of other factors, considered as potential confounding variables in 
this study, were independent predictors of outcome for children with ADHD.  
For example, medication use was found to be independently associated with 
higher levels of peer and conduct problems at age 10. This finding is in contrast to 
previous research suggesting that children with ADHD who are taking medication 
feel more accepted by peers and is of interest as previous studies have found 
limited impact of medication on measures of functioning with peers (Frankel, 
Cantwell, Myatt, & Feinberg, 1999; Hoza, 2007). Whilst unclear, it is possible 
that children who are prescribed medication may have been a more impaired 
group to begin with. The higher impairment experienced in those who use 
medication is one of the key reasons underlying the difficulty in establishing 
evidence, within observational designs, for the long-term benefits of medication 
use as the initial impairment distorts any potential differences between medicated 
and non-medication groups over time. Externalising disorders were also 
independently associated with lower levels of prosocial behaviour, which is not 
surprising given that those with externalising disorders are likely to display 
behaviours that are adverse to peers and result in peer rejection likely reducing the 
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desire to act pro-socially (Dodge, Pettit, McClaskey, & Brown, 1986; Patterson, 
DeBaryshe, & Ramsey, 1989). Overall, this study highlights the importance of 
thoroughly assessing for both internalising and externalising comorbidities in 
ADHD.  
With regards to the non-ADHD control group, following adjustments, 
depressive symptoms at age 7 were associated with poorer quality of life, poorer 
prosocial behaviour and more conduct problems at age 10. Consistent with 
previous research on children with MDD, this suggests that depressive symptoms 
in typically developing children also impact quality of life and social and 
behavioural functioning(Angst, Angst, & Stassen, 1999; Briggs-Gowan, Horwitz, 
Schwab-Stone, Leventhal, & Leaf, 2000; Druss & Rosenheck, 1999; Fergusson & 
Woodward, 2002; Garrison et al., 1990; Goldston et al., 1999; Haarasilta, 
Marttunen, Kaprio, & Aro, 2005; Harrington et al., 1990; Kovacs, Goldston, & 
Gatsonis, 1993; Lewinsohn, Holm-Denoma, Small, Seeley, & Joiner, 2008; 
Lewinsohn, Rohde, Seeley, Klein, & Gotlib, 2000; Pfeffer et al., 1993; Saarijärvi, 
Salminen, Toikka, & Raitasalo, 2002; Shaffer et al., 1996; Spitzer et al., 1995). It 
extends findings by demonstrating that even subclinical depressive symptoms, as 
experienced within the non-ADHD control group, impair functioning to some 
extent.  
There was a different pattern seen in caregiver and teacher reported 
outcomes. Specifically, a consistent pattern of relationships between depressive 
symptoms and caregiver reported outcomes was evident whereas the only teacher 
reported outcome associated with depressive symptoms was academic 
functioning. Teachers may be better reporters of academic functioning due to 
their exposure to the child’s academic abilities on a daily basis but may not be 
privy to their peer and conduct behaviours outside of the classroom (Biederman et 
al., 1996; Geller et al., 1994). Teachers may have, by virtue of their profession, 
higher tolerance levels for peer and conduct behaviours/problems. Likewise 
caregivers, due to their child’s young age, ADHD diagnosis and their own 
emotional involvement, may be more alert/hypersensitive to any behaviour that 
may suggest difficulties. Finally, the difference may be methodological in that the 
same caregiver was used at age 7 and age 10 whereas the teacher was different. 
Using different teachers may have meant that they had different frames of 
references/could not accurately judge functioning longitudinally, though 
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consistent with the halo effect the use of the same caregiver for the predictor and 
outcome may have meant that an effect was more likely to be found (DeVries, 
Hartung, & Golden, 2017). This disparity highlights the importance of using child 
report for detecting depressive symptoms and including both caregiver and 
teacher reports on functioning in order to avoid the potential for the halo effect 
and ensure a comprehensive understanding of the cross-setting impact.  
Overall findings suggest that not only do children with ADHD experience 
more depressive symptoms and MDD but as a result of depressive symptoms also 
have peer, conduct and academic difficulties, as well as a reduced quality of life. 
This finding is expected but worrying as children with ADHD are already 
vulnerable to poorer outcomes, and the addition of depressive symptoms 
compounds this vulnerability.  
 
10.2 Study Strengths 
This thesis had a number of strengths. Study one reviewed a large number 
of articles and included 11 diagnostic interviews which to our knowledge is the 
largest systematic review to be conducted on structured diagnostic interviews for 
childhood internalising disorders. Further, the focus on both the clinical utility 
and psychometric quality serves to align research with the scientist practitioner 
model.   
Study two and three represented the first to use a symptom-based 
approach to track depressive symptoms and their impact in a community-based 
sample of 6 and 8 year old children with and without ADHD across 3 years. To 
date, most studies have focused on clinical populations of children with ADHD 
(e.g., Brassett-Harknett & Butler, 2007; Cuffe et al., 2015; Diler et al., 2007) and 
have tended not to use matched controls (e.g., Diler et al., 2007; Chao et al., 2008; 
Lundervold et al., 2016; Yang et al., 2013). Increasing confidence in the 
generalisability of results were the increased efforts that were made to ensure that 
the sample adequately represented the vast sociodemographic within Victoria, 
Australia, the inclusion of females within the sample (n = 38, 30% ADHD; n = 
55, 40%) and the inclusion of all ADHD presentations. Previous studies tended to 
have small sample sizes of children with ADHD ranging from 12 to 120 
participants. In contrast, this thesis had a larger sample size (n = 179), increasing 
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confidence in the generalisability of results. Contrasting previous studies that 
have tended to utilise a large age range, this study recruited children within a 
small age range thereby enabling documentation of the presence and impact of 
depressive symptoms within this specific developmental stage.  
A key strength and a notable improvement from previous research is the 
use of a longitudinal design. To date much of the research examining ADHD and 
MDD has been cross-sectional, which has limited the ability to track symptoms 
and outcomes across time. The use of a longitudinal design in this study enabled 
the tracking of depressive symptoms and functioning across a three year period. 
This permitted an understanding of the persistence, emergence and improvement 
of MDD over time. The design also enabled a detailed examination of how 
depressive symptoms early in life predict a host of outcomes three years later.  
A further strength of this thesis was the use of a structured diagnostic 
interview to assess ADHD, depressive symptoms and other comorbidities. 
Utilising the DISC-IV meant that symptoms could be examined from both a 
diagnostic level and symptom-based level. This contrasts previous studies that 
have focused on diagnostic confirmation as opposed to symptom investigation 
and utilised screening measures as opposed to robust structured diagnostic 
interviews. Adding to this strength was the use of completely blinded interviewers 
at both time points, which ensured that no interviewer bias could be introduced 
whilst also improving the robustness of the assessment process.   
 
10.3 Study Limitations 
While the findings of this thesis add valuable knowledge to area of 
comorbid ADHD and MDD, several limitations need to be considered. The main 
limitation of the systematic review was the inability to accurately calculate the 
psychometrics of diagnostic interviews due to substantial heterogeneity (e.g., 
different age groups used, time elapsed between test-retest reliability studies, 
different statistical methods) across studies and between structured diagnostic 
interviews as these differences are likely to have distorted the ranges of 
psychometric results obtained (Cohen, O'Connor, Lewis, Velez, & Malachowski, 
1987). A further limitation was the focus on internalising disorders as opposed to 
MDD specifically, as this has limited the transferability of findings with regards 
to application to specific disorders. However, the choice to broaden the focus 
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from MDD to internalising disorders was made to account for the manner in 
which the disorders were conceptualised and assessed within research. For 
example, some studies combined depressive and anxiety disorders into 
internalising disorders, others separated them to represent each depressive and 
anxiety related disorder that is present in the DSM. Future research should seek to 
increase specificity of findings by focusing on specific disorders.  
Study two and three have a number of limitations. Firstly, although the 
sample size was large, the number of children with depressive 
symptoms/experiencing MDD was low. Consequently, subgroup analyses should 
be interpreted with caution. The low number of children with MDD also meant 
that confidence intervals tended to be quite large. However, it is important to note 
that the low prevalence of MDD at this age is to be expected. For example, 
research suggests that the prevalence of MDD for children under the age of 11 is 
approximately 1% (Cohen et al., 1993; Lawrence et al., 2015; Nolan, Gadow, & 
Sprafkin, 2001). Nevertheless, future research would benefit from the inclusion of 
a larger sample of children with and without ADHD who experience MDD. This 
would allow for consideration of confounding variables which was not able to be 
included in many of the analyses due to the low number of children with MDD. 
Delineating how these variables impact the occurrence, presentation and long 
term outcomes of depressive symptoms will assist with determining which factors 
should be targeted in prevention and treatment. This could be achieved by 
actively seeking to recruit those with comorbid ADHD and MDD. Similarly, due 
to the sample size, the functional outcomes by MDD status could not be 
compared and thus a dimensional consideration of how depressive symptoms are 
associated with functioning was undertaken.  
Previous research has suggested that ADHD persists in approximately 60 
to 80% of cases (Biederman et al., 1996; Karam et al., 2015; Kessler et al., 2005). 
This is consistent with the present findings which have indicated that 
approximately 40% of the current sample spontaneously recovered from ADHD. 
These findings extend previous research by indicating that the pattern of 
persistence is evident even in young children with the disorder. Although the 
spontaneous recovery from ADHD is believed to be a true artefact given the 
consistency with previous research, it is possible that measurement error may play 
a role. Furthermore, it is possible that the recovery may be due to treatments that 
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the children may have been receiving for ADHD. Future research would benefit 
from investigating this further. As outcomes were assessed across time a further 
limitation of study three was the attrition of the sample (32% of the sample at age 
7 did not participate at age 10). Whilst this attrition rate is relatively high, it was 
considered reasonable and is similar to other prominent longitudinal studies 
within the ADHD field whose attrition rates have varied between 22% and 49% 
(Hartsough et al., 1996; Hechtman & Weiss, 1984; Klein, 1989; Loney, Whaley-
Klahn, Kosier, & Conboy, 1983; Mannuzza, Klein, Bessler, Malloy & LaPadula, 
1993; Weiss & Hechtman, 1986). Researchers have suggested that this attrition 
rate is largely due to the characteristics of the population (de Graaf, van 
Dorsselaer, Tuithof, & ten Have, 2013). Further, as previously mentioned a 
number of steps were put into place in order to reduce and address attrition 
including a rigorous follow up protocol, regular communication with participants, 
as well as the option of reducing the load on participants by giving them an option 
of only completing the critical times. Although the attrition rate is consistent with 
previous research and whilst there were no significant differences between those 
with complete and incomplete data, it is unclear whether the results generalise to 
the 32% that chose not to participate at age 10. To address this and assist with 
increasing participation rates, future research should aim to reduce the time 
involved across the assessment process. Although all attempts to reduce missing 
data, including checking questionnaires and contacting participants, were made, 
there was a large number of participants with incomplete data. Whilst this was 
beyond the scope of this clinical thesis, future research could address these 
limitations via the use of multiple imputation.  
Whilst caregiver and teacher report were utilised, both studies lacked child 
report of symptoms and outcomes. Research suggests that best practice 
assessment of MDD in children, due to the internalising nature of the disorder, 
should include child report (Birmaher, Brent, & AACAP Work Group on Quality 
Issues, 2007; Luby et al., 2004). Utilising all three respondents would have 
ensured accurate understanding from all perspectives as well as providing 
information about the child’s lived experience (Birmaher et al., 2007; Daviss et 
al., 2006; Diler et al., 2007; Jensen et a., 1999). Consequently, future research 
should seek to replicate findings with child report as well in order to ensure a 
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comprehensive understanding of the situation and difficulty from all involved. 
This will also help avoid any potential impact from the halo effect. 
Whilst the DISC is one of the most widely utilised diagnostic interviews, 
can be applied cross culturally and has the second highest inter-rater reliability 
with regards to childhood internalising disorders, studies investigating the DISC’s 
psychometric properties suggest that the test-retest reliability and validity is as 
low as 0.50. Although there are other measures that possess higher test-retest 
reliability or validity, the psychometrics tend to be inconsistent. Consequently, 
standardised investigation into the psychometrics of structured diagnostic 
interviews in comparison to one another is required in order to better inform the 
choice of diagnostic tool to utilise in the future.  
In study two, depressive symptoms were higher in children with ADHD 
and an anxiety disorder when compared to children with ADHD only. 
Consequently, it is possible that the presence of anxiety disorders accounted for 
and were driving the ongoing depressive symptoms and impaired functioning. 
Given the high co-occurrence of depressive and anxiety disorders in children with 
ADHD, future research should seek to delineate the impact of anxiety disorders 
on the presentation of depressive symptoms in children with ADHD.  
Whilst the symptom specific findings serve to extend the research base 
with regards to the specific symptom presentation, due to the significant overlap 
in diagnostic criteria for ADHD and MDD, it is difficult to determine whether the 
symptom presentations were due to ADHD, MDD or their co-occurrence. Further, 
as the structured diagnostic interview directly aligns with diagnostic criteria, 
symptoms were only enquired about through one item each. Consequently, 
although the use of a diagnostic interview was a strength as it ensured only the 
depressive symptoms that are required for a diagnosis of MDD were enquired 
about, findings relied heavily on the interpretation of the question. For example, 
the child may be experiencing anhedonia and so stops finding pleasure in school 
activities but still finds pleasure in family activities. The specific question “does 
your child seem to not experience pleasure in activities previously found 
pleasurable” would be answered no despite some anhedonia being present. 
Assigning more questions to each diagnostic criterion, asked in a different 
manner, may assist with ensuring symptoms are detected but the limitation of this 
would be making an already lengthy interview, longer. Finally, given the 
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categorical nature of the DISC-IV it is possible that children may have just missed 
out on the diagnosis of MDD at each time point. Consequently, use of a structured 
diagnostic interview such as the DISC-IV alongside a dimensional measure that 
asks multiple questions per symptom domain will assist with ensuring a reliable 
measurement of the presence of depressive symptoms is achieved.  
 
10.4 Future Research Suggestions 
Structured diagnostic interviews have many benefits and are, with 
increased understanding of childhood internalising disorders, improving. Even 
though effectively and comprehensively assessing childhood internalising 
disorders depends on adequate assessment tools, there is a lack of extensive and 
systematic investigation into the psychometric properties of these diagnostic 
interviews, both individual and comparatively. Consequently, research directly 
comparing each instrument’s psychometric qualities to one another is required. 
This research should first focus on developing a standardised manner in which to 
research and evaluate structured diagnostic interviews. 
As study two and three have comprehensively mapped out depressive 
symptoms in early childhood, the next step is to extend this to adolescents and 
adults with ADHD. Whilst findings suggest that depressive symptoms emerge 
from a young age and are predictive of later MDD and depressive symptoms, this 
research is limited to a specific age band. Consequently, understanding whether 
these findings continue across other developmental periods would be worthwhile. 
Determining whether these findings hold across the lifespan will aid in 
understanding the clinical presentation of comorbid ADHD and MDD whilst also 
assisting with determining the ongoing risk.  
This thesis demonstrated that the presentation of MDD in children aged 6 
to 8 years with and without ADHD is unidimensional. Future research would 
benefit from applying the Rasch Model to analyses as it models responses at an 
item level and overcomes the inherent weaknesses in classical test theory by 
converting ordinal data into continuous interval measures meaning an objective 
measurement from ordered category responses can be obtained (Barker, Donovan, 
Schubert, & Walker, 2017).  
As previously mentioned, study three was limited to assessment of MDD 
at only two time points. Future research should continue to assess MDD 
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symptoms in children with ADHD so that the trajectory of MDD symptoms can 
be more reliably assessed from early primary school into adolescence. This would 
facilitate examination of the reciprocal longitudinal relationship between 
depressive symptoms and ADHD.  
This thesis addressed the assessment aspect of depressive symptoms in 
children with ADHD and demonstrated that depressive symptoms are elevated in 
young children with ADHD. Thus another crucial step in research is determining 
how best to improve depressive symptoms in children with ADHD. To extend on 
this research it would be useful to examine whether current treatment options 
(e.g., CBT and interpersonal therapy) for children with MDD are effective in 
treating depressive symptoms in children with ADHD and whether these 
interventions have any flow on benefits for functional outcomes. This research 
should seek to identify which are the key factors that should be targeted; should 
depressive symptoms be addressed first or second, do active treatments for 
ADHD assist in comorbid symptoms and are behavioural interventions more 
useful? A recent paper by Sciberras and colleagues (2018) investigating the 
treatment of anxiety symptoms in children with ADHD provides a potential 
framework for research into the treatment of depressive symptoms in children 
with ADHD. It points to the success of an adapted version of the Cool Kids CBT 
program for treating anxiety symptoms and improving functioning in children 
with ADHD. Consequently, future research should seek to investigate how this 
program applies to children with comorbid ADHD and MDD. To assist with 
developing targeted interventions, future research should also seek to identify the 
mechanisms by which depressive symptoms contribute to poorer functioning.  
 
10.5 Implications 
The systematic review builds upon the expanding literature on structured 
diagnostic interviews by compiling information together and presenting it in an 
easy to read format thereby allowing clinicians and researchers to make quick 
reference to it and choose their desired instrument accordingly. The systematic 
review highlights the two measures which appear to show the most promise, the 
DISC and MINI-KID, and provides recommendations for further expansion 
within this field. It also provided evidence for the clinical utility of measures such 
as the ChIPS and MINI-KID, which require less training, less administration time 
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and encourage clinical input. They also offer relatively good psychometric 
properties. Consequently, the ChIPS and MINI-KID may offer an opportunity to 
embed diagnostic interviews into clinical practice.  
With more than 1,000 unique symptom combinations that qualify for a 
diagnosis of MDD, determining whether children with ADHD experience the 
same pattern of symptoms as those without and thus whether current measures are 
applicable to children with ADHD was an important first step in understanding 
the presentation of MDD in children with ADHD. This finding provides support 
for the comparison of symptoms across samples, which is a critical step forward 
as it validates the comparison of depressive symptoms across samples. Finally, it 
also indicates that differences in the presentation of symptoms are due to true 
differences rather than measurement error.  
Study two offers the first community-based study to determine that 
depressive symptoms emerge in young childhood and are present in children with 
ADHD as young as 6 years of age. The determination that a number of children 
with ADHD experience depressive symptoms but do not meet full criteria 
provides clinicians and researchers with an understanding that examination from a 
symptom level rather than diagnostic level may be more useful for children. Study 
two also serves to highlight the importance of acknowledging, assessing and 
monitoring for depressive symptoms in children with ADHD from a young age. It 
highlights that within clinical practice clinicians should pay attention to the 
presence or absence of depressive symptoms in children with ADHD.  
  Whilst previous research has highlighted the relatively ongoing nature of 
depressive symptoms in adolescents and adults (Orvaschel, Lewinsohn, & Seeley, 
1995), this study provides the first evidence of the clinical significance of 
depressive symptoms in young children with ADHD across time. Specifically, the 
association between early depressive symptoms and later depressive symptoms 
and MDD is clinically important, particularly as research has demonstrated that if 
not treated persistent depressive symptoms negatively impact brain functioning 
and structure (Sheline et al., 1999). Consequently, identifying early depressive 
symptoms that were associated with later MDD diagnosis, as this research has 
done, facilitates accurate screening and targeted interventions. This will then 
assist with reducing the impact of co-occurring ADHD and MDD before a 
chronic course is established.  
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The findings that depressive symptoms exacerbate and are associated with 
a host of impairments across time in children with ADHD indicates the need to 
identify depressive symptoms as early as possible. It suggests that the assessment 
of depressive symptoms and diagnosis of MDD may be an important prognostic 
indicator for clinicians. It highlights the importance of intervention as soon as 
depressive symptoms present in children with ADHD and suggests that managing 
depressive symptoms may be one way of improving the broader functioning of 
children with ADHD and preventing further impairments.   
These studies through their examination of specific symptoms have 
enabled specific examination of depressive symptoms which enhances clinical 
interpretability of the comorbidity between ADHD and MDD. Establishing the 
symptoms that are most common, and thus which symptoms to screen for, 
reduces the burden associated with the large number of symptom combinations 
possible and has provided clinicians with some screening clarity. Specifically, 
these findings assist in alerting clinicians to the importance of screening for 
depressive symptoms even in young children, highlighting the symptoms that 
should be screened for, whilst also emphasising the need to intervene even if only 
subclinical symptoms of MDD are present in children. 
 
10.6 Conclusion 
This thesis found that the DISC represents among the most sound 
structured diagnostic interviews for assessment of childhood internalising 
disorders. This study confirmed that the measurement of MDD is similar in 
children with and without ADHD. This meant that observed differences between 
children with and without ADHD in terms of depressive symptoms were not due 
to group specific measurement effects but rather were due to true group 
differences with regards to how depressive symptoms present. This thesis has 
highlighted the importance of considering, assessing and monitoring for both 
depressive symptoms, and MDD in young children with ADHD. Findings suggest 
that, if systematically assessed, depressive symptoms are identifiable by early 
primary school age and occur at substantially higher levels in children with 
ADHD compared to non-ADHD controls, indicating that MDD is a key 
comorbidity in children with ADHD. This study also found that depressive 
symptoms at age 7 are predictive of later depressive symptoms and MDD at age 
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10 in children with ADHD. It also identified the depressive symptoms that may 
be of particular importance in children with ADHD thereby ensuring that 
symptoms do not go undetected in children with ADHD. This identification of 
depressive symptoms thus has the potential to assist with preventing MDD in 
children with ADHD via early identification and treatment. This thesis also 
demonstrated that depressive symptoms in children with ADHD are associated 
with poorer functioning across all domains and suggests that the assessment, 
diagnosis and treatment of depressive symptoms, where appropriate, may be one 
avenue for improving the long term prognosis of children with ADHD. 
Consequently, identifying these symptoms and implementing targeted treatment 
is important, particularly given the prevalence and burden of depressive 
symptoms on children with ADHD.  However, future research is required to 
determine how best to treat depressive symptoms in children with ADHD as 
currently this is not known. The present studies overcome the limitations of 
previous research in this field through the incorporation of a longitudinal 
assessment, community-based sample, confirmation of diagnosis and robust 
assessment measures as well as a focus on the symptom level. Future research 
would benefit from utilising a symptom-based approach to investigating whether 
these findings hold across older ages. 
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Appendix A: Article Published in the European Child and Adolescent 
Psychiatry   
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Appendix D: Baseline Age 7 and Follow up Age 10 CAP Caregiver 
Questionnaire 
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Appendix F: Conners 3 ADHD Index Caregiver 
Here are some things parents might say about their children. Please tell us about 
your child and what he/she has been like in the past 4 WEEKS. Read each item 
carefully, then mark how well it describes your child or how frequently it has 
happened in the past 4 WEEKS. Please select only one answer for each item. It is 
important to respond to every item. For items that you find difficult to answer, 
please give your best guess. 
In the past 4 WEEKS, this was … 
 
(Please tick one box on each line) 
Not true 





















a. Fidgeting.      
b. Does not seem to listen to 
what is being said to 
him/her.  
    
c. Doesn’t pay attention to 
details; makes careless 
mistakes.  
    
d. Inattentive, easily 
distracted.  
    
e. Has trouble organizing tasks 
or activities.  
    
f. Gives up easily on difficult 
tasks.  
    
g. Fidgets or squirms in seat.      
h. Restless or overactive.      
i. Is easily distracted by sights 
or sounds.  
    
j. Interrupts others (for 
example, butts into 
conversations or games).  
    
  
ADHD AND MDD IN CHILDHOOD                                                                312 
 
   
Claire I Joseph Deakin University 210667098 
 
Appendix G: Conners 3 ADHD Index Teacher 
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Appendix H: Outcome Measures SDQ – Full Scale 
For each item, please select the box for Not True, Somewhat True or Certainly 
True. It would help us if you answered all items as best you can even if you are 
not absolutely certain. Please give your answers on the basis of the child’s 
behaviour over the past 6 MONTHS 




1. Considerate of other people’s feelings Prosocial    
2. Restless, overactive, cannot stay still for long    
3. Often complains of headaches, stomach-aches or 
sickness 
   
4. Shares readily with other young people, for 
example CDs, games, food Prosocial 
   
5. Often loses temper Conduct    
6. Would rather be alone than with other young 
people Peer 
   
7. Generally well behaved, usually does what 
adults request Conduct 
   
8. Many worries or often seems worried    
9. Helpful if someone is hurt, upset or feeling ill 
Prosocial 
   
10. Constantly fidgeting or squirming    
11. Has at least one good friend Peer    
12. Often fights with other young people or bullies 
them  Conduct 
   
13. Often unhappy, depressed or tearful     
14. Generally liked by other young people  Peer    
15. Easily distracted, concentration wanders     
16. Nervous in new situations, easily loses 
confidence  
   
17. Kind to younger children  Prosocial    
18. Often lies or cheats  Conduct    
19. Picked on or bullied by other young people  
Peer 
   
20. Often volunteers to help others (parents, 
teachers, children)  Prosocial 
   
21. Thinks things out before acting     
22. Steals from home, school or elsewhere Conduct    
23. Gets along better with adults than with other 
young people Peer 
   
24. Many fears, easily scared    
25. Good attention span, sees chores or homework 
through to the end  
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Peer problems  




1. Rather solitary, prefers to play alone    
2. Has at least one good friend    
3. Generally liked by other children    
4. Picked on or bullied by other children    
5. Gets along better with adults than with other 
children 
   
 
Prosocial  




1. Considerate of other people’s feelings     
2. Shares readily with other children, for example 
toys, treats, pencils 
   
3. Helpful if someone is hurt, upset or feeling ill    
4. Kind to younger children    
5. Often volunteers to help others (parents, 
teachers, other children) 
   
 
Conduct Problems 




1. Often loses temper    
2. Generally well behaved, usually does what 
adults request 
   
3. Often fights with other children or bullies them    
4. Often lies or cheats    
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Appendix I: Outcome Measures SSIS Academic Competence 
Please assess this student’s academic or learning behaviours in your classroom. 
Compare this student with other students in the same classroom. Mark all items 
using a scale of 1 to 5. Mark “1” if this student is in the lowest 10% of the class.  
Mark “5” if this student is in the highest 10% of the class. 
 














1. Compared with other 
students in my classroom, 
the overall academic 
performance of this student 
is:  
     
2. In reading, how does this 
student compare with other 
students?  
     
3. In mathematics, how does 
this student compare with 
other students?  
     
4. In terms of grade-level 
expectations, this student’s 
skills in reading are:  
     
5. In terms of grade-level 
expectations, this student’s 
skills in mathematics are: 
     
6. This student’s overall 
motivation to succeed 
academically is: 
     
7. Compared with other 
students in my classroom, 
this student’s intellectual 
functioning is:  
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Appendix J: Outcome Measures (PedsQL) – Short Form 
 
For the following list, please tell us how much of a problem each one has been for 
your child in the past 4 WEEKS. 
Physical Functioning (problems 
with….) 







a. Walking more than one block       
b. Running       
c. Participating in sports activity 
or exercise  
     
d. Lifting something heavy       
e. Doing chores around the 
house  
     
 
Emotional Functioning (problems 
with….) 







f. Feeling afraid or scared      
g. Feeling sad or blue       
h. Feeling angry       
i. Worrying what will happen 
to him or her  
     
    
Social Functioning (problems 
with….) 







j. Getting along with other 
children  
     
k. Other kids not wanting to be 
his or her friend  
     
l. Getting teased by other 
children  
     
 
School Functioning (problems 
with….) 







m. Paying attention in class       
n. Forgetting things       
o. Keeping up with schoolwork       
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Appendix K: Baseline Age 7 Caregiver Plain Language Statement  
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Appendix L: Baseline Age 7 Caregiver Consent Form 
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Appendix N: Baseline Age 7 Teacher Consent Form 
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Appendix O: Follow up Age 10 Plain Language Statement  
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Appendix P: Follow up Age 10 Caregiver Consent Form  
At follow up only caregivers were required to complete a consent form. Once 
caregivers consented to the teacher survey the respective teachers were sent the 
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Appendix Q: Analyses excluding outlier 1764 
 
Assumption analyses indicated that there was a potential outlier within the 
ADHD. Consequently, all analyses on the ADHD group were re-run without this 
case. Results remained significant.  
 
Are depressive symptoms at age 7 associated with depressive 
symptoms at age 10 within the ADHD group?  
After the removal of the outlier, results continued to indicate that within 
the ADHD group, the presence of depressive symptoms at age 7 was significantly 
associated with the presence of depressive symptoms at age 10 F(1, 125) =26.02, 
p < .001) with an Adjusted R² of 0.17. Results which controlled for the 
heteroscedasticity that was present were similar, F(1,125)=18.68, p < .001) with 
an R² of 0.17.  Both the results indicated that the presence of depressive 
symptoms at age 7 explained 17% of the variance in depressive symptoms at age 
10. It also indicated that for each 1 point increase in depressive symptoms at age 
7, there was a 0.51 increase in the chances of depressive symptoms at age 10.  
 
Are depressive symptoms at age 7 associated with MDD at age 10 
within the ADHD group? 
As seen in Table 20, with the outlier removed, a 1 unit increase in 
depressive symptoms at age 7 was related to 1.35 increase in the odds of 
experiencing MDD at age 10.  
 
Table 20.  
Association between Depressive Symptoms at Age 7 with MDD at age 10 in 
Children with ADHD 
 OR 95% CI p 
Unadjusted 1.35 1.16 to 1.57 < .001 
Adjusted (robust) 1.35 1.17 to 1.56 < .001 
 
